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General introduction and 





Atrioventricular septal defect (AVSD) covers a spectrum of heart anomalies with a common 
atrioventricular junction. AVSD comprises 7% of all congenital heart diseases (CHD) and is often 
associated with Down syndrome [1;2]. The nomenclature used to subdivide AVSD based on the 
variability in the defect in the septal tissue around the atrioventricular valves is not consistently 
used in literature, potentially hampering comparison of results reported between different cen-
ters. Currently, the diagnosis of AVSD is usually made prenatelly and can in specialized centers 
be made during early pregnancy [3]. Surgical correction of an AVSD is usually performed in early 
life to prevent longstanding pulmonary overflow [4]. Survival after correction is excellent in the 
current era. However re-operation frequency is relatively high due to regurgitation of the left 
atrioventricular valve (LAVV) [5]. The optimal timing for reoperation is still unclear [6]. 
Knowledge regarding development of CHD has markedly increased in the last decades [7]. 
Multiple genetic [8;9] and epigenetic [10] factors have been associated with AVSD development, 
but the exact pathogenesis is not completely unraveled. Evaluation of the cardiac morphology 
in the developing human fetus is restricted due to the limited availability of human embryonic 
and fetal material. Literature describes differences in morphology of AVSD between patients 
with Down syndrome and non-syndromic patients [11;12] and cardiac anomalies have been 
suggested in patients with Down syndrome without overt septal defects [13]. Blood flow 
through the heart has been marked as an essential factor for proper cardiogenesis [14]. Recently, 
high frequency ultrasound became available to analyze blood flow during the early stages of 
heart development in mouse embryos [15]. This allows the evaluation of the influence of blood 
flow during heart development.
Also after birth, in children and adults with (congenital and acquired) heart disease, intra-
cardiac blood flow plays an important role in cardiac remodeling [16] and can be evaluated with 
echocardiography and MRI. Data on cardiac function long-term after AVSD correction is scarce. 
As the LAVV after AVSD correction has an aberrant morphology, intra-cardiac blood flow might 
be affected in these patients, possibly resulting in less efficient flow. Furthermore, quantification 
of LAVV regurgitation showed to be challenging with echocardiography in patients after AVSD 
correction [17]. 4-dimensional velocity-encoded cardiac magnetic resonance imaging (4DFlow 
MRI) allows direct quantification of intra-cardiac blood flow [18]. Moreover, newly available ap-
plications to visualize blood flow, such as streamlines [19] and particle tracing [20] and analysis 
of vortex formation [21;22] potentially provide further insight into intra-cardiac blood flow 
pathways in healthy hearts and those with CHD. 
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AIm
The first aim of this thesis was to review current knowledge, as well as current unclarities re-
garding the development, morphology, diagnosis and treatment of AVSD (Part 1). The second 
aim was to study the pathology of AVSD in human and rodents, using microscopic analysis, 
gene expression patterns, electrophysiological studies including optical mapping as well as 
high frequency ultrasound measurements in developing hearts (Part 2). Finally, cardiac func-
tion long-term after AVSD correction was analysed with special emphasis on intra-cardiac flow 
patterns with the use of 4DFlow MRI in corrected AVSD patients and healthy controls. (Part 3). 
ouTLINE oF THE THESIS
In Part 1, Chapter 1.2 the available literature regarding developmental aspects, involved 
genetic and epigenetic factors, nomenclature, anatomy, diagnosis, surgical techniques and 
outcome of AVSD is summarized. In this bench to bedside review special consideration is given 
to differences between non-syndromic AVSD and AVSD in patients with Down syndrome.
Subsequently, in Part 2 of this thesis the developmental aspects of AVSD are further investi-
gated. In Chapter 2.1 the membranous septum and atrioventricular valves, that are aberrantly 
evolved in AVSD hearts, are studied in depth in patients with Down syndrome without an AVSD, 
as literature suggests that abnormalities are also present in this patient group. In Chapter 2.2 
the possibilities and limitations of fetal echocardiography to detect CHD in the first trimester in 
human are examined and correlated with morphology in fetal human specimens. Fetal echocar-
diography in mice allows analyses of intra-cardiac flow during heart development. In Chapter 
2.3 reference values of high frequency fetal echocardiography in subsequent developmental 
stages of wild type mouse embryos are provided and discussed. This technique is combined 
with optical mapping, immunohistochemical analysis and qPCR in Chapter 2.4, to analyze heart 
development in a mouse model with a mutation in the Vascular Endothelial Growth Factor gene, 
which in human is associated with AVSD and Tetralogy of Fallot. In this chapter special attention 
is given to the inflow tract of the heart, including the sinoatrial node. 
In Part 3 of this thesis, long-term follow-up data of corrected AVSD patients is provided. 
In Chapter 3.1 an overview of the clinical use of 4DFlow MRI is given and novel blood flow 
visualization applications are discussed. In Chapter 3.2 streamline visualization is used to opti-
mize left ventricular inflow quantification and differences in inflow direction between healthy 
controls and corrected AVSD patients are analysed. The difference in intra-ventricular blood 
flow between patients and controls is further investigated with the use of particle tracing in 
Chapter 3.3. In Chapter 3.4 a novel MRI method to assess velocity propagation, a parameter 
used to analyze diastolic function, is described. In Chapter 3.5, a previously published method 
to analyse three-dimensional quantitative vortex core formation in the left ventricle [22] is ap-
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1.1plied in corrected AVSD patients to study the impact of the abnormal LAVV and the lateral inflow 
direction on vortex formation. In Chapter 3.6 4DFlow MRI with retrospective valve tracking and 
streamline evaluation is used to characterize and directly quantify regurgitation of the LAVV in 
corrected AVSD patients. In Chapter 3.7 the blood flow in the left atrium in patients with LAVV 
regurgitation after AVSD correction is described with the use of streamlines, vortex extraction, 
particle tracing and quantification of pulmonary vein flow. 
Part 4 summarizes the key findings of this thesis and discusses future perspectives.
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CMR  Cardiovascular magnetic resonance
CX  Connexin
DS  Down syndrome
EF%  Ejection fraction
E-peak  Early diastolic filling peak
LA  Left atrium
LAVV  Left atrioventricular valve
LV  Left ventricle
MRI  Magnetic resonance imaging
SAN  Sinoatrial node
VEGF  Vascular endothelial growth factor
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ABSTRACT
Atrioventricular septal defect (AVSD) covers a spectrum of heart anomalies with a common 
atrioventricular connection and has an incidence of 4–5.3 per 10.000 live births. About half of 
the AVSDs occur in patients with Down syndrome. This review provides a bench to bedside 
overview of AVSD. Developmental aspects, nomenclature, anatomy, and classification of AVSD 
are discussed. Furthermore an overview of genetic and maternal risk factors for AVSD is provided, 
and available literature on (fetal) diagnosis, surgical techniques and follow-up is presented. 
Special attention is given to differences in developmental, anatomical and prognostic factors of 




The term atrioventricular septal defect (AVSD) covers a spectrum of heart anomalies with a 
common atrioventricular (AV) junction [1]. With an incidence of 4–5.3 per 10.000 live births, 
AVSD comprises 7% of all congenital heart diseases (CHD) and is often associated with Down 
syndrome [2–5]. Despite intensive investigation, the morphogenesis of AVSD is still not fully 
understood. Furthermore controversy remains in nomenclature and long-term follow-up data 
are scarce. Recent developments in knowledge on heart development provide new insights in 
(epi)genetic factors in AVSD development. 
The aim of the current review is to give a complete bench to bedside overview, from em-
bryonic development to clinical aspects of AVSD. Special attention is given to the difference 
between non-syndromic and syndromic, in particular Down syndrome, patients.
NomENCLATuRE AND TyPES oF AVSD 
An overview of nomenclature is presented in Figure 1. Controversies exist on nomenclature 
and subdivision of the varying morphology of AVSDs, and several different descriptions are cur-
rently used. The terms ‘atrioventricular canal defect’ and ‘endocardial cushion defect’ are used as 
synonyms for AVSD. 
In this review we will use the classification as agreed upon by the International Paediatric and 
Congenital Cardiac Code (www.IPCCC.net) [6, 7]. Complete AVSD according to the IPCCC includes 
an ostium primum defect of the atrial septum and a non-restrictive defect in the inlet portion 
of the ventricular septum, with one AV annulus and a common AV valve. The common AV valve 
classically is composed of two (a superior and an inferior) leaflets bridging across the ventricular 
septum, as well as a left lateral (mural) leaflet, a right antero-superior and a right inferior leaflet 
(Figure 1). In complete AVSD shunting takes place at both the atrial and ventricular level. In an 
AVSD with an isolated atrial component (also known as ASD primum, ostium primum defect or 
partial AVSD) the bridging leaflets are attached to the ventricular septum. Although there is one 
annulus, the attachment of the bridging leaflets to the ventricular septum results in two orifices 
and shunting can take place only above this level, at the atrial level (Figure 1). Less common is 
an AVSD with an isolated ventricular component (also known as partial AVSD), where the partially 
fused bridging leaflets are attached to the atrial septum and shunting is just at the ventricular 
level. This type of AVSD is in the clinical setting mostly referred to an inlet VSD (Figure 1). Fourthly, 
the IPCCC defines an intermediate (or transitional) AVSD with an ostium primum defect and a 
(often restrictive) VSD just below the AV valves, but with two remaining separate AV orifices 
due to fusion of the bridging leaflets (Figure 1). Of note, some authors distinguish between a 
transitional AVSD, being an AVSD with two annuli and an inlet VSD and an intermediate AVSD, 
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being an AVSD with 1 annuli and 2 orifices [8]. This difference is not acknowledged by the IPCCC 
that equally classifies the 2 forms. We support the latter, as we do not consider AVSD to have 2 
annuli, but rather a common annulus and a common AV valve that can have 2 orifices in case 
of attachment of the valve to either the ventricular (most common) or atrial septum. Fifth, the 
IPCCC describes an AVSD with ventricular imbalance, with an unequal position of the common 
AV valve above the (unbalanced) ventricles with a variable degree of ventricular hypoplasia. The 
imbalance may occur in the setting of either a complete, partial or intermediate/transitional 
AVSD. 
Another defect at the level of the AV septum is the so-called Gerbode defect. This malfor-
mation is on the spectrum between an AVSD and a membranous VSD being a defect in the 
membranous part of the AV septum allowing shunting between the left ventricle (LV) and right 
atrium (RA). According to Gerbode [8] shunting can take place either directly (supra-annular) 
through the membranous septum or indirect (infra-annular) via a perimembranous VSD and a 
defect in the tricuspid valve. In the IPCCC the Gerbode defect is classified as a subtype of VSD [9], 
however as the defect is present in the AV septum one could also argue that the anomaly could 
be designated a form of AVSD. 
The Rastelli classification, originally described in 1966 [10], subdivides complete AVSD based 
on the anatomy of the superior (anterior) common/bridging leaflet. A completely split leaflet 
(i.e., the superior bridging leaflet is divided), with the superior bridging leaflet almost completely 
adherent to the left ventricle and firmly attached on the ventricular septum by multiple chordal 
insertions is designated as Rastelli type A. Type A is the most frequently found [11]. A divided 
(split) superior leaflet, with the superior bridging leaflet attached over the ventricular septum by 
an anomalous papillary muscle of the right ventricle is designated Rastelli type B. Rastelli type 
C indicates a large, non-divided, superior leaflet without chordal attachment to the interven-
tricular septum, also known as the ‘free floating’. Type C is often seen in association with other 
cardiac defects [12]. From classes A to C ventricular shunting increases. The Rastelli classification 
was originally designed to predict the outcome of surgery. However, due to the lack of corre-
spondence between the classification and surgical outcome and enormous variability in leaflets 
[13,14], the use of the Rastelli classification is currently largely omitted in literature. 
A mitral cleft in an otherwise normal mitral valve (isolated mitral cleft) should not be considered 
the same as the ‘cleft’ in the left part of the common AV valve in AVSD. An isolated cleft is a cleft 
in the aortic (anterior) mitral leaflet, whereas a ‘cleft’ in the setting of AVSD is a gap between the 
superior and inferior bridging leaflets, clearly distinguishing the anatomy of the left AV valve in 
AVSD from a normal mitral valve anatomy [15–17]. Although anatomically features are different 
from the cleft in AVSD, an isolated mitral cleft is frequently seen in families with AVSD and, like 
AVSD, is associated with Down syndrome [18], therefore a developmental relationship between 
an isolated mitral cleft and a cleft seen in AVSD has been suggested [18]. 
Distribution numbers of AVSD-types vary in the literature, which may be due to an inconsistent 
use of nomenclature. The majority (56%–75%) of AVSDs are complete AVSDs [2,4,19]. Subtype 
23Review AVSD
1.2
distribution of AVSD differs between patients with and without chromosomal abnormalities, with 
complete AVSD more frequently seen in syndromic patients [4,5,20] (Table 1). Unbalanced AVSD 
occurs in 6%–10% of complete AVSDs [5,21,22] and is more frequently seen in non-syndromic 
patients (Table 1). 
The spectrum of AVSD can thus range from partial AVSD to intermediate AVSD and complete 
AVSD. Abnormalities are also found in the membranous septum of relatives of patients with 
AVSD [23] and in patients with Down syndrome without AVSD [24,25], indicating that the AV 
septum may be abnormal without overt deficiency. Some authors have even suggested the oc-
currence of AVSD without shunting, i.e., an AVSD-valve morphology (common valve with linear 
insertion), where the common valve is attached to both the atrial and the ventricular septum 
[26]. The observed variability in anatomy may relate to the complex development of the AV 
septum and AV valves during embryology.
Figure 1. Schematic presentation of nomenclature of different types of AVSD. 
The defect can occur at atrial, ventricular or atrioventricular level. Black arrows indicate the defects, but do not neces-
sarily represent blood flow direction. RA = right atrium, LA = left atrium, RV = right ventricle, LV = left ventricle. In the 
complete AVSD the five leaflets are shown: superior bridging leaflet (1), left lateral (mural) leaflet (2), inferior bridging 
leaflet (3), right inferior leaflet (4) and right antero-superior leaflet (5).
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Table 1. Studies that report differences between non-syndromic (NS) patients with AVSD and patients with AVSD and 
Down syndrome (DS) in incidence of type of AVSD, associated (cardiac and non-cardiac) defects and outcome. Ao = 
aorta, papill. = papillary, IVC = inferior vena cava, LAVR = left atrioventricular valve repair. * Indicates a study only in 




30 % 24 % [20]
60 % 20 % [4]
70 % 12 % [117]
51 % 13 % [19]
Complete 
26 % 70 % [20]
40 % 80 % [4]
30 % 88 % [117]
29 % 73 % [19]
Unbalanced 
31 % 35 % [21]*
29 % 5 % [115]*
25 % 3 % [71]*
11 % 6 % [69]
Associated cardiac 
AV Valve dysplasia 
24 % 3 % [53]*
10 % 13 % [54]*
Heterotaxy 32 % 0 % [20]
Tetralogy of Fallot
3 % 9 % [71]
4 % 13 % [69]
Coarctation Ao
17 % 1 % [71]
6 % 0 % [115]
17 % 5 % [69]
Sub Ao stenosis
3 % 0 % [71]
3 % 1 % [112]
8 % 4 % [69]
Single papill. muscle 9 % 2 % [71]
Double orifice MV 4 % 2 % [71]
Additional VSD
4 % 1 % [71]
6 % 7 % [115]
4 % 2 % [112]
7 % 1 % [69]
PDA
33 % 70 % [115]
17 % 33 % [112]
5 % 5 % [69]
Common atrium 7 % 1 % [112]
Extra cardiac 
Laterality 23 % 0 % [20]
Musculoskeletal 13 % 25 % [20]
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EmBRyoNIC AND FETAL DEVELoPmENT:  
(ABNoRmAL) ATRIoVENTRICuLAR SEPTATIoN 
Normal development 
Cardiac septation takes place in the first 9 weeks of pregnancy. The primary heart tube forms 
from a myocardial progenitor population from the splanchnic mesoderm. Additionally, a second 
pool from the splanchnic mesoderm, the so-called second heart field population, situated dorsal 
to the primary heart tube, will contribute cells to the arterial and venous side of the heart.
Table 1. (Continued)
NS DS Reference
Eye and ear 0 % 10 % [20]
Central Nerve 0 % 9 % [20]
Renal and urinary 11 % 5 % [20]
Digestive 7 % 5 % [20]
Respiratory 6 % 0 % [20]
Facial cleft 5 % 0 % [20]
outcome
In hospital mortality
4 % 2.6 % [111]
14 % 10 % [115]
12 % 16 % [53]
5 % 13 % [116]
46 % 17 % [117] *
13 % 5 % [71]
6 % 5 % [112]
Non-cardiac compl. 15 % 49 % [54]*
Long term survival
75 % 84 % [112]
75 % 87 % [20]
95 % 80 % [116]
85 % 78 % [136]
90 % 94 % [137]*
86 % 94 % [71]
Re-operation
19 % 5 % [71]
11 % 8 % [115]
32 % 11 % [53]
29 % 25 % [112]
Re-operation due to LAVR
27 % 18 % [112]
13 % 9 % [136]
15 % 4 % [137]*
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The heart tube initially consists of an inner endocardial layer and outer myocardial layer, sepa-
rated by cardiac jelly. Cells from the endothelium migrate into this jelly mesenchyme, a process 
known as endothelial to mesenchymal transformation (EMT) [27]. As a result four endocardial 
cushions are formed at the AV junction: inferior, superior and two lateral cushions (purple in 
Figure 2A), that will contribute to the AV valves during later development. Besides endocardial 
cushion formation, AV septation requires growth of the muscular atrial septum primum toward 
the AV canal with on its lower rim a cushion-like structure, known as the mesenchymal cap 
(green in Figure 2A). Initially, the septum primum will not connect to the AV canal, leaving an 
opening, the ostium primum. Subsequently, the mesenchymal cap fuses with the superior and 
inferior AV endocardial cushions. To complete AV septation, the mentioned structures fuse with 
the so-called dorsal mesenchymal protrusion (DMP) or vestibular spine (yellow in Figure 2A), a 
mesenchymal (second heart field) protrusion at the base of the atrial septum [28,29] (Figure 2). 
During development the DMP will partly myocardialize, and a remnant of the DMP will form the 
tendon of Todaro, which is the continuation of the Eustachian valve of the inferior vena cava and 
the Thebesian valve of the coronary sinus [30].
Figure 2. Anatomical structures involved in normal and abnormal atrioventricular septation during development. 
Panel A shows the three main structures involved in AV-septation: endocardial cushions (EC, light purple), mesenchymal 
cap (MC, green) and dorsal mesenchymal protrusion (DMP, yellow). Modified after Webb et al. [28]. Panel B shows an 
early stage (E10.5) embryonic heart, with a common AV canal, guarded by two endocardial cushions. In panels C and D 
(caudal section) the three structures are shown in a wild type 12.5 day old mouse embryo, where only a small ostium 
primum can be seen at this developmental stage. Panel E shows the situation after AV septation has been completed in 
human. The ostium primum had been closed. In the Pdgfr-α knock-out embryo the MC and DMP are less well formed 
as schematically shown in F. Panel G shows an early (E10.5) embryo and subsequent sections show a 13.5 day old 
Pdgfr-α−/− embryo (E-F) with a dotted circle showing the reduced volume of the MC, the * showing the atrial defect and 
the # the ventricular defect. In Panel J, a complete AVSD is shown. Developmental stages are given as days/weeks after 
conception. Right atrium (RA), LA = left atrium, RV = right ventricle, LV = left ventricle, RCV = right cardinal vein, LCV= left 
cardinal vein, PV = pulmonary vein, VS = ventricular septum, AS= atrial septum. Black bars in panels B–D and G–I indicate 
200 um and in panels E and J 1 mm. Panel J is published with permission from Calkoen et al. [25].
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The endocardial cushions, mesenchymal cap and DMP thus all contribute to the membranous 
septum. The membranous septum will eventually contain an atrioventricular part, situated be-
tween the left ventricle and right atrium and an interventricular part, situated between the left 
and right ventricles. Initially however, only the AV part is present, but with detachment of the 
tricuspid valve the interventricular membranous septum develops [31]. The superior and inferior 
endocardial cushions also contribute to the septal leaflet of the tricuspid valve, and the anterior 
(aortic) leaflet of the mitral valve [32]. The right lateral cushions will form the lateral (anterior and 
posterior) leaflets of the tricuspid valve and the left lateral cushion forms the lateral (posterior) 
leaflet of the mitral valve [32]. Next to cells derived from the endocardium, also epicardial derived 
cells contribute to the formation of the annulus fibrosis and the parietal leaflets of the mitral and 
tricuspid valves [33,34].
Abnormal development
Early studies on AVSD development with transgenic mouse models focused mainly on mal-
formation of the endocardial cushions. Attention has shifted in the past decades to the DMP 
as well as the mesenchymal cap. Also abnormal looping may play a role. Several examples are 
listed below. The trisomy 16 (Ts16) mouse which is suggested to be a model for Down syn-
drome, develops, among other cardiac malformations, a complete AVSD. The pathogenesis of 
complete AVSD in the Ts16 mouse model is attributed to insufficient looping, fused but smaller 
endocardial cushions [35], as well as aberrant mesenchymal cap and DMP development [36]. 
Heterozygous mutations in the genes GATA4 [37] and NR2F2 [38] in mouse can result in partial 
(ASD1) or complete AVSDs, suggested to be caused by deficient endocardial cushion formation. 
Wnt [39], (SHF specific) Shh [40] and Pdgfr-a [41] knock-out mice all have a diminished DMP 
development leading to a partial or complete AVSD. In general, in mutant mouse studies little 
attention is addressed to difference in origin of partial, intermediate or complete AVSD. Also, the 
significance of knowledge of the “culprit” anatomical deficiency (i.e., due to a defect in either 
endocardial cushion, mesenchymal cap, DMP, or a combination) in terms of outcome/prognosis 
of the resulting AVSD, is currently unclear. In human embryos with AVSD no abnormal develop-
ment of the endocardial cushions is described to date [42], whereas a diminished DMP develop-
ment was observed in fetuses with Down syndrome and an AVSD [43]. In addition, abnormalities 
in fetal blood flow may affect septation and valve formation [44–46].
Abnormal AV septation may also affect formation of the AV conduction system. During normal 
development both an anterior and posterior node are present and a fusion of both nodes in 
order to form the definitive AV node was suggested [47]. A study in human embryos with Down 
syndrome showed that the posterior and anterior AV-node fail to fuse in AVSD and that the 
(posterior) AV node remains at a more posterior position in AVSD hearts comparable to normal 
hearts at earlier developmental stages [48].
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ANATomy oF THE AV VALVES AND CoNDuCTIoN SySTEm IN AVSD
It is important to realize that the leaflets, chordae and papillary muscles of the AV valves of all 
AVSD types, even after surgical correction, are different compared to the normal tricuspid and 
mitral valves [49]. Basically, in all types of AVSD, there is a common valve, in which the leaflets 
are to a variable extent fused with each other and/or with the atrial or ventricular septum. The 
posterior (lateral) leaflet of the normal mitral valve covers about 2/3 of the circumference of the 
valve, whereas the left posterior (lateral) leaflet in a corrected AVSD heart only covers 1/ 5. The 
right half of the inferior leaflet in AVSD is comparable with the normal posterior tricuspid leaflet. 
The size of the right anterior leaflets depends on the superior bridging leaflet. The different valve 
leaflet division causes a different position of the papillary muscles as compared to normal hearts, 
which can cause regurgitation or stenosis [50] and influences the direction of the inflow of blood 
into the LV [51].
Another feature that may contribute to valvular dysfunction later in life is dysplasia of the com-
mon AV valve, especially of the lateral leaflet [52]. Al-Hay et al. [53] reported marked differences 
in valve dysplasia in patients with Down syndrome (3%) versus non-syndromic patients (24%), 
although this was not confirmed by a recent study (nonsyndromic 10% and Down syndrome 
13%) [54].
Right bundle branch block, first degree AV block and more rarely 2nd and 3rd degree AV block 
are all described in patients with AVSD even before surgical correction [55,56]. Several studies in 
human hearts have described the morphology and position of the cardiac conduction system in 
AVSD [50,57]. The AV node is positioned more posteriorly and inferiorly compared to the normal 
position in the triangle of Koch (Fig. 3). This aberrant position, especially when it is combined 
with a significant defect of the ventricular septum, necessitates the presence of a long non-
branching (His) bundle, in order to reach the top of the ventricular septum [57]. Knowledge on 
the anatomy of the conduction system in AVSD contributes to reduction of surgically induced 
AVblock [50].
SyNDRomES, GENES AND mATERNAL RISK FACToRS INVoLVED IN HumAN AVSD
Several syndromes are associated with AVSD. In a recently studied large cohort, 49% of patients 
with an AVSD had Down syndrome [5]. In live born children with Down syndrome the incidence 
of AVSD is as high as 25% [58]. In patients with heterotaxia syndrome AVSD is often found; in right 
isomerism (or asplenia syndrome), the prevalence of complete AVSD is 90% [59]. In left isomer-
ism (or polysplenia syndrome), the prevalence of partial AVSD is 60%–70% [60], indicating that 
the morphogenesis of at least some cases of AVSD may be related to the loss of normal right/
left asymmetry in the body. Genes involved in regulation of normal body asymmetry including 
PITX2, NODAL, ZIC3, CFC1, and NKX2.5 are also associated with AVSD. Other regularly encountered 
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associated syndromes are CHARGE (coloboma, heart defects, atresia of choanae, retardation of 
growth, genital defect, ear anomalies) syndrome, Noonan syndrome, VATER (vertebral anomalies, 
anal atresia, trachealoesophageal fistula, renal anomalies) association, Holt–Oram syndrome and 
Smith–Lemli–Opitz syndrome [5,20,61–63].
The high incidence of Down syndrome in AVSD patients makes genes located on chromo-
some 21 suspect for involvement in the morphogenesis of AVSD. However not all patients with 
trisomy 21 develop an AVSD, suggesting a multigenic influence. The most frequently described 
associated gene in both patients with and without Down syndrome is CRELD1 on chromosome 
3. The penetrance of AVSD in Down syndrome is incomplete; therefore CRELD1 is seen as a risk 
factor [64,65]. Interestingly CRELD+/− mice do not have septal defects. When they are however 
crossed onto the ‘Down syndrome mice’ Ts65Dn, they do develop septal defects [66]. Table 2 
gives a summary of other reported humane genes associated with AVSD. Several syndromes 
associated with AVSD have mutations in genes related to Sonic Hedgehoc (SHH) [63]. SHH acts 
on the outflow tract formation via contribution of endocardial cushion cells as well as on AV 
septation via DMP contribution [40]. These studies all suggest that a single gene can contribute 
Figure 3. The cardiac conduction system. 
Panel A shows the normal heart. The atrioventricular node (AVN) is positioned in the triangle of Koch (red dotted line), 
formed by the septal tricuspid valve leaflet, the ostium of the coronary sinus and the Tendon of Todaro (TD) (remnant 
of the embryological dorsal mesenchymal protrusion). In AVSD hearts (panel B), the AVN is positioned more posteri-
orly and inferiorly (to the base of the triangle of Koch) as compared to the normal heart and the His bundle needs a 
longer course in order to reach its position on top of the ventricular septum. RA = right atrium, LA = left atrium, RV = 
right ventricle, LV = left ventricle, SCV = superior vena cava, IVC = inferior vena cava, SAN = sinoatrial node, SC = sinus 
coronarius, PV = pulmonary vein, TV = tricuspid valve, MV = mitral valve, RAVV= right atrioventricular valve, LAVV= left 
atrioventricular valve, VS = ventricular septum.
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to the arterial pole of the heart causing outflow tract defects and the venous pole of the heart 
(DMP), causing AVSD [67], which could also explain frequent co-occurrence of AVSD with for 
example tetralogy of Fallot. This may also relate to recent findings that genes involved in the 
VEGF-A pathway are not only associated with outflow tract defects, but also AVSD [64].
Table 2. Genes involved in human development of AVSD.
Affected humane gene Chromosome Ref Proposed impact




GATA5 20 [65] Myocardial and endocardial differentiation. Interaction with GATA4 
and VEGF
GATA6 18 [139] Looping
Epicardial contribution 
Cardiomyocyte differentitation
Nkx2.5 5 [140,141] Looping
SHF contribution
Zic3 X [142] Left right asymmetry
TBX5 12 [143] Cardiomyocyte differentitation
SHF
Interacts with Nkx2.5 and Gata4
NoDAL 10 [144] Looping
Left right asymmetry
CFC1/CRyPTIC 2 [144] Looping
Left right asymmetry
(nodal related)
LEFTy2 1 [144] Left right asymmetry
(nodal related)
ACVR2B 3 [145] Left right asymmetry
(nodal related)
BmP4 14 [140] Endocardial cushions
SHF contribution
ACVR1/ALK2 2 [146] SHF contribution (via BMP signaling)
VEGF 6 [147] Endocardial cushions
CoL6A1-2 21 [24,64] Endocardial cushions (Vegf path)
FBLN2 3 [64] Endocardial cushions (Vegf path)[148]
FRZB 2 [64] Endocardial cushions (Vegf path) [149]
DSCAm 21 [150] Cell-cell adhesion of cushion fibroblasts[150]
CRELD1 3 [65] Left right asymmetry (Vegf path)
GJA1/Cx43 6 [151] Looping
Left right asymmetry
NR2F2/Coup-TFII 15 [38] Endocardial cushion (EMT)
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Besides genetic risk factors there are several maternal risk factors reported. In infants without 
Down syndrome a strong association between complete AVSD and maternal diabetes was 
found (odds ratio 21) [4]. Moreover, a recent study found an association between complete AVSD 
and pregestational diabetes, gestational diabetes and obesity (BMI N 30 kg/m2 ) [68]. In another 
study, correlation between heavy smoking and AVSD was seen [62], however this study did not 
correct for diabetes. These findings indicate that epigenetic and genetic factors are likely to 
contribute to the genesis of AVSD.
ASSoCIATED ANomALIES
Non-syndromic AVSD patients often have associated cardiac anomalies [7,69]. In patients with 
chromosomal anomalies associated cardiac defects are rare (8%) [5,70], with the exception of 
tetralogy of Fallot cooccurring more often with AVSD in patients with Down syndrome than in 
non-syndromic patients [71] (Table 1). In patients with an AVSD the aorta is in a more anterior 
position, possibly due to improper wedging of the outflow tract during development. Moreover 
the ventricular septum is shorter in AVSD patients [72]. This together leads to a longer outlet than 
inlet part. The anterior position of the aorta can be seen on a chest x-ray or ventricular angiogra-
phy and is described as a “gooseneck”. There is a correlation between different arrangements of 
the out- flow tract and Rastelli subtypes [73]. The combination of the more anterior placed aorta 
and a narrow sub-aortic outflow tract [74] might lead to the most frequent associated cardiac 
anomalies: subaortic stenosis and coarctation of the aorta [5].
Taking syndromic and non-syndromic patients together, in 5% of patients with a complete 
AVSD a double outlet right ventricle (DORV) is seen [75]. Double orifices of the left AV valve and 
a single papillary muscle (i.e., parachute valve) are observed in AVSD patients in respectively 
14% and 1% [76]. AVSD is commonly observed in heterotaxy syndrome, and can also occur 
concomitant with Ebstein’s anomaly, anomalous pulmonary venous return and transposition of 
the great arteries. 75% of patients with an AVSD have anomalies in other organs than the heart. 




In utero prevalence of AVSD has been reported as high as 18% of CHD affected individuals. 
The discrepancy with the prevalence in live births is possibly due to a high number of fetal 
demises and elective termination, most frequently in cases with aneuploidy [77]. AVSD can be 
detected with fetal echocardiography as early as 12 weeks of gestation specialized centers [78] 
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(Figure 4A–C). The detection rate in routine screening, using the four-chamber view, is, however 
reported to be as low as 27% [79]. Recent data show, however, that detection rate as high as 
67% for balanced AVSD and 93% for unbalanced AVSDs can be achieved in national organized 
screening programs, using distinct protocols and adequate training of the ultrasonographers 
[80]. To improve detection rate, additional tools as the atrial to ventricular ratio [81] and level of 
linear insertion [82] have been suggested. Recent reports from the United States and Europe 
report elective termination of pregnancy of respectively 32% [83] and 31% [5] of cases, however 
in these studies the incidence of Down syndrome and associated CHD in the terminated fetuses 
were not specifically reported. Heterotaxia, unbalanced ventricles and a syndrome other than 
Down syndrome were detected as negative prognostic factors for late survival when an AVSD 
was detected at 20 weeks’ gestation [83]. When pregnancy is not terminated, fetuses with Down 
syndrome have a better survival compared with nonsyndromic fetuses [84]. As the incidence 
of associated cardiac anomalies, extra-cardiac abnormalities and aneuploidy (40%–50% Down 
syndrome) is high in AVSD patients, third level ultrasound and invasive testing should be offered, 
including array comparative genomic hybridization to detect the presence of copy number 
Figure 4. Diagnosis of AVSD. 
(A) Prenatal ultrasound with an oblique plane through the thorax at 12 weeks pregnancy. (B) Section of a complete 
AVSD heart of fertilization age 14 weeks stained with troponin I with black scale bar indicating 1 mm. (C) The com-
mon valve seen from the left ventricle in a specimen of a 13 week old AVSD heart. D and E) Echocardiography of a 
5-week-old patient with a complete AVSD during diastole (D) and systole (E). (F) A specimen of an uncorrected partial 
AVSD (ASD1). RV = right ventricle, LV = left ventricle, A = atrium, RA = right atrium, LA = left atrium, Ao = Aorta, SBL = 
superior bridging leaflet, IBL = inferior bridging leaflet, ML = mural leaflet. Modified after Jansen et al. [78].
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variations [85]. No studies are performed that investigate the advantage of prenatal diagnosis of 
AVSD above postnatal diagnosis on postnatal morbidity and mortality, but the association with 
other defects makes prenatal detection important to provide parents all necessary information 
to aid the decision to continue the pregnancy.
Postnatal diagnosis. 
Clinical presentation depends on the type of AVSD with the associated level and degree of 
shunting. Mild central cyanosis can be present in the newborn due to bidirectional shunting 
because of the high pulmonary resistance at birth. Due to the left to right shunt at atrial and 
ventricular level in complete AVSD and, if present, the AVV regurgitation, the child will develop 
congestive heart failure and if uncorrected, eventually Eisenmenger’s syndrome [86]. Cases 
with a partial AVSD (ASD1) can remain asymptomatic for years. With physical examination the 
AVV regurgitation can be heard as a holosystolic murmur and the increased diastolic flow as 
a mid-diastolic rumble. On electrocardiography the posterior and inferior displacement of the 
conduction system results in a left and superior QRS axis. First degree AV block can be present 
due to enlargement of the right atrium, or displacement of the AV-node Also higher degree 
AV block including complete heart block can be observed. On chest x-ray ventricular enlarge-
ment and the “goose neck” appearance reflecting the more anterior position of the aorta can be 
detected. Echocardiography is the main diagnostic modality of AVSD (Fig. 4D–E) and can assess 
the presence and size of atrial and ventricular shunting, AVV morphology and orientation, size 
of left and right ventricle, number and location of papillary muscles, left and right outflow tract 
obstruction, additional septal defects and associated anomalies [87].
Three-dimensional echocardiography can have additive value in surgical planning, because 
AVV and LVOT morphology can be assessed with more detail, as is reviewed by Kutty and 
Smallhorn [88]. Although intra-operative transoesophageal echocardiography is influenced 
by differences in hemodynamics during surgery and does not always correspond with post-
operative echocardiography [89], it can decrease the incidence of re-operation due to left AVV 
regurgitation [90]. Small studies reported the use of MRI in pre-operative assessment of AVSD, 
to visualize morphology and quantify ventricular size pre-operatively [91]. Angiography is not 
suggested in clinical decisions making prior to AVSD correction [87].
TREATmENT
Before surgical repair digoxin, diuretics and angiotensin-converting enzyme inhibitors may 
be used to treat congestive heart failure and food supplements may be necessary to achieve 
weight gain [87,92].
Surgical repair of a complete AVSD was first described by Lillehei et al. [93] in 1955. Three 
techniques have been described (Figure 5) [87]: 1) the single-patch technique where one piece 
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of prosthetic material is used to close the atrial or ventricular shunt (Figure 5A), 2) the twopatch 
technique where one patch is used to close the VSD and one other patch used to close the ASD 
(Figure 5B), and 3) the modified single-patch technique in which the common valve is sutured 
to the ventricular septum and the ASD is closed with a patch (Figure 5C). Partial AVSDs are closed 
with the single-patch technique. Complete AVSDs are mostly closed with the double-patch 
technique. An intermediate AVSD can be closed by the double-patch technique or modified 
singlepatch. Recent studies report the modified single-patch technique for closure of a com-
plete AVSD, with the benefit of a shorter cardiac pulmonary bypass and aortic cross-clamp time 
and low mortality and low incidence of left AVV (LAVV) regurgitation [94]. Choice of techniques 
varies from patient to patient and depends on the extent of the atrial and ventricular defects. 
In all three techniques besides insertion of a patch 1) the “cleft” of the left AVV is suture-closed, 
to prevent AVV regurgitation [95–97]; 2) the anterior and posterior right leaflets of the RAVV are 
approximated; and 3) the two left lateral commissures of the LAVV are approximated (Figure 5 
lower planes). As AVSD can cooccur with tetralogy of Fallot and DORV, combined repair is often 
performed with desirable results [75]. Patients with an unbalanced AVSD, where a biventricular 
repair is not possible, are a high risk group [97]. Decisions to perform a univentricular repair can 
be made based on the so-called AV valve index, (i.e., the LAVV area/total AV valve area), with an 
index between 0.4 and 0.6 considered as a balanced AVSD [98].
Because morbidity of AVSD repair in small infants is low in the current era [99–101] and 
pulmonary vascular obstructive disease needs to be prevented [102], repair of complete AVSD 
currently is advised to be performed around 3 months of age [87]. However timing of surgery 
is influenced by many factors, as co-occurrence of other heart defects. Correction in children 
below 5 kg was suggested a risk factor for late LAVV regurgitation [99], however, correction at 
an age above 6 months has also been considered a risk factor for reoperation [103]. In studies 
including patients corrected after the year 2000, the mean age at correction of complete AVSD 
ranged between 3.6 months [19] and 7.2 months [7]. Patients with intermediate AVSD usually 
undergo surgery around 1 year of age [104]. Patients with partial AVSD (ASD1) without severe 
LAVV regurgitation, can be asymptomatic and controversy exists when repair is indicated and 
what the optimal age for repair of partial AVSD is. The median age of surgical correction reported 
in recent studies varied from 1.8 [104] to 7.9 years [105]. In a study by Minich et al. [104] surgical 
correction of partial AVSD before 4 years of age is associated with significant catch-up growth 
and less LAVV regurgitation [104], whereas Bowman et al. [105] report that older age at surgical 
correction results in less morbidity and mortality. The guidelines of the European Society of 
Cardiology (ESC) for Grown-up Congenital Heart Disease (GUCH) [106] recommend surgical 
correction of partial AVSD in case of significant overload of the RV (Class I, level of evidence C).
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Figure 5. Different surgical techniques for correction of an AVSD. 
Single patch correction (A), double patch correction (B) and modified single patch (C) where the valve is attached 
to the ventricular septum are shown. In all techniques closure of the so-called cleft in the left atrioventricular valve 
(LAVV) is performed (1) and often approximation of the septal parts of the right atrioventricular valve (RAVV) (2) and 
approximation of the 2 left lateral commissures of the LAVV (3) are performed. RA = right atrium, LA = left atrium, RV 
= right ventricle, LV = left ventricle.
Figure 6. 4D-Flow MRI with streamline visualization. 
Disturbed inflow and regurgitation after AVSD correction. Compared to a control heart (A and B) in patients with 
a corrected AVSD eccentric regurgitation (arrow in C) can be seen and more laterally directed inflow (arrow in D). 
Streamlines with color coding representing velocity magnitude. RV = right ventricle, LV = left ventricle, RA = right 




Early hospital mortality (thirty-day mortality) of biventricular AVSD correction has decreased 
in the last decades [107] and in current era (2000–2014) ranges between 0% [54,101,108,109] 
and 10.7% [110]. According to some studies early mortality is associated with a younger age at 
operation [56,95], whereas others report AVSD correction to be save at younger age [99–101]. 
Weight below 3.5 kg showed to be a risk factor for mortality [111]. Controversy in literature exists 
as to whether the presence of Down syndrome influences early postoperative outcome of AVSD 
correction (Table 1). On the one hand patients with Down syndrome have a higher incidence 
of pulmonary hypertension, pulmonary vascular obstructive disease and respiratory disease, 
which can complicate anesthesia. On the other hand extensive abnormalities of the AV valves, 
complex co-occurring cardiac anomalies (as in heterotaxia [20]), left ventricular outflow tract 
obstruction and right ventricular dominance are more frequently seen in patients with a normal 
karyotype [53,112,113]. While an early study suggested that patients with Down syndrome are of 
higher risk and should be treated differently [114], more recent studies do not show difference 
in early hospital mortality between Down syndrome and non-Down syndrome patients [53, 
71,112,115–117] or even a lower in-hospital mortality and complication incidence in patients 
with Down syndrome [111] (Table 1).
Late follow-up
The overall 10 year survival after surgical AVSD correction also decreased in the last decades 
[107] ranging between and 70% [118] and 100% [108], largely dependent on era of surgery and 
complexity of the cardiac anatomy [20,118]. Surgery related postoperative arrhythmias, includ-
ing complete heart block leading to pacemaker implantation (incidence ranging between 0.5% 
[19] an 7.5% [109]), are more frequently seen after repair of complete AVSD. 
After correction of the AVSD, the need for reoperation ranges from 1.8% [119] to 28.9% [120] 
of all patients. In most cases reoperation is performed for the indication of LAVV regurgitation 
[53,121–123]. Other indications for reoperation are sub-aortic stenosis [122–124], a residual atrial 
septal- or ventricular septal defect [122,123], left ventricular out- flow tract obstruction [123] 
and right AVV regurgitation [122]. According to several studies patients with Down syndrome 
have a lower risk of reoperations compared to patients without Down syndrome (Table 1). This 
may be due to less LAVV abnormalities and less dysplastic mural leaflets [52,53] as compared 
to non-Down patients. LAVV regurgitation is equally found in patients with corrected partial 
and complete AVSD [95]. The guidelines of the ESC for adults (GUCH) [106] suggest surgical 
correction of moderate to severe LAVV regurgitation in symptomatic patients or asymptomatic 
patients with enlarged left ventricle and/or reduced EF% (Class I recommendation). Furthermore, 
surgical correction should be considered in asymptomatic patients with moderate to severe 
LAVV regurgitation who have signs of volume overload of the LV and a substrate of regurgitation 
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that is very likely to be amenable for surgical repair (Class 2a recommendation) [106]. However 
guidelines are based on level B and C evidence, as data from large randomized cohorts are 
lacking. Decision making for surgical correction is especially challenging due to the difficulty 
to quantify LAVV regurgitation reliably with echocardiography, which is due to presence of dy-
namic, eccentric regurgitation jets (Figure 6C). 4DFlow MRI enables characterization and more 
reliable quantification of these jets [125]. 
Rhodes et al. [126] report that after increase of LAVV regurgitation in the first 3 years after 
re-operation, regurgitation stays stable. The longterm effect of chronic regurgitation on exercise 
capacity, cardiac function and arrhythmias requires further investigation. Surgical correction 
of LAVV regurgitation can be performed by LAVV repair or LAVV replacement [127]. Survival is 
higher after valve repair than after replacement [121,128,129]. Furthermore, valve replacement 
has the disadvantage of the need for anti-coagulants, increased risk of infection and during 
pregnancy a higher risk of cardiac and neonatal complications [130]. In a study by Hoohenkerk 
et al. [121] a second re-operation (mostly replacement) in patients who underwent a LAVV repair 
was performed in 33%. The incidence of heart block after LAVV repair is reported as high as 
37.5% [131]. Because of the occurrence of LAVV regurgitation, residual shunts, subaortic stenosis 
and arrhythmias the guidelines of the ESC for GUCH [106] suggest lifelong follow-up at least 
every 2–3 years in a GUCH center, although this does not seems to be general practice currently 
as low follow-up rates at out-patient clinics have been reported [132].
The majority of studies on AVSD follow-up focus on survival and reoperation, and little is 
known about systolic and diastolic function after AVSD correction. Takahashi et al. [133] exten-
sively studied the LAVV, AV annuli and papillary muscles after AVSD correction using 3D echocar-
diography. They observed a larger annular area, more prolapse of the mural leaflet and a lateral 
displacement and angulation of the anterolateral papillary muscle in corrected AVSD patients 
with moderate regurgitation as compared to healthy control hearts. The abnormal valvular 
structure is a possible explanation of the lateral inflow direction in corrected AVSD patients (Fig. 
6D) [51]. Whether the disturbed inflow direction leads to less efficient cardiac pumping remains 
to be investigated.
Pregnancy
According to the ESC GUCH guidelines closure of a significant partial AVSD before pregnancy 
should be considered. In patients with severe pulmonary hypertension pregnancy is contra-
indicated [106]. Patients with a corrected AVSD with AVV regurgitation who have no indication 
for surgery tolerate pregnancy well [106]. However in 17% of pregnancies of women with a 
corrected AVSD increase of the LAVV regurgitation is observed, in 23% deterioration of the NYHA 
class is observed and in 19% arrhythmias were recorded [134]. These cardiac complications were 
more frequently seen in patients after surgical correction of complete AVSD compared with 
patients after partial AVSD correction. Recurrence of AVSD in the offspring of mothers with an 
AVSD is reported to be 10%–12.5% [134,135].
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CoNCLuSIoN AND FuTuRE STuDIES
AVSD is a spectrum of cardiac anomalies with a common AV junction with a variety in septal defect(s) 
and valve abnormalities, which can be divided in partial (atrial or ventricular shunt), intermediate 
and complete AVSD. More consistent use of nomenclature will improve communication between 
anatomists, (pediatric) cardiologists and surgeons and enable better comparison of studies. Recent 
studies concerning AVSD development focus on the role of abnormal DMP, endocardial cushions 
and mesenchymal cap with the atrial and ventricular septum. Whether the range of defects found 
is a result of a sliding scale in maldevelopment of the different structures involved in AV septation 
and/or of differences in which gene is disturbed, remains to be investigated. 
Recent genetic studies suggest CRELD and genes in the VEGF-A and SHH pathway to be 
important culprit genes for AVSD development. Early detection rate of AVSD is increasing due 
to improvement of early fetal echocardiography. Although correction of AVSD in early life has 
a good prognosis, re-operation due to regurgitation of the LAVV is often required. Because 
indications for surgical re-operation are debatable, improvement of quantification techniques is 
necessary to measure complex regurgitation in corrected AVSD patients. Quantification of LAVV 
regurgitation is challenging with echocardiography, while velocity encoded MRI might allow for 
reliable quantification and can contribute to surgical decision making for correction of the LAVV 
regurgitation. The corrected LAVV differs from the normal mitral valve in many aspects, and this 
might not only result in regurgitation of the LAVV, but also in abnormal inflow. Future studies 
focusing on the impact of valve abnormalities on intra-cardiac flow patterns and efficiency will 
add to knowledge of pathophysiological mechanisms and may contribute to identification of 
prognostic factors for valve and chamber dysfunction. The disturbance of the cardiac conduc-
tion anatomy in AVSD patients is known, but future studies are required to report types of ar-
rhythmia and conduction disorders and risk factors. Furthermore little is known about diastolic 
and systolic function as well as exercise capacity, long after AVSD correction. As pregnancy in 
corrected AVSD patients is related to cardiac complications and recurrence of congenital heart 
disease in offspring, careful follow-up during pregnancy is warranted. 
Anatomy and associated cardiac defect are different between patients with Down syndrome 
and non-syndromic patients. Although, the current available literature is not consistent enough 
to consider Down syndrome a risk or protective factor for outcome, most recent studies suggest 
a better outcome in Down syndrome patients than nonsyndromic patients. Long-term follow-up 
will have to establish the impact of AVSD correction on cardiac function and the possible differ-
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Congenital heart disease is present in 44–56% of fetuses with Down syndrome (DS). There are, 
however, signs that hearts in DS without apparent structural heart defects also differ from those 
in the normal population. We aimed to compare the atrioventricular (AV) septum and valves in 
3 groups: DS without AV septal defect (DS noAVSD), DS with AVSD (DS AVSD) and control hearts. 
methods
The ventricular septum, membranous septum and AV valves were examined and measured 
in histological sections of 15 DS no-AVSD, 8 DS AVSD and 34 control hearts. In addition, the 
ventricular septum length was measured on ultrasound images of fetal (6 DS AVSD, 9 controls) 
and infant (10 DS no-AVSD, 10 DS AVSD, 10 controls) hearts. 
Results
The membranous septum was 3 times larger in DS no-AVSD fetuses compared to control fetuses, 
and valve dysplasia was frequently (64%) observed. The ventricular septum was shorter in pa-
tients with DS both with and without AVSD, as compared to the control group. 
Conclusion
DS no-AVSD hearts are not normal as they have a larger membranous septum, shorter ventricular 
septum and dysplasia of the AV valves as compared to control hearts. 
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INTRoDuCTIoN
Congenital heart disease (CHD) occurs in 44–56% of fetuses with Down syndrome (DS), most 
commonly in the form of atrioventricular septal defects (AVSDs) [1, 2]. In AVSDs, the membra-
nous septum is partly or completely absent. During normal development, several structures 
contribute to the formation of the membranous septum, which consists of an atrioventricular 
(AV) and an interventricular part. These structures include the endocardial cushions present in 
the AV canal (also contributing to the putative AV valves), the so-called dorsal mesenchymal 
protrusion (DMP) [3] (also known as vestibular spine, a mesenchymal protrusion at the base of 
the atrial septum), and an extension of cushion tissue covering the lower rim of the interatrial 
septum, known as the mesenchymal cap. The AV part of the membranous septum is positioned 
between the left ventricle and right atrium, and the interventricular part is positioned between 
the left and right ventricles [4]. AVSDs cover a spectrum of heart anomalies with a common AV 
junction. In the case of a complete AVSD, a common AV valve, with 2 bridging leaflets, is present 
between the atria and ventricles with shunting occurring at both the atrial and ventricular level. 
When the bridging leaflets are attached to the atrial or ventricular septum (partial AVSD), shunt-
ing can solely take place at the ventricular or atrial level, respectively. 
In addition to AVSD, patients with DS may present with other septal anomalies, such as 
aneurysms of the membranous ventricular septum [5] and inlet ventricular septal defects [6]. 
Although half of the patients with DS do not present with CHD, there are signs that the hearts of 
these fetuses, in particular the AV valves, are not normal. Tricuspid regurgitation during prenatal 
echocardiography is associated with DS [7, 8], and adults with DS without overt CHD show a 
high frequency of mitral valve prolapse [9, 10] . 
The above data suggest that fetuses with DS without overt congenital heart defects are still 
at risk of developing cardiac abnormalities. Furthermore, the etiology of maldevelopment of the 
(AV) membranous septum in patients with DS seems largely unexplained to date. The question 
arises whether hearts designated as normal in DS may in fact be abnormal, and if so, what causes 
this abnormality? Interestingly, recent studies on cerebellar and neural cells in DS have shown a 
response deficit to the mitogenic effects of sonic hedgehog (SHH), a gene involved in establish-
ing cell fates at multiple points during development and known to contribute to cardiac septa-
tion [11, 12] . SHH is therefore one of the candidate genes for heart abnormalities in DS patients. 
The aim of the current study was to evaluate the hearts of fetuses with DS without overt CHD, 
focusing on: (1) morphology and size of the membranous septum (AV and interventricular part), 
(2) morphology and the size of the ventricular septum and (3) morphology of the AV valves.
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mETHoDS
Light microscopy of serial sections
This study was performed in accordance with the local ethics committee and the Dutch and 
Polish regulations for proper use of human tissue for medical research purposes. Serial sections 
of postmortem fetal hearts were selected from the Leiden Collection (Department of Anatomy 
and Embryology, LUMC, the Netherlands) and the heart collection of The Medical University 
of Warsaw in order to examine the fibrous tissue, the interventricular septum and the valvular 
structures. The age of the specimens ranged from 10 + 0 weeks’ gestational age (GA) to 3 days 
postpartum. 
For the current study, 3 groups of hearts with known karyotype were selected. Group 1 in-
cluded 15 human hearts with DS without septal defect (GA 12–22 weeks, further referred to as 
DS noAVSD); group 2 contained 8 human hearts with DS and AVSD (GA age 11–18 weeks, further 
referred to as DS AVSD); group 3 contained 34 structural normal human hearts with normal 
karyotype (GA 10 weeks to 3 days postnatally, further referred to as control hearts). 
All fetuses were obtained either following pregnancy termination or miscarriage after fetal or 
neonatal death. The hearts were sectioned in transverse, frontal, or sagittal planes. The histologi-
cal and immunohistochemical tissue markers used in these serial sections were HE (to analyze 
general anatomy), resorcin-fuchsin-iron (staining fibrous tissue), hematoxylin-picric acid-thiazin 
red (modified Van Gieson’s stain, staining fibrous tissue and myocardium) and troponin I (staining 
myocardial tissue, 1/250 SC-15368, Santa Cruz Biotechnology Inc., Dallas, Tex., USA). To assess a 
possible role of the SHH pathway in septation and valve development, selected hearts were also 
stained with antibodies for SHH (1/100 SC- 1194, Santa Cruz Biotechnology) and its downstream 
effector Gli1 (1:50 AB-49314; Abcam, Cambridge, Mass., USA). Primary antibodies were dissolved 
in PBS-Tween-20 with 1% bovine serum albumin (Sigma Aldrich, St. Louis, Mo., USA). Between 
subsequent incubation steps, all slides were rinsed in PBS (2×) and PBSTween-20 (1×). The slides 
were incubated with the secondary antibodies for 60 min: for troponin I and Gli1 with 1/200 goat 
antirabbit biotin (BA-1000, Vector Laboratories, Burlingame, Calif., USA) and 1/66 goat serum 
(S1000, Vector Laboratories) in PBSTween-20, and for SHH with 1/200 horse anti-goat biotin (BA-
9500 Vector Laboratories) and 1/66 horse serum (S-2000, Vector Laboratories) in PBS-Tween-20. 
To amplify the signal, all slides were incubated with ABC reagent (PK6100, Vector Laboratories) 
for 40 min. For visualization, the slides were incubated for 10 min with 400 μg/ml 3-3 ′ diami-
nobenzidine tetrahydrochloride (D5637, SigmaAldrich) dissolved in Tris-maleate buffer pH 7.6 
to which 20 μl of H 2 O 2 was added. Counterstaining was performed with 0.1% hematoxylin 
(Merck, Darmstadt, Germany) for 3 s, followed by rinsing with tap water for 10 min. Finally, all 
slides were dehydrated and mounted with Entellan (Merck). As staining quality depended on 
the fixation method of the hearts, we used the smooth muscle cells in the esophagus as positive 
control for SHH and Gli1 in each heart.
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membranous septum measurements in sections of fetal hearts
The membranous septum was defined as a nonmuscular structure comprising an interven-
tricular part between the left and right ventricle and an AV part between the left ventricle and 
right atrium, as previously described by Allwork and Anderson [4] (figure. 1 a, b). In hearts with 
sufficient four-chamber views (defined as visibility of 2 atria, 2 ventricles and the AV valves) in 
transverse sections of similar GA (DS no-AVSD, n = 6; DS AVSD, n = 6; control, n = 10), the presence 
of the AV part of the membranous septum and the ventricular part of the membranous septum 
was analyzed. The volume of the membranous septum was estimated based on the Cavelieri’s 
principle [13] . Regularly spaced (49 mm 2 ) points were randomly placed on resorcin-fuchsin-
iron- or troponin-stained hearts. The distance between the subsequent sections was between 
0.056 and 0.2 mm. Volume measurements were performed using an Olympus microscope with 
a ×40 magnification objective for hearts of embryos 13 weeks. 
Echocardiographic assessment of the ventricular septum in fetal hearts
The ventricular septum length was assessed in DS AVSD and control fetuses to compare the find-
ings in the fetal specimens with living fetuses. We examined 2-D ultrasound images, obtained 
from STIC (spatiotemporal image correlation) volumes, of all cases with DS from a prospectively 
recorded database of fetuses, which were referred to our center for fetal echocardiography. STIC 
is a modality to record the heart in 3 directions during one complete heart cycle, which allows 
the heart to be visualized in any desired plane [14, 15] . This database also contains a series of 
normal controls. Fetal ultrasound images of 6 DS AVSD fetuses (GA 20 + 0 to 30 + 0 weeks) and 
9 randomly selected controls of comparable GA (GA 19 + 4 to 32 + 2 weeks) were available. The 
ventricular septum was measured on the available four-chamber view from the septal attach-
ment of the tricuspid valve to the endocardium of the apex.
Transthoracic echocardiographic assessment of the ventricular septum 
in hearts of infants
To gain more insight into the postnatal situation, measurements were also obtained from hearts 
of live-born infants. Ten DS no-AVSD infants (1 day to 15 years), 9 DS AVSD infants (39 days to 2 
years) and 10 control infants (1 day to 15 years) were measured. We selected all cases with DS 
from a prospectively recorded database of ultrasound images of infants who were referred to 
our center for echocardiography. No ultrasound recordings were available of older patients with 
AVSD, as most of these patients undergo surgery at an early age. The ventricular septum was 
measured from the septal attachment of the tricuspid valve to the endocardium of the apex on 
the available four-chamber view in the case of sufficient quality (figure 2).
morphology of the AV valves in sections of fetal hearts
The insertion of the AV valves was studied in specimens in the 3 groups (DS no-AVSD, n = 15; DS 
AVSD, n = 8; control, n = 34). Furthermore, each heart was assessed for dysplastic features of the 
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AV valves (plump, irregular contours). The tricuspid valve of a normal heart has a more apical in-
sertion as compared to the mitral valve, also known as ‘differential insertion of the atrioventricular 
valves’ [16] . A linear insertion (attachment of the AV valves to the septum forming a straight line) 
is a feature of AVSD when imaging is performed at a specific level [16]. Linear insertion has also 
been suggested as a landmark for DS without AVSD, although data are limited [17].
Statistical analysis
Statistical analysis of the differences in length and volume measurements of the membranous 
septum between (1) DS no-AVSD hearts, (2) DS AVSD hearts and (3) control hearts was performed 
with SPSS software (SPSS Inc., Chicago, Ill., USA). A linear regression analysis was performed, and 
data were corrected for GA. Outcome data as well as GA were log transformed to reach normal-
ity, and the antilog was used for the result.
RESuLTS
membranous septum: morphology
Between 8 and 16 weeks’ GA, neither DS no-AVSD hearts nor the hearts of controls showed an 
interventricular component of the membranous septum. At 16– 28 weeks’ GA, 66% of the fetuses 
in the control group showed both an interventricular and an AV component of the membranous 
septum. The remaining 43% only had an AV septum (figure 1 a–c). 
In the DS no-AVSD hearts (figure 1 d), more variations in the membranous septum were ob-
served: only 20% presented with both an interventricular and an AV septum, 20% with only an 
interventricular septum, 40% with only an AV septum and 20% with merely a fibrous continuity 
between the left and right AV valves. In the DS fetuses with a (complete) AVSD, fibrous tissue was 
observed at the top of the ventricular septum in 3 cases. In one of these cases, the central part 
of this fibrous tissue was attached to the ventricular septum as well as to the atrial septum in the 
four-chamber view immediately beneath the aortic outflow tract (figure 1 e). The shunt was only 
visible at another level (figure 1 f, g). 
In summary, in DS no-AVSD fewer fetuses had both components of the membranous septum 
as compared to controls, and in DS AVSD a part of the AV septum is present.
membranous septum: volume
Linear regression analysis showed a 2.6 times (p = 0.0001, 95% CI 1.70–3.98) larger volume of the 
membranous septum in DS no-AVSD as compared to controls. The mean membranous septum 
volume estimation was 0.19 cm 3 in DS no-AVSD hearts (GA 16 ± 4 weeks) and 0.08 cm 3 in 
control hearts (GA 14 ± 6 weeks).
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Figure 1. The atrioventricular and ventricular components of the membranous septum. 
A: Transverse section immediately beneath the aortic outflow tract of a first-trimester control heart with solely an AV 
(white arrow) component of the membranous septum. B: Transverse section immediately beneath the aortic outflow 
tract of a second-trimester control heart with an AV (white arrow) and an interventricular (black arrow) membranous 
septum. C , D: Transverse section immediately beneath the aortic outflow tract in 2 hearts of fetuses with DS no-AVSD 
showing a longer and plump membranous septum with white arrows indicating the AV component of the membra-
nous septum and the black arrow the interventricular component. E: Transverse section immediately beneath the aortic 
outflow tract of a heart from a patient with DS AVSD showing a membranous septum [with an AV (white arrow) and an 
interventricular (black arrow) part] where the central fibrous body attaches to the ventricular septum as well as the atrial 
septum. F: Same heart as in e in the fourchamber view, more towards the diaphragm. At this level, the complete AVSD 
can be observed. G: 3-D reconstruction of the same DS AVSD heart with part of the membranous septum (asterisk). Red 
indicates the great arteries, yellow fibrous tissue and grey ventricular myocardium. Colors refer to the online version only. 
The section in B is stained with resorcin-fuchsin-iron, all other sections are stained with troponin I. RA = Right atrium; RV 
= right ventricle; LA = left atrium; LV = left ventricle; LAVV = left AV valve; RAVV = right AV valve.
Ventricular septum length
Using ultrasound imaging, the ventricular septum length was measured in fetuses and in infants. 
In fetuses, the ventricular septum length in DS AVSD was 0.7 times the length of controls (p = 
0.001, 95% CI 0.6–0.9). Infants with DS with and without AVSD both showed a smaller ventricular 
septum length compared to controls (DS noAVSD 0.78 times the size of the control, 95% CI 
0.65– 0.93, p < 0.0001; DS AVSD 0.67 times the size of the control, 95% CI 0.56–0.79, p = 0.006; 
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figure 2). There was no statistically significant difference in septum length between infants with 
DS with and without AVSD (p = 0.07).
morphology and insertion of the AV valves
Control hearts (n = 34) showed a differential insertion of the AV valves just below the aortic 
outflow tract. Fetal DS AVSD hearts (n = 15) showed a linear insertion in the four-chamber view 
just below the aortic outflow tract, as described previously [16] . The AV valves of hearts with 
DS without septal defect showed either a differential (n = 12) or a linear insertion (n = 3, with 
GA 12.3, 14.4 and 22 weeks) in the four-chamber view sections just below the aortic outflow 
tract. Furthermore, the AV valves of these hearts showed dysplastic features in 4 of the 5 hearts 
between 8 and 16 weeks’ GA and in 3 of 6 hearts between 16 and 28 weeks’ GA (figure 3). The 
tricuspid valve appeared more affected than the mitral valve. Dysplastic features of valves were 
not observed in control fetuses.
Expression of SHH/Gli1
In first-trimester hearts, clear SHH expression was detected in the tendon of Todaro (the remnant 
of the DMP [18] ) in control hearts (figure 4 c). This was also observed in DS no-AVSD and DS 
AVSD hearts (figure 4 d). In first-trimester hearts, Gli1 expression was not observed in the AV 
valves and septum of control hearts (n = 5). In contrast, in DS no-AVSD fetuses, clear expression 
of Gli1 was present in the dysplastic plump AV valves and membranous septum in 2 out of 4 
cases (figure 4 f ). In DS AVSD fetuses, no Gli1 expression was observed. In the second-trimester 
hearts, no clear SHH and Gli1 staining could be detected in any group.
Figure 2. Method of ventricular septal length measurement (white arrow) with transthoracic echocardiography. 
Measurements were performed in four-chamber views, from the endocardial border to the septal attachment of the 
tricuspid valve. A: Control postnatal heart of a 29-day-old infant. B: Heart of a 24-day-old infant with DS no-AVSD. C: 
Heart of a 51-day-old infant with DS AVSD. RV = Right ventricle; LV = left ventricle.
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Figure 3. Plump atrioventricular valves in hearts of patients with DS no-AVSD. 
A: Transverse section of a control heart, 12 + 1 weeks, with resorcin-fuchsin-iron (RF) staining showing slim, well-
developed tricuspid valve leaflets (asterisks). B , C: Transverse sections of DS no-AVSD hearts (B 12 + 3 weeks, stained 
with RF; C 20 + 0 weeks stained against troponin I) with plump (asterisks) AV valve leaflets compared to the control 
heart. RA = Right atrium; RV = right ventricle.
Figure 4. Expression of SHH and Gli1. 
A: Transverse section of a control heart with resorcin-fuchsin-iron (RF) staining, showing the tendon of Todaro (rect-
angle). B: Transverse section of a DS AVSD heart with troponin I staining, showing the tendon of Todaro (rectangle). 
C: A consecutive slide of the section in A, with SHH expression in the tendon of Todaro. D: A consecutive slide of the 
section in b with SHH expression in the tendon of Todaro. E: Transverse section of a control heart with Gli1 expression 
in the lungs (arrow), but not in membranous septum (asterisk) and AV valves. F: Transverse section of a DS no-AVSD 
heart with increased Gli1 expression in the membranous septum and AV valves (black arrows). RA = Right atrium; RV 
= right ventricle; LA = left atrium; LV = left ventricle; CS = coronary sinus; SVC = superior vena cava.
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DISCuSSIoN
This study presents an overview of morphological findings in hearts of fetuses with DS without 
apparent cardiac malformations. This group showed: (1) a larger membranous septum, (2) a 
shorter ventricular septum, (3) dysplastic AV valves and (4) increased levels of Gli in the AV valves 
and membranous septum. 
DS is associated with CHD, most frequently AVSDs, atrial septal defects, ventricular septal 
defects and tetralogy of Fallot [19] . AVSD has been described as a spectrum of disease [20] 
with varying levels of atrial and ventricular shunting. An inheritable shorter AV membranous 
septum, observed in families of patients with nonsyndromal AVSD, suggests a shorter membra-
nous septum to be an intermediate phenotype towards AVSD [21] . In contrast, in other studies, 
patients with DS without a septal defect were suggested to have a long membranous septum, 
indicating a long membranous septum being a sliding scale towards AVSD [22] , which is in 
line with the findings in the current study. This discrepancy might partially be explained by the 
level in the heart where the largest membranous septum is observed in patients with a normal 
heart and in AVSD. It has been previously shown that in normal fetal hearts, in a plane equal to 
the echocardiographic four-chamber view and moving from the outflow tracts in the caudal 
direction towards the diaphragm, the distance between the insertion of the AV valves to the 
septum becomes smaller. The distance (i.e. the amount of differential insertion) is maximal in 
the four-chamber view just below the outflow tracts and smallest in the four-chamber view just 
above the diaphragm [16]. 
The larger membranous septum, based on microscopy, and shorter ventricular septum, based 
on echocardiography, in DS no-AVSD hearts in the current study, may reflect the end of the 
spectrum of a ‘normal’ heart in DS, which may form a sliding scale with an AVSD, as was postu-
lated by Rosenquist and Sweeney [23]. A smaller inlet/outlet ratio is a feature of hearts with an 
AVSD, and a higher atrial to ventricular length ratio measured in a four-chamber view has been 
considered as a detection method for an AVSD [24] . The shorter ventricular septum in DS hearts 
with and without AVSD measured in our study supports this association. A shorter ventricular 
inlet septum, as was described previously [25], may hinder fusion of the endocardial cushions 
(which were shown to have a normal size in patients with an AVSD [26] ) with the septum. 
Furthermore, we encountered in our study a fetal heart with an AVSD, in which a significant 
part of the membranous septum could still be distinguished. The central part of this fibrous 
tissue attached to the ventricular septum as well as to the atrial septum in the fourchamber 
view immediately beneath the aortic outflow tract (figure 1 e). Scrolling through the heart more 
caudally, this central part separated from the top of the ventricular septum and a common valve 
was visualized. We suggest that this centrally attached part could be regarded as a part of the 
membranous septum. However, in early pregnancy it is difficult to distinguish the membranous 
septum histologically from the annulus fibrosis and the valves because together they comprise 
the fibrous tissue of the heart [27, 28]. 
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Several studies report valvular heart disease in patients with DS, including mitral valve pro-
lapse in the majority of asymptomatic adults [11, 29, 30]. Tricuspid valve regurgitation has been 
suggested as a useful feature for detection of fetuses with DS [7, 8]. The increased prevalence 
of tricuspid valve regurgitation is considered to be related to the structural changes associated 
with DS: decreased number of myocytes, abnormal orientation of myocytes and myofibrils and 
abnormal connective tissue [31]. The observed dysplastic, plump AV valves in fetal hearts with 
DS confirm an abnormal development of the AV valves in patients with DS. 
The high incidence of AVSD in DS suggests that genes on chromosome 21 are likely to be 
involved in the development of AVSD. However, not all patients with DS develop an AVSD, 
suggesting a multifactorial influence [32]. The observed SHH expression in the tendon of To-
daro, a structure derived from the DMP and necessary for normal AV septation [33] , suggests 
a similar role of SHH in septation in humans as has previously been described in mice [12, 34] 
. We observed an increased expression of Gli1, a marker for SHH activity, in AV valves and the 
membranous septum in fetal hearts in DS without AVSD. Although numbers in the current study 
are too small to draw valid conclusions, it is tempting to speculate that the increased expression 
is a result of a previously suggested response deficit of SHH signaling in DS [35]. Increased Gli1 
expression in fetuses with DS might also be caused by Yak1-related kinase (Dyrk), which induces 
Gli1 and is found on the DS critical region and is increased in patients with DS [36, 37]. The ex-
tensive Gli1 expression in the mesenchymal AV septum possibly influences cell fate, resulting in 
reduced myocardialization. Such a mechanism would implicate that inhibitors of Dyrk, currently 
experimentally used to improve cognitive function of DS patients, might be a focus for research 
concerning therapy of CHD in DS patients as well [38]. Further studies are required to investigate 
the role of SHH in heart development in fetuses with DS. 
The current study is based on a unique collection of fetal specimens. This however causes 
limitations, including the small number and variable age of the observed hearts, inherent to the 
limited availability of human fetal material with known phenotype. Some stainings could not be 
performed in all hearts due to differences in the quality of the material. 
In conclusion, hearts of patients with DS, even without overt CHD, appear to be abnormal 
in the majority of specimens examined. Hearts of fetuses with DS without septal defects have 
a different, elongated, membranous septum in comparison to hearts of fetuses with a normal 
karyotype and show abnormal dysplastic AV valves, which may explain the valve dysfunction 
observed both pre- and postnatally in patients with DS. Correlation with clinical data is neces-
sary to explore if cardiac follow-up in patients with DS without overt CHD is warranted. 
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ABSTRACT 
First trimester sonography is a widely used technique to examine the foetus early in pregnancy. 
The desire to recognise complex anatomy already in early developmental stages stresses the 
need for a thorough knowledge of basic developmental processes as well as recognition of 
cardiac compartments based on their morphology. In this paper, we describe the possibilities 
and limitations of sonographic assessment of the foetal heart between 10 and 14 weeks of ges-
tation and correlate this to morphology. Examples of the most commonly detected congenital 
anomalies are atrioventricular septal defects, transposition of the great arteries, and hypoplastic 
left heart, which are shown in this paper.
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INTRoDuCTIoN
Heart development is a complex proces during which the heart needs to evolve from a single 
myocardial tube towards a fully septated heart with two atria, two ventricles, and a separated 
outflow tract. Figure 1 shows the cardiac events that must occur to achieve a normal circula-
tion. These developmental processes do not occur sequentially, but largely overlap in time. It 
is therefore not surprising that maldevelopment during one timepoint might affect multiple 
processes. Correct remodelling of the heart most likely requires normal haemodynamics. Studies 
on chick and zebrafish demonstrate that reduced blood flow during heart development leads 
to impaired looping, incomplete septation, and abnormal valvulogenesis; [1,2] therefore, abnor-
mal blood flow through the cardiovascular system during early embryonic stages can result in 
structural heart disease [3,4]. 
Congenital heart disease affects four to eight newborns per 1000 live births and is the most 
frequently encountered congenital malformation [5]. Congenital heart malformations are 
responsible for majority of infant deaths in the first year of life.5 Second trimester ultrasound 
screening programmes are routine pregnancy care in most developed countries. In the last 2 
decades, ultrasound systems have improved rapidly, allowing the visualisation of the first trimes-
ter heart in detail. First trimester echocardiography is defined as an attempt to visualise foetal 
heart anatomy at a gestational age before 14 completed weeks (13+6). The use of first trimester 
echocardiography to detect foetal anomalies at this early gestational age is increasingly gaining 
popularity, driven by the urge to detect foetal anomalies at very young stages. These examina-
tions are conducted mainly in high-risk pregnancies, for example, in cases with increased nuchal 
Figure 1. Schematic overview of the time span of development of the different cardiac components. 
Modified after Jongbloed et al [87].
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translucency or in patients with a positive family history for cardiac malformations [6]. At the 
same time, the desire to recognise complex anatomy already in these early developmental 
stages stresses the need for a thorough knowledge of basic developmental processes as well as 
recognition of cardiac compartments based on their morphology. 
Despite several studies that stated that foetal heart examination could be incorporated in the 
first trimester examinations, its use is currently still limited to a few specialised centres. In the 
current paper, we aim to provide a comprehensive overview of the use first trimester echocar-
diography and the correlation with morphology. In addition, we give an overview of the current 
possibilities and limitations, and define the indications in which first trimester echocardiography 
could be offered.
VISuALISATIoN oF THE FoETAL HEART BEFoRE 10 WEEKS oF GESTATIoNAL AGE: 
uLTRASouND VERSuS moRPHoLoGy
Organogenesis occurs in the first 8 weeks after conception. In this relatively short period, which 
corresponds to 10 completed weeks of gestation, all major organ systems develop. At the end of 
this period, most organs have reached a size that can be visualised by ultrasound. 
The cardiovascular system begins to develop within the lateral intra-embryonic mesoderm at 
4 weeks gestational age [7]. At this time, the primitive heart tube is formed and starts pulsating 
after 5 completed weeks of gestation, that is, day 22 after conception [8]. This single tube pro-
pulses the blood initially in a peristaltic manner. The primitive myocardial heart tube undergoes 
a process of looping, remodelling, and septation, thereby transforming the single lumen into 
the four chambers of the definitive heart with a separated out- flow tract. This forms the basis 
for the separation of the pulmonary and systemic circulations at birth [8]. The final closure of 
the ventricular septum and ultimate formation of the atrioventricular valves is finished at 10 
completed weeks of gestation [9,10]. After development, the different cardiac compartments 
can be distinguished based on their morphological characteristics [11]. 
Ultrasonographic studies on the foetal heart, before a gestational age of 10 completed weeks, 
have to take into account that heart morphology is not definitive yet. Therefore, examinations 
before this gestational age are studies on the developing embryo, rather than a diagnostic tool. 
Timor-Tritsch et al described embryonic development in 38 well-dated pregnancies [12]. He 
observed that foetal heartbeats could be visualised from 5+5 weeks gestational age. In a similar 
study, the ventricular septum was seen at 9+1 weeks and the four chambers were identified 
at 14 weeks [13]. With the use of 7.5 MHz transvaginal probes, more detailed structures of the 
foetal heart could be identified [14] The atrial and ventricular walls were visualised at the end 
of week 8, and the atrioventricular valves at the end of week 10 by Blaas et al. In this study, 
reference curves for the diameter of the foetal heart at this early gestation were constructed [15] 
Allan et al compared the results of echocardiographic studies at 5–12 weeks gestational age, 
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using transvaginal ultrasonography, with the anatomy of microdissectioned hearts [16] Before 
a gestational age of 9 weeks, cardiac morphology could not be visualised by ultrasound. The 
results in the study by Johnson et al, agree with these findings [17]. At 9 weeks gestational age, 
Allan found the foetal heart to be centrally positioned in the foetal chest, directionally opposite 
the foetal spine [16] The pulmonary trunk could be visualised in the B-mode, in contrast to the 
ascending aorta, which could only be identified with colour Doppler. At 10 weeks gestational 
age, they found the heart’s position changing to a more left-sided orientation, as is typical later 
in pregnancy. Figure 2 shows an example of first trimester echocardiography and the correlation 
to morphology. 
ECHoCARDIoGRAPHy IN LATE FIRST TRImESTER FoETuSES
From 10 completed weeks of gestation onwards, the foetal heart has reached its definitive 
anatomy for foetal life. The final closure of the foramen ovale and the occlusion of the ductus 
arteriosus occur after birth and results in the definitive separation of the systemic and pulmonary 
circulation. 
In the ultrasonographic examination of the foetal heart from 10 weeks gestational age 
onwards, a predefined strategy can be applied, similar to the way mid-gestational cardiac 
examination is conducted. Owing to the increased axial (0.3–0.4 mm) and lateral resolution of 
the modern broadband probes, the foetal heart and its detailed structures up to 1 mm can be 
readily visualised. Initially, the majority of early first trimester echocardiographic studies were 
conducted using transvaginal probes. More recent studies showed that modern high-frequency 
abdominal probes could reach a sufficient level of imaging quality [18–23]. Transabdominal scan-
ning has the advantage that the imaging plane can be acquired in more angles compared with 
transvaginal ultrasound. In a review by Rasiah et al [24], it was stated that regarding specificity, 
transabdominal approach appears superior to transvaginal approach, but Gembruch et al stated 
that at lower gestational age transvaginal approach has better feasibility [25]. Considering these 
limitations it seems advisable to master both methods, to be able to individualise the approach 
according to the goal of the ultrasound, detecting or excluding/reassuring, and technical factors 
such as patient stature and size of the foetus). 
The first published studies on the diagnosis of heart malformations in the first trimester foetus 
were case reports [26–28], published up to 4 years before Dolkart and Reimers [29] systemati-
cally described the possibilities of examining the normal foetal heart in this early period of gesta-
tion. Following these case reports, larger series of diagnosed malformations were published by 
several authors. Table 2 provides an overview of the structural heart defects that have been 
described to be accurately diagnosed in the first trimester. 
Chapter 2.268
THE FouR-CHAmBER VIEW
The transverse section through the foetal heart at the inflow level, called “the four-chamber 
view”, is incorporated in routine second trimester obstetric scanning in nearly every centre. In 
this ultrasonographic plane, the size and position of the heart, two equally sized ventricles and 
atria, the opening and closure of the mitral and tricuspid valves, and an intact ventricular septum 
up to the cardiac crux are evaluated (Figure 2e). Allan et al and later Copel et al described that 
a normal “four-chamber view” ruled out the majority of foetal heart malformations in midgesta-
tional foetuses [30,31].
An attempt to visualise the four-chamber view in first trimester foetuses proved feasible 
in several articles, as reviewed by Haak et al. [32] In the past few decades, the visualisation of 
this plane has increased to 90% of the examinations from 12 weeks gestational age onwards. 
Furthermore, a shift towards earlier gestational ages in which the four-chamber view can be 
visualised is observed. These improvements in early foetal echocardiography are probably be-
cause of the development of new transvaginal and transabdominal probes. Higher frequencies 
are used nowadays, and the increased variety in postprocessing possibilities produce a very 
high image quality, leading to more detailed visualisation of small structures [33,34]. The most 
frequently reported congenital heart defects in first trimester echocardiography are those with 
an abnormal four-chamber view, such as atrioventricular defects or defects with asymmetrical 
or disproportional ventricles. In most cases, follow-up ultrasounds are necessary to determine 
additional details and definitive diagnosis of the abnormalities and state the correct diagnosis, 
or sporadically conclude that there is a normal cardiac anatomy [6,22].
ouTFLoW TRACTS
During development, the outflow tract of the heart needs to develop from a single tube to a 
situation where the aorta and pulmonary trunk are separated and connect to the proper ven-
tricle. During this process, a lengthening of the pulmonary part of the outflow tract will occur, 
whereas the aorta will stay relatively short [35] After normal development, the great arteries are 
located ventrally, wedged in between both atrial appendages. In the normal heart, the aorta has 
a right posterior position with respect to the pulmonary trunk (Fig 3a). 
Although the four-chamber view is a potent plane to screen for major heart defects, it is not 
sufficient to rule out heart defects concerning the outflow tracts. To detect outflow tract anoma-
lies with a normal four-chamber view, several planes have to be added to the examination [36]. 
The position and size of the ascending aorta is the first plane cranial to the fourchamber view. 
This is a relatively difficult plane to achieve, because the probe has to be rotated and slightly 
tilted. 
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Figure 2. Normal echocardiography versus morphology. 
The transverse plane of the three-vessel view is depicted by the square (a). First trimester ultrasound (b) and a histo-
logical (c) section of the three-vessel view clearly show the superior vena cava (SVC), aorta (Ao), pulmonary trunk (PT), 
ductus arteriosus (DA), descending aorta (AoD). Plane (d) depicts a normal foetal heart, corresponding to ultrasound 
(e), and histological (f ) sections of the four-chamber view showing the left ventricle (LV), right ventricle (RV), left 
atrium (LA), and right atrium (RA). Spine (S) marks the dorsal side of the foetus on the ultrasound plane.
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Just above the four-chamber view, above the outflow of the aorta, both the pulmonary trunk 
and the aorta can been seen in their spatial relationship in a transverse plane through the foetal 
chest. The superior caval vein is visible next to the aorta. This “three-vessel view” is not difficult 
to acquire and easy to teach to ultrasonographers (Figure 2a–c). It is generally accepted to be 
of great benefit in screening programmes, as it is abnormal in several heart malformations with 
abnormal position of the great vessels. 
In the first trimester foetuses, the ascending aorta and pulmonary trunk measure about 1–2 
mm at the valve annulus [25,37]. Haak et al [32] observed an increase in the visualisation of the 
outflow tracts in the past few decades up to 95% at gestational age of 13 weeks, confirmed by 
later studies [38]. Table 1 provides an overview of the visualisation rates of both the outflow 
tracts and the four-chamber view. 
Figure 3. Echocardiography and morphology of a foetal heart with transposition of the great arteries. 
The aorta has, compared with the normal posterior position (a), in transposition of the great arteries, a right anterior 
position (panel (b) and enlargement (c)). On a transverse section through the foetal chest at the level of the “three-
vessel view” (d), only the aorta (Ao) and superior vena cava (SVC) can be observed, owing to the caudal position of 
the pulmonary trunk. Spine (S) marks the dorsal side of the foetus on the ultrasound plane.
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Reports on diagnosis of malformations solely affecting the outflow tracts, before 14 weeks 
gestational age, are increasingly being published, but mainly in the last decade. This suggests 
that these types of defects are more difficult to diagnose in the first trimester. Table 2 summarises 
several examples of outflow tract malformations detectable by echocardiography. Possibly, the 
most important of these is transposition of the great arteries, which is one of the most frequently 
missed severe heart defects, and could possibly benefit the most from prenatal detection [39] 
(Figure 3, transposition of the great arteries is further described below).
SENSITIVITy AND SPECIFICITy oF ECHoCARDIoGRAPHy IN  
FIRST TRImESTER FoETuSES
As discussed, echocardiography in first trimester foetuses has been proven feasible. More recent 
studies have assessed the reliability and accuracy for detecting or excluding congenital heart 
disease. In a systematic review by Rasiah et al [24] a high sensitivity (85%) and specificity (99%) 
were reported in a pooled group of foetuses predominantly with a high risk for congenital 
heart defects such as increased nuchal translucency, previous child with cardiac defect, and 
cardiotoxic medication. These studies had all been conducted by specialised obstetricians in 
tertiary care hospitals. Large population-based studies concerning second trimester screening 
of low-risk pregnancies have demonstrated the limited accuracy regarding the detection of 
congenital heart defects. Specialised tertiary centres markedly showed higher detection rates 
[40]. It is therefore probable that considering first trimester echocardiography in population-
based screening programmes will achieve lower reliability. A large randomised control trial41 
demonstrated a low detection rate in a 12-week scan policy (11%). This did not differ significantly 
from an 18-week scan policy (15%), likely reflecting the level of training and experience of the 
ultrasonographers in this programme. Evidence regarding first trimester screening for congeni-
tal heart defects of low-risk mothers is scarce42 and does not assess cardiac anatomy only, but 
focuses on first trimester detection of structural defects in general [43–45]. The results of these 
pioneering studies are conflicting and no systematic reviews are available yet.
Table 1. Visualization of both four chamber view as well as the outflow tract, obtained by different studies.
Authors Visualization rates in % (number of fetuses)
10+0 -10+6 11+0- 11+6 12+0- 12+6 13+0- 13+6
Johnson, 1992 17 0 (26) 0 (33) 31 (51) 43 (61)
Gembruch, 199373 - 67 (15) 80 (30) 100 (51)
Gembruch, 200025 44 (9) 75 (16) 93 (15) 100 (16)
Haak, 200237 - 20 (85) 60 (85) 92 (85)
Vimpelli, 200674 - 60 (53) 67 (201) 72 (330)
Smrcek, 200675 67 (9) 100 (22) 98 (41) 100 (24)
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EXAmPLES oF CARDIAC mALFoRmATIoNS DETECTABLE WITH FIRST TRImESTER 
uLTRASouND; uLTRASouND VERSuS moRPHoLoGy
The following section describes three examples of congenital malformations in the first trimester.
In transposition of the great arteries, there is a concordant atrio-ventricular connection in 
combination with ventriculo-arterial discordance. The aorta connects to the morphological right 
ventricle and the pulmonary trunk connects to the morphological left ventricle. There is often a 
Table 2. Overview of heart anomalies detected by first-trimester sonography (up to 14 weeks of gestational age). 
HLHS=hypoplastic left heart syndrome.
Structural anomalies Detected in first trimester - published by
Left persisting superior caval vein Volpe 201142
Atrioventricular defect Gembruch 199027, Areias 199876, Carvalho 199818, Gembrug 199373, Achiron 
199477, Carvalho 199818, Baschat 199978, Haak 200279, Huggon 200280, Comas 
200281, Galindo 200382, McAuliffe 200538, Becker 200683, Weiner 200861, Bellotti 
201023, Persico 201122, Hartge 201162, Volpe 201142, Eleftheriades 201263
Left Isomerism Huggon 200280,21
Ventricular septal defect DeVore 198726, Bronshtein 199184, Haak 200279, Huggon 200280, Comas 200281, 
McAuliffe 200538, Weiner 200861, Persico 201122, Hartge 201162, Eleftheriades 
201263
Univentricular heart Gembruch 199373, Becker 200683, Hartge 201162
Ebstein’s anomaly Huggon 200280, Eleftheriades 201263
Tricuspid atresia / hypoplastic right 
heart
Comas 200281, Galindo 200382, Carvalho 2004 21, Weiner 200861, Bellotti 201023, 
Hartge 201162, Eleftheriades 201263
Hypoplastic left heart Bronshtein 199184, Haak 200279, Huggon 200280, Comas 200281, Carvalho 21, 
McAuliffe 200538, Weiner 200861, Bellotti 201023, Persico 201122, Hartge 201162, 
Volpe 201142, Eleftheriades 201263
Aortic stenosis (developing HLHS) Axt-Fliedner 200685, Hartge 201162, Volpe 201142, Eleftheriades 201263
Interrupted aortic arch Carvalho 199818, Volpe 201142
Vascular ring/right aortic arch Volpe 201142
Truncus arteriosus Achiron 199477, Huggon 200280, Weiner 200861, Hartge 201162
Double outlet right ventricle Gembruch 199373, Baschat 199978, Haak 200279, Comas81 2002, Carvalho 20046, 
McAuliffe 200538, Belotti 201023, Hartge 201162
Transposition of the great arteries Baschat 199978, Galindo 200382, Carvalho 21, Weiner 200861, Bellotti 201023, Persico 
201122, Volpe 201142
Tetralogy of Fallot
(Ventricular septal defect and 
overriding aorta)
Bronshtein 199028, Achiron 199477, Comas 200281, Galindo 200382, Weiner 200861, 
Persico 201122, Hartge 201162, Volpe 201142
Pulmonary stenosis Gembruch 199373, Baschat 199978, Hartge 201162, Volpe 201142
Pulmonary atresia Huggon 200280, Persico 201122, Hartge 201162
Uhl’s disease Achiron 199477
Ectopia cordis Achiron 199477, Comas 200281, McAuliffe 200538, Bellotti 201023, Hartge 201162
Cardiacdiverticle Prefumo 200586, McAuliffe 200538α
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parallel course of the great arteries, with a right anterior position of the aorta with respect to the 
pulmonary orifice [46] (Figure 3b–c). There is usually a fibrous continuity of the mitral valve and 
pulmonary valve, whereas the aortic valve is separated from the tricuspid valve by a muscular 
infundibulum. In transposition of the great arteries, both the aortic valve and the pulmonary 
valve are often situated at the same level, in contrast to normal hearts where the aortic valve is 
situated at a lower level than the pulmonary valve. In about 50% of the cases of transposition of 
the great arteries, a ventricular septal defect is present [47].
Transposition of the great arteries is frequently missed during routine second trimester 
anomaly scans [48] This is probably owing to the normal four-chamber view in this defect. In 
transposition of the great arteries the vessel that arises from the left ventricle branches in a 
Figure 4. Echocardiography and morphology of a foetal heart with an atrioventricular septal defect.
The common valve between the atria (a) and ventricles (RV and LV) can be recognised on the ultrasound four-
chamber view (A; printed with permission of Ultrasound in Obstetrics and Gynaecology. Please note that this figure 
displays an oblique plane through the thorax. Owing to persistent foetal position, a correct fourchamber view was 
not obtainable) and histological section (b). On plane C, the common valve is seen from the left ventricle. IL = inferior 
bridging leaflet; SL= superior bridging leaflet.
Figure 5. Echocardiography and morphology of a hypoplastic left heart. 
On ultrasound at 12 weeks gestational age (a), disbalance between the right ventricle (RV) and left ventricle (LV) can 
be observed. Foetal specimens of 13 (b) and 25 (c) weeks also show hypoplasia of the ascending aorta. Right atrium 
(RA), left atrium (LA), aorta (Ao), pulmonary trunk (PT). *Shows pericardial fluid.
Chapter 2.274
transverse plane. This is called “laterally branching”, which identifies the pulmonary artery. The 
vessel that arises from the right ventricle is the aorta, which gives rise to the neck vessels (su-
periorly branching). Easier to recognise is the fact that the “three-vessel view” described above 
cannot be achieved in transposition of the great arteries. In transposition of the great arteries, 
the vessel that arises from the right ventricle produces a “two-vessel view”. These two vessels are 
the aortic arch and the superior caval vein. Figure 3d illustrates that it is possible to diagnose 
transposition of the great arteries, even at an early gestational age. The images are comparable 
to those encountered in the second trimester transposition of the great arteries. 
Another example of a congenital malformation that may be detected during first trimester 
echocardiography is atrioventricular septal defect. Atrioventricular septal defects cover a 
spectrum of heart malformations resulting in a common atrioventricular junction and common 
atrioventricular valve (Figure 4). The extent of the incomplete development of the atrioventricu-
lar septum varies and is used to categorise atrioventricular septal defects. A complete atrioven-
tricular septal defect includes an ostium primum defect of the atrial septum, as well as a defect 
in the inflow portion of the ventricular septum. In incomplete or partial atrioventricular septal 
defect, the common atrioventricular annulus and valve are combined with an atrial septal defect 
– only shunting at the atrial level – or, less commonly, a ventricular septal defect – shunting 
only at the ventricular level. Extreme disbalance of the ventricles may result in hypoplastic right 
heart, in cases of left ventricular predominance, or hypoplastic left heart, if the right ventricle is 
predominant) [49–51]. 
In echocardiography, atrioventricular septal defects can be recognised in the four-chamber 
view (Figure 4a) by the absence of the crux and a common atrioventricular valve. As the four-
chamber view is the most basic plane to screen for heart defects, atrioventricular septal defects, 
especially complete atrioventricular septal defects with moderate to large ventricular septal 
defects, are usually not missed, even in the first trimester scanning. As balanced complete atrio-
ventricular septal defects carry a risk of around 60–80% for Down syndrome, karyotyping has to 
be offered. A careful examination of other organs is furthermore warranted, as 75% of cases with 
atrioventricular septal defects have anomalies in other organ systems [49]. A high prevalence 
of atrioventricular septal defects is also observed in patients with heterotaxy syndrome [52,53]. 
The final example is the hypoplastic left heart, in which aortic atresia or aortic stenosis is com-
bined with either mitral atresia or mitral stenosis. The left side of the heart is underdeveloped, 
with a left ventricle of about 1/3 or less of its regular size, and there is hypoplasia of the ascend-
ing aorta and left atrium. When inflow of blood into the heart exceeds the outflow, a profound 
intimal thickening called fibro-elastosis can be observed. Whereas this intimal thickening can 
be readily observed during later development stages, this is usually not observed during first 
trimester echocardiography yet. A profound disbalance of the ventricles can be visible already 
during first trimester echocardiography (Figure 5). However, this disbalance may also occur only 
later in development, so that the observation of equal-sized ventricles does not always rule out 
the hypoplastic left heart. Follow-up studies are mandatory.
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LImITATIoNS FoR FoETAL CARDIAC EVALuATIoN DuRING FIRST TRImESTER
The most important disadvantage and therefore the major limitation of first trimester echocar-
diography is the intrauterine development of congenital heart disease at later gestation [54,55]. 
Several malformations, such as mild pulmonary [56,57] and aortic stenosis or coarctation58 or 
even the hypoplastic left heart [59] can develop in second or third trimester foetuses. Further-
more, some heart lesions such as cardiac rhabdomyoma or cardiomyopathy may not be present 
in the first or second trimester and can evolve in later gestation or even after birth [60]. Therefore, 
it is important to clarify to parents that some lesions could be missed in early pregnancy, even 
after detailed examination, and that, however rarely, a serious defect can develop after the 
mid-trimester. This statement is also supported by reports of heart defects, being missed in the 
first trimester ultrasonography [6,38,42,61–63]. Thus, after the first trimester echocardiography, 
a follow-up examination on the second trimester of pregnancy should always be conducted. 
The knowledge that ventricular septal defects usually remain undetected in second trimester 
echocardiography [64,65], probably because the size of these defects are beyond the resolution 
of the currently available ultrasound devices, makes it a neglectable aspect of first trimester 
examination, at which time this technical limitation is even more severe. 
Another disadvantage of the first trimester echocardiography is the possible detection of 
defects that could resolve spontaneously in later pregnancy, such as muscular ventricular septal 
defects [66]. This could result in unnecessary anxiety of the parents. If the first trimester echo-
cardiography is performed transvaginally, the direction of probe manipulation is limited. If the 
foetal position is consistently unfavourable, the technique does not provide sufficient images of 
the foetal heart. Transvaginal scanning, however, produces images with detail comparable to the 
second trimester abdominal scanning. In our opinion, transvaginal scanning should therefore 
be the preferred approach, despite the fact that specific training is needed. Finally, probably the 
most significant reason that first trimester echocardiography (abdominal or transvaginal) is still 
a rarely applied method is the need for highly skilled staff with several years of experience in 
second trimester echocardiography, and the use of high-end ultrasound equipment with high-
frequency (transvaginal) probes [67].
CoNCLuSIoN
Although the advantages of first trimester transvaginal echocardiography seem of considerable 
value for couples at risk for having offspring with cardiac defects, this method is nowadays 
still limited to a few specialised centers. The numerous reports on the poor performance of 
mid-gestational sonography, regarding the detection of cardiac abnormalities, as well as the 
aforementioned limitations, could be the reason that centres are discouraged to extend echo-
cardiography to the first trimester. Furthermore, high-end ultrasound facilities are needed, as 
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well as operators that are experienced and have a particular interest in echocardiography. These 
factors, as well as the need for a follow-up examination at 20 weeks, are probably responsible 
for the limited utilisation of first-trimester echocardiography, and its restricted use in foetuses at 
a high risk of cardiac abnormalities. In short, it seems clear that the capacity of highfrequency 
transvaginal probes is sufficient to perform echocardiographic examination in the late first 
trimester of pregnancy. However, the capability to detect and correctly diagnose heart defect 
is highly dependent on the operator, as is the case in the second trimester echocardiography.
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Heart development is a complex process, and abnormal development may result in congenital 
heart disease (CHD). Currently, studies on animal models mainly focus on cardiac morphology 
and the availability of hemodynamic data, especially of the right heart half, is limited. Here we 
aimed to assess the morphological and hemodynamic parameters of normal developing mouse 
embryos/fetuses by using a high-frequency ultrasound system. 
methods
A timed breeding program was initiated with a WT mouse line (Swiss/129Sv background). All 
recordings were performed transabdominally, in isoflurane sedated pregnant mice, in hearts of 
sequential developmental stages: 12.5, 14.5, and 17.5 days after conception (n = 105). 
Results 
Along development the heart rate increased significantly from 125 ± 9.5 to 219 ± 8.3 beats 
per minute. Reliable flow measurements could be performed across the developing mitral and 
tricuspid valves and outflow tract. M-mode measurements could be obtained of all cardiac 
compartments. An overall increase of cardiac systolic and diastolic function with embryonic/
fetal development was observed. 
Conclusion
High-frequency echocardiography is a promising and useful imaging modality for structural and 
hemodynamic analysis of embryonic/fetal mouse hearts.
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INTRoDuCTIoN
Heart development is a complex process during which the heart will form from a single myocar-
dial heart tube to a full septated four-chambered heart with functional atrioventricular (AV) and 
ventriculoarterial valves and a separated outflow tract. The primary heart tube is derived from 
the splanchnic mesoderm in the embryonic plate and initially consists mainly of a left ventricle 
(LV) and AV canal. During further development, significant contributions to the heart tube will 
continue to be made from the mesenchyme situated behind the heart, the so-called second 
heart field (SHF). The cells of the SHF will formthe right ventricle (RV) and outflow tract at the 
arterial pole of the heart as well as myocardial and vascular structures at the venous pole of the 
heart [1]. 
Abnormal heart development results in congenital heart disease (CHD), the most common 
birth defect with an estimated incidence of six per 1000 live born children [2]. In the last decade, 
knowledge regarding genes, growth and transcription factors important in heart development 
has dramatically increased, which has led to the generation of specific genetically mutated 
mouse models to study the etiology of CHD [3]. Up till now description of both normal and 
abnormal heart development in these mouse models mainly focused on the morphology of the 
heart, whereas functional data like hemodynamics and in vivo imaging are limited. Furthermore, 
functional parameters and their course at subsequent stages of normal mouse heart develop-
ment have only been described in a few studies [4-7]. Specifically, knowledge regarding RV 
inflow and myocardial function during embryonic development is scarce.
In clinical practice ultrasound is the most frequently used minimally invasive imaging modal-
ity at pre- and postnatal stages of heart development. Clinical ultrasound machines have also 
been used for imaging of embryonic mouse hearts, however, ultrasound frequencies (8-15MHz) 
are not sufficient for a detailed morphological and hemodynamic analysis. Recently developed 
high-frequency ultrasound systems (30-50MHz) are able offer sufficient spatial-temporal resolu-
tion for detailed and reliable imaging of embryonic mouse hearts. Thus far, there are only limited 
studies describing the hemodynamic and morphological changes at subsequent stages of heart 
development using such ultrasound systems [4;6;8]. 
Hemodynamics play an important role in normal heart development by the activation of 
shear-stress dependent signaling pathways. During development genes like Klf-2 [9] and perios-
tin [10] are expressed in regions of the heart that are known to be subjected to high mechanical/
hemodynamical stress. It has also been demonstrated that artificial alterations in hemodynamics 
throughout heart development result in aberrant activation of genes at the endocardial sur-
face of the heart [11], which might lead to disturbed cardiogenesis, i.e. CHD. A first step in the 
interpretation of hemodynamic parameters during development is the acquisition of a reliable 
reference series during normal heart development.
In the current study we aim to provide an overview of hemodynamic and morphological 
changes during embryonic and fetal stages of normal mouse heart development using a high-
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frequency ultrasound system. Knowledge of these functional parameters is highly relevant for 
the interpretation of results obtained in genetically mutated mouse models. We expect that 
knowledge of how echocardiographic parameters shift over development will eventually con-
tribute to the early detection of CHD during human pregnancy.
mATERIAL AND mETHoDS
Animals
Animal experiments were approved by the local animal welfare committee (DEC no:10177) of the 
Leiden University Medical Center. A timed breeding program was initiated with a WT (Swiss/129Sv 
background) mouse line. The day after breeding was considered to be 0.5 days post conception 
(dpc). All pregnant mice (n=11) were subjected to high-frequency ultrasound recordings at 3 
subsequent stages of embryonic/fetal development, being 12.5, 14.5 and 17.5dpc. At 12.5dpc, 
the pregnant mother mouse was anaesthetized using Isoflurane (induction 5%, maintenance 
during assessment 1.5%), the most commonly used anesthetic in mouse experiments [6;12]. 
Subsequently, the sedated mouse was placed in the experimental setup (VisualSonics Vevo770 
system, Toronto, Canada), which includes a heated table and rectal probe for maintenance and 
control of body temperature (36.5-37.50C). Electrodes were attached to the paws for monitoring 
the maternal electrocardiogram, heart and breathing rate during the experiments. 
Abdominal hair was removed using a commercially available chemical hair remover followed by 
application of ultrasound transmission gel (Aquasonic, Parker Laboratories, Fairfield, NY, USA). 
The ultrasound recordings were performed with a high-frequency ultrasound system (30MHz, 
VisualSonics Vevo 770 system, Toronto, Canada) with an axial resolution of 55μm, a focal length 
of 12.7mm and a maximal field of view of 20mm. Scanning time was kept as short as possible 
according to the ALARA principle[13]. Between the three subsequent developmental stages that 
were assessed the pregnant mice were housed in cages in the animal facility.
ultrasound recording protocol 
All ultrasound recordings were performed by NDH and EEC. During the ultrasound recordings 
the two laterally located uterus horns were scanned for the presence and position of the em-
bryos/fetuses (n=105). In individual embryos/fetuses, the left and right side was established to 
identify the position of the heart including the individual cardiac compartments and structures. 
At 12.5dpc these compartments included the left atrium (LA), right atrium (RA), LV, RV, the 
common AV canal (cAVC) encompassing the future mitral valve (MV) and tricuspid valve (TV) 
orifices, common outflow tract (cOFT), developing inter-ventricular septum (IVS) and the inter-
ventricular foramen i.e. the continuity between the LV and RV before completion of ventricular 
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septation. At later stages (14.5 and 17.5dpc) the MV and TV orifices, aorta (Ao) and pulmonary 
trunk (PT) were identified. 
Pulsed-wave Doppler recordings
The methods that were used for pulsed-wave Doppler flow recordings are summarized in Table 
1. For flow measurements automatic Doppler angle corrections were accepted up to 45 degrees. 
Flow recordings across the cAVC (12.5dpc: future MV n=1;future TV n=11) and developing MV 
and TV orifices (14.5dpc: MV n=17, TV n=20;17.5dpc: MV n=16, TV n=14) were performed to 
assess the peak-E (Early/passive ventricular filling by ventricular relaxation in early diastole) and 
peak-A wave velocities (active ventricular filling due to atrial contraction), hence the E/A-ratios 
Table 1. The methods used for performing Doppler flow recordings per gestational age. DFT = diastolic filling time, 
IVRT = isovolumetric relaxation time, IVCT = isovolumetric contraction time, ET = ejection time, VTI = velocity time 
integral, cAVC = common atrioventricular canal, cOFT = common outflow tract, LVOT = left ventricular outflow tract, 
RVOT = right ventricular outflow tract. MV = mitral valve, TV tricuspid valve, Ao = aorta, PT = pulmonary trunk, IVS = 
interventricular septum.
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were calculated. The recordings across the cAVC and developing MV orifice were also used to 
evaluate the embryonic heart rate (HR) in beats per minute (BPM), cardiac cycle length (RR-
interval), diastolic ventricular filling time (DFT;12.5dpc n=11, 14.5dpc n=17 and 17.5dpc n=16), 
ejection time (ET;12.5dpc n=11, 14.5dpc n=17 and 17.5dpc n=16), isovolumetric contraction 
time (IVCT;12.5dpc n=7, 14.5dpc n=17 and 17.5dpc n=16) and isovolumetric relaxation time 
(IVRT;12.5dpc n=7, 14.5dpc n=17 and 17.5dpc n=16 ) of the LV (Figure 1a). The myocardial 
performance index (MPI;12.5dpc n=5;14.5dpc n=17;17.5dpc n=16) i.e. Tei-index that evaluates 
the combined LV systolic and diastolic function was calculated using the following formula: 
(IVRT+IVCT)/ET [14].
Pulsed-wave Doppler recordings were also performed in the cOFT at 12.5dpc (n=15) and Ao 
and PT at 14.5dpc (n=18 and n=12) and 17.5dpc (n=12 and n=4;Table 1). Furthermore, the veloc-
ity time integral (VTI) i.e. the area under the Doppler velocity envelope for one heart beat was 
determined (12.5dpc n=15;14.5dpc Ao n=18 and PT n=12;17.5dpc Ao n=12 and PA n=4) and 
the diameters of the cOFT (n=2) and Ao (14.5dpc n=3 and 17.5dpc n=2) were evaluated from 
B-mode echo-loops in order to calculate the mean stroke volume (SV) per developmental stage 
according to the following formula: mean SV=mean TVI x (mean diameter of Ao or cOFT/2)2 x 
π. Hence, the mean cardiac output (CO) was calculated (mean CO=mean SV x mean HR) for the 
three developmental stages.
m-mode measurements
For morphological assessment M-mode measurements in short or a long-axis views of the 
ventricles were performed, to evaluate the end-systolic and end-diastolic ventricular inner 
diameter of the LV (LVID;12.5dpc n=9, 14.5dpc n=11 and 17.5dpc n=14) and RV (RVID;12.5dpc 
n=9, 14.5dpc n=10 and 17.5dpc n=12) and IVS diameter (12.5dpc n=4, 14.5dpc n=6 and 17.5dpc 
n=9). Cardiac fractional shortening (FS%) for the LV and RV were calculated using the formula: 
(VIDdiastole–VIDsystole)/VIDdiastole x 100%. Due to the size of the hearts at 12.5dpc, the resolu-
tion often limited the possibility to discriminate the epicardial, myocardial and endocardial layer 
of the ventricular free wall. Therefore, at this stage the distances from the epicardial layer to the 
IVS in end-systole and end-diastole were used to calculate the FS%.
Although a complete hemodynamic and morphological assessment for each heart was aimed 
for (Table 2 for overview), imaging possibilities were regularly limited by the position of the 
embryo/fetus. All echocardiographic recordings were stored for off-line data analysis by NDH 
and EEC, inter-observed analysis demonstrated a high level of consistency (r=0.8-1.0;P<0.05). 
Flow parameters were calculated by the average of pulsed-wave Doppler complexes of three 
consecutive beats, similar methods were applied for M-mode recordings and diameter calcula-
tions on B-mode echo-loops.
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Figure 1. Development of left ventricular inflow patterns. 
(a) Shows an example of a pulsed-wave Doppler recording across the MV at 17.5dpc. (a’) Indicates the magnification 
of the boxed area in (a) in which the individual time intervals are indicated i.e. RR, DFT, IVCT, ET and IVRT. (b) Through 
(e) indicates the course of the DFT, ET, IVCT and IVRT respectively, throughout embryonic/fetal life. All values in (b-e) 
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Cardiac morphology and three-dimensional reconstructions
After the experiments, the pregnant mouse was sacrificed by cervical dislocation and embryos/
fetuses were extracted. We refer to previous publications for details regarding embryonic/fetal 
processing, sectioning, immunohistochemistry with MLC2a specific antibodies and preparation 
of the three-dimensional AMIRA reconstructions (AMIRA software package, Template Graphics 
Software, San Diego, USA) [15]. 
Statistics
All statistics were performed with the statistical package for the social sciences 15.0 (SPSS Inc, 
Chicago Ill, USA) and GraphPad Prism (GraphPad Software, La Jolla CA, USA). A P<0.05 (2-tailed) 
was considered to be significant, all values are given as mean±SEM. All boxplots indicate the 
upper and lower quartile of the median, which is indicated by the horizontal bar. The whiskers 
indicate max/min range of the values.
RESuLTS
Cardiac morphology
Reliable imaging of hearts as small as 2 mm was feasible in all stages examined. Representative ex-
amples are shown in online Movie 1 (available online at http://dx.doi.org/10.1155/2014/531324.) 
At embryonic stages (12.5dpc) ventricular septation has been initiated but is not completed 
resulting in a primitive inter-ventricular foramen that directly connects the lumen of LV and RV. 
M-mode recordings at these stages show a mean systolic IVS diameter of 0.20±0.045mm. Figure 
2a shows a reconstruction of a 12.5dpc embryonic heart, in which the lumen of the four cardiac 
chambers, inter-ventricular foramen and the OFT can be identified. The atrial and ventricular 
chambers are connected via the cAVC that harbors large AV cushions, which will contribute 
to formation of the MV and TV. The AV canal is still partly positioned above the LV at this stage. 
The developing OFT is still positioned completely above the RV and contains cushion tissue 
that will form the semilunar valves of the Ao and PT. They will further form the basis for the 
muscular subpulmonary infundibulum and will contribute to the membranous part of the IVS. 
Consequently, the blood from the LV runs via the primitive inter-ventricular foramen into the 
cOFT i.e. future Ao and PT. 
Table 3. The parameters used for calculation of the mean CO per gestational age.
Parameter 12.5 dpc (coFT) 14.5 dpc (Ao) 17.5 dpc (Ao)
VTI (mm) 33.9±1.37 42.3±2.0 29.2±2.05
mean diameter (mm) 0.23 0.18 0.48±0.03
mean HR (bpm) 134±11.2 148±6.1 206±9.8
mean Co (mL/min) 0.19 0.16 0.96
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Figure 2. Cardiac morphology and shortening fraction calculation. 
(a) Shows a reconstruction of anterior view of an embryonic heart of 12.5dpc. The myocardium is indicated in grey 
transparent. The LA and RA are indicated in transparent dark grey. The left ventricular (LV) and right ventricular (RV) 
lumen are indicated in red and blue, respectively. Note that the outflow tract lumen (purple) is positioned completely 
above the future RV, which is surrounded by large outflow tract cushions (green transparent). At these stages devel-
opment of the interventricular septum (IVS) has not yet completed leading to a direct connection between the LV 
and RV via the inter-ventricular foramen (arrow). (b) Anterior view of an early fetal heart of 14.5dpc. At this stage IVS 
development has completed and four separate cardiac chambers can be identified. The outflow tract consists of a 
separate aorta (Ao) and pulmonary trunk (PT) including their valve apparatus, which at these stages mainly consist 
of cushion tissue (green transparent). (c) Anterior view of a late fetal heart of 17.5dpc. At this stage the heart shows a 
mature morphological phenotype. (d) Schematic representation of LV and RV diameters and (e) shortening fraction 
at the three consecutive stages of development. RA = right atrium. LA = left atrium.
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At early fetal stages 14.5dpc the heart has increased in size (Figure 2b) and ventricular septa-
tion is now complete. The systolic diameter of the IVS has increased (0.24±0.018mm). In the AVC 
the TV orifice has expanded and is now situated entirely above the RV. Also the MV orifice can be 
identified as well as the developing AV valves. The cardiac OFT now consists of a separate Ao and 
PT connecting to the LV and RV, respectively. The Ao and pulmonary valves still show immaturity 
and consist of cushion tissue. 
Figure 3. Development of left ventricle and right ventricle inflow patterns. 
The graphs represent the course of the E/A-ratio (a,b), Peak-E wave (c,d) and Peak-A wave (e,f ) across the developing 
mitral valve and tricuspid valve at the three subsequent developmental stages. 
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At late fetal stages (17.5dpc) the size of the RV and LV and IVS (0.39±0.009mm) has increased 
significantly (Figure 2c). Mature valves are present at the levels of the in- and outflow part of 
both ventricles. 
Diastolic and Systolic function
During embryonic and fetal development the HR increases significantly (P<0.0001) from 125±9.5 
up to 219±8.3BPM. Ventricular inflow patterns across the developing MV and TV annulus were 
studied by pulsed-wave Doppler imaging. The DFT corrected for the RR-interval (DFT/RR) did not 
differ significantly at the three stages assessed (Figure 1b). LV and RV filling was dominated by the 
peak-A wave. Between 12.5 and 17.5dpc the peak-A wave of the developing MV annulus increased 
significantly (0.33±0.001m/s vs 0.42±0.014m/s;P<0.0001) whereas that of the TV also showed 
an increasing trend, albeit not significant (0.37±0.018m/s vs 0.41±0.019m/s;P=NS). The peak-E 
wave also increased significantly for both the LV (0.05±0.006m/s vs 0.18±0.005m/s;P=<0.0001) 
and RV (0.06±0.006m/s vs 0.18±0.012m/s;P=<0.0001), and showed a relatively greater increase 
than the peak-A wave during development. As a resultant, the E/A-ratio, a measure for the 
ventricular diastolic function, showed a significant increase for both the LV (0.16±0.015 vs 
0.44±0.013;P=<0.0001) and RV (0.16±0.010 vs 0.44±0.014;P=<0.0001) (Figure 3a-f ). 
The IVRT, one of the measures for diastolic LV function, corrected for the RR-interval (IVRT/
RR) demonstrated a significant (P=0.037) decrease between 12.5 (0.15±0.011) and 14.5dpc 
(0.12±0.004), and remained stable at later fetal stages 17.5dpc (0.12±0.003) (Figure 1e), indicat-
ing that LV myocardial relaxation remains stable after completion of IVS development during 
fetal life.
Figure 4. Pulsed wave Doppler flow measurements.
Pulsed wave Doppler flow measurements in the 
common outflow tract (OFT), Aorta and Pulmonary 
Trunk. The graph demonstrates the significant in-
crease of the peak blood flow measured in the cOFT 
at 12.5 and Aorta and Pulmonary trunk at 14.5 and 
17.5dpc. 
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The systolic function of the developing ventricles was assessed through studying the course 
of the FS%, IVCT/RR and ET/RR. Throughout embryonic and fetal development the FS% re-
mained constant for both ventricles and values ranged between ≈30-40%. Furthermore, except 
for 17.5dpc (LV: 40.6%, RV 35.7%;P=0.046) no significant differences were observed between the 
FS% of the LV and RV (Figure 2d,e). The mean IVCT/RR remained stable during all three stages 
≈0.09%, the ET/RR showed no changes between 12.5dpc (0.42±0.015) and 14.5dpc (0.43±0.010) 
but significantly decreased at 17.5dpc (0.40±0.006;P=0.017) (Figure 1c,d).
A combined assessment of LV systolic and diastolic function was performed by calculating 
the MPI. At embryonic pre-septated stages (12.5dpc), the MPI was 0.64±0.012 and decreased to 
0.49±0.017 (P=0.0002) after closure of the IVS at 14.5dpc. At late fetal stages (17.5dpc) the MPI 
did not change significantly (0.53±0.022;P=NS).
outflow tract and Cardiac output
The pulsed-wave Doppler recordings performed in the cOFT demonstrated a peak-flow of 
0.27±0.021m/s at pre-septated stages. As from 14.5dpc two individual ventricular outflow tracts 
could be discriminated, especially the high echo-density of the blood at these stages enabled to 
discriminate the flow in the Ao (0.34±0.013m/s) and PT (0.33±0.021m/s) that are closely related 
to each other. As can be observed in Figure 4, the peak flow increased significantly in the Ao (from 
0.27±0.021m/s to 0.36±0.016m/s;P=0.010) and PT (0.27±0.021m/s to 0.44±0.030m/s;P=0.003) 
along fetal life. 
Table 3 summarizes the HR, VTI and the diameters of the cOFT and Ao that were used to 
calculate the mean CO at the three developmental stages. Between 12.5 and 14.5dpc the CO 
remained stable, where after it increased to 0.96ml/min at 17.5dpc.
DISCuSSIoN
Heart development is a complex process, which has been extensively studied in both WT and 
genetically mutated mouse models [3]. It is only in the last decades that modern imaging tech-
niques like ultrasound enable the assessment of real-time hemodynamic and morphological 
changes that occur during mouse heart development [4-6;8;16-18]. Knowledge regarding these 
functional parameters is essential since abnormal flow in the developing heart might lead to 
CHD through aberrant activation of shear-stress responsive genes important in cardiogenesis 
[9;11]. In early reports describing the course of functional parameters during heart develop-
ment major variability exists in measured values. This is most likely related to the relatively low 
ultrasound frequencies of clinical ultrasound machines used to image the small hearts of mouse 
embryos/fetuses [16], and externalization of uterus horns during ultrasound assessment [18], 
which influences embryonic/fetal physiology. Isoflurane anesthesia, used in this study, only has 
a minimal effect on hemodynamics and diastolic function in adult mice and effect on embryos 
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is supposed to be marginal [6]. In the current study we aimed to provide an overview of hemo-
dynamic parameters and changes that occur at subsequent stages of heart development, using 
a high-frequency ultrasound system.
Compared with other reports in mouse using similar ultrasound techniques we did not only 
focus on development of the future LV but also on that of the RV. Key findings of our study are: 
1. A reliable assessment of LV and RV in- and outflow patterns can be performed from 12.5dpc 
to term; 2. A significant improvement occurs in the diastolic and systolic function of both LV and 
RV; 3. Over the developmental period of 12.5dpc to 17.5dpc, the ratio between RV and LV size, as 
well as the FS% of both ventricles did not change significantly. 
Knowledge regarding the functional parameters of the RV is important since the RV is com-
monly affected in CHD. During development, the RV including the TV annulus develops subse-
quent to the LV by addition of SHF derived cells to the developing heart [1]. Many genes have 
been identified that have an important role in the SHF contribution to the developing heart and 
mutations in these genes may lead to CHD [19].
At early embryonic stages endocardial cushion tissue is positioned in the primitive AVC and 
OFT, which later on will contribute to formation of the TV and MV and Ao and PT semilunar 
valves. Some clinical studies argued that AV valve regurgitation is a common phenomenon dur-
ing the first trimester of pregnancy [20]. Our study, in accordance with several others in mouse 
[4;6] and human [13] did not show signs of regurgitation at both early and late stages of heart 
development. Pulsed-wave Doppler recordings across the cAVC at 12.5dpc and MV and TV at 
14.5dpc demonstrated that the AV cushions mimic the function of normal AV valves at 17.5dpc. 
In our opinion especially the flow in the cOFT at early embryonic stages, which is completely 
positioned above the RV (see Figure 2a) might wrongly be identified as regurgitation of the de-
veloping AV valves/cushions. This stresses the importance of detailed knowledge regarding the 
rapid morphological changes the heart undergoes at especially the very early developmental 
stages. 
Regarding growth of the heart we demonstrated that there was a 31% increase of LVID, 34% 
of RIVD and 35% of IVS diameter from 12.5 up to17.5dpc. We showed a trend towards a smaller 
RVID as compared with the LVID at all stages, which was not mentioned in other studies. 
Diastolic and systolic function during heart development.
Improvement of ventricular systolic and diastolic function occurs throughout the length of 
embryonic and fetal development. With respect to the diastolic function we demonstrated a 
significant increase of E/A-ratio across the developing MV and TV orifices, which was related to 
an increase of the peak-E wave, i.e. the fraction of diastolic ventricular filling that is defined by 
ventricular relaxation. These data are in accordance with the study of Zhou and colleagues, who 
demonstrated that the E/A-ratio is increasing during development, which seems to continue up 
to approximately 3 weeks after birth [6]. Around day four after birth, the peak-E wave measured 
across the MV becomes more dominant than the peak-A wave indicating an improvement of 
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cardiac compliance and that LV filling becomes dominated by passive ventricular relaxation. 
Remarkably, these changes were not observed for the RV inflow patterns, where the peak-A 
wave remains dominant [6]. Human embryonic and fetal hearts show the same maturation 
course of E/A-ratios across the developing MV and TV as was demonstrated in multiple studies 
[21-25]. An abnormal course of E/A-ratio i.e. a decreasing [25;26] or an increasing trend [27] 
along development has been related to the presence of CHD.
With respect to systolic ventricular function, the FS% remained stable (≈30-40%) for both 
ventricles throughout development. We did find a significant difference favoring the LV FS% as 
compared with the RV FS% at 17.5dpc. Interestingly, the same phenomenon of FS% difference 
between LV and RV has been reported in a study of human fetal hearts between 14 and 40 weeks 
of pregnancy . However, as in mouse, differences between human LV and RV FS% is subtle, [28] 
and whether a decreased or decreasing FS is a predictor of CHD remains unknown. Furthermore, 
we did not find a decreasing trend of both LV and RV FS as was recently demonstrated during 
human fetal life [28;29]. With respect to the CO we noticed no change around the proces of ven-
tricular septation (between 12.5 and 14.5 dpc), where after a major increase occured to 0.96mL/
min near term (17.5 dpc). The initial CO decrease might be related to the fact that the mean 
diameter of the unseptated cOFT diameter was used at 12.5dpc compared with the isolated Ao 
diameter at 14.5dpc. The subsequent CO increase is mostly related to the dramatic increase of 
HR along fetal life. 
The MPI or Tei-index [14] is a measure for combined systolic and diastolic cardiac function and 
can be calculated for both ventricles. In order to assess the MPI three different time intervals 
are needed, the IVCT, IVRT and ET. For the LV these parameters can be easily obtained, since 
all three parameters can be assessed at once by placing the Doppler ultrasound beam across 
the developing MV orifice. Noticeably, in literature there is less data regarding RV MPI and its 
course along development, which might be related to the fact that for the RV not all three time 
intervals can be assessed in one view as was also suggested in a recent review by Godfrey et al 
[14]. The current study demonstrated a significant decrease of LV MPI between 12.5 and 14.5dpc, 
which might be related to the rapid morphological changes the heart goes through including 
completion of IVS leading to altered hemodynamic conditions in the developing heart. It is 
however also important to notice that at pre-septation stages not always the IVCT and IVRT can 
be identified separately so that calculation of the MPI is frequently not possible at very early 
stages of embryonic development. Between 14.5 and 17.5dpc we noticed a slight increase of the 
MPI suggesting that cardiac function improves at subsequent fetal stages; similar results have 
also been demonstrated in mouse [4] and human [30]. However, discussion remains regarding 
the exact course of the MPI, IVCT, IVRT and ET and whether isolated changes of one of the 
factors is a predictor for fetal demise and CHD. Interestingly with respect to IVRT% we observed 
a decreasing trend near completion of the IVS (between 12.5 and 14.5) whereafter it more or less 
remained stable throughout fetal life. A similar course was observed in a recent ultrasound study 
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in embryonic/fetal C57Bl6 mice [4]. Human embryos also showed a decreasing course of the 
IVRT% [13;21], and an elevated IVRT% has been implicated as a predictor of CHD [13].
CoNCLuSIoN
We demonstrated the course of several morphologic and hemodynamic parameters along 
embryonic and fetal life. Our data show that a reliable assessment can be made not only of the 
left, but also of right ventricular function during embryonic/fetal stages. We demonstrate an 
overall improvement of cardiac diastolic and systolic function of both LV and RV along heart 
development. The implementation of high-frequency ultrasound in embryonic/fetal mouse 
heart development is a promising and useful tool. The data presented in this study might be 
useful as reference values in future studies in genetic mutated mouse models of CHD. 
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Sinus node dysfunction is frequently observed in patients with congenital heart disease (CHD). 
Variants in the Vascular Endothelial Growth Factor-A (VEGF) pathway are associated with CHD. In 
Vegf120/120 mice, overexpressing VEGF120, a reduced sinoatrial node (SAN) volume was suggested. 
Aim of the study is to assess the effect of VEGF over-expression on SAN development and func-
tion. 
methods
Heart rate was measured in Vegf120/120 and wildtype (WT) embryos during high frequency 
ultrasound studies at embryonic day (E)12.5, 14.5 and 17.5 and by optical mapping at E12.5. 
Morphology was studied with several antibodies. SAN volume estimations were performed, and 
qualitative-PCR was used to quantify expression of genes in SAN tissues of WT and Vegf120/120 
embryos. 
Results
Heart rate was reduced in Vegf120/120 compared with WT embryos during embryonic echocar-
diography (52±17 versus 125±31 beats per minute (bpm) at E12.5, p < 0.001; 123±37 vs 160±29 
bmp at E14.5, p=0.024; and 177±30 vs 217±34 bmp, at E17.5 p=0.017) and optical mapping 
(81±5 vs 116±8 bpm at E12.5; p=0.003). The SAN of mutant embryos was smaller and more 
vascularized, and showed increased expression of the fast conducting gap junction protein, 
Connexin43. 
Conclusions
Over-expression of VEGF120 results in reduced heart rate and a smaller, less compact and hyper-
vascularized SAN with increased expression of Connexin43. This indicates that VEGF is necessary 
for normal SAN development and function. 
ABBREVIATIoNS
CX  Connexin
DFT  Diastolic filling time
ET  Ejection Time
HCN  Hyperpolarization-activated cyclic nucleotide-gated channel
ISL-1  Insulin gene enhancer protein
IVCT  Isovolemetric Contraction Time 
IVRT  Isovolemetric Relaxation Time
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MPI  Myocardial performance index
NKX2.5  Homeobox protein 2.5
PDGFR-alfa Platelet-derived growth factor receptor- alfa
SAN  Sinoatrial node
SSS  Sick sinus syndrome
TBX  T-box transcription factor
SHOX2  Short stature homeobox 2
VEGF  Vascular endothelial growth factor
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INTRoDuCTIoN
Sinus node (SAN) dysfunction, or sick sinus syndrome (SSS), can cause sudden cardiac death and 
is a frequent cause of pacemaker implantations [1]. SSS increases with age, but can be present 
in newborns and young patients in association with congenital heart disease (CHD) [2, 3]. The 
mechanism of SSS is not always surgery related and can be detected already in embryonic life 
in many CHD patients [4]. 
The SAN develops from the fifth week of development in humans (around embryonic day 
(E) 10.5 in mouse) from the sinus venosus myocardium, which expresses many genes including 
TBX18, TBX3, SHOX2, HCN4, ISL-1 and PDGFR-alpha [5]. The mature SAN consists of a head and tail 
and is vascularized by a SAN artery, in 65% of the cases arising from the right coronary artery, 
in 22% from the circumflex branch of the left coronary artery, and from both arteries in 10% [1].
In humans, genetic variants in the Vascular Endothelial Growth Factor-A (VEGF-A or VEGF) 
pathway have been associated with CHD like persistent truncus arteriosus [6], tetralogy of Fallot 
[7] and atrioventricular septal defects (AVSD) [8].
VEGF121, VEGF165 and VEGF189 are the three main isoforms of VEGF in humans, represented by 
Vegf120, Vegf164 and Vegf188 in mouse. Mutant Vegf120/120 mouse embryos over-express VEGF120 and 
do not express VEGF164 and VEGF188 [9], causing a local increase of VEGF and NOTCH expression 
[10]. Previous studies in the Vegf120/120 mouse focused on abnormalities of the outflow tract and 
coronary arteries [10, 11]. Compared with studies in humans with VEGF mutations [8], there are 
no studies in mouse describing the abnormalities of the inflow tract of the heart comprising the 
sinus venosus, pulmonary and cardinal veins (putative superior caval vein and coronary sinus), 
atria, and atrioventricular connection. Interestingly, Vegf120/120 mice have a reduced heart rate [9]. 
Moreover, the SAN was suggested to be hypoplastic in Vegf120/120 embryos, this was however not 
investigated in detail [12] and no data are available on the cardiac function of Vegf120/120 embryos. 
Furthermore, in-vitro studies revealed that VEGF can increase the expression of the gap junction 
protein, Connexin43 (CX43), thereby altering the conduction properties of the cardiac muscle 
[13, 14]. Additionally, Notch, which can be stimulated by VEGF through activation of VEGFR2, is 
suggested to keep cardiomyocyte precursors in a primitive state and promotes the expressions 
of NKX2.5 and HCN1 [15, 16].
New techniques, such as embryonic echocardiography [17, 18] and optical mapping [19] allow 
the assessment of cardiac function and hemodynamic consequences as early as E12.5 in mouse 
embryos [18]. In the current study, these techniques were used to establish the role of the VEGF 
signaling pathway on SAN and inflow tract development and function in the Vegf120/120 mouse 
model.
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mETHoDS
All experiments were approved by the local animal welfare committee (DEC no: 10177) of the 
Leiden University Medical Center and performed according to institutional guidelines. SAN 
function and cardiac development were studied in wildtype (WT) and Vegf120/120 embryos. Heart 
rate and hemodynamic parameters were assessed at E12.5, E14.5 and E17.5 with high frequency 
ultrasound, enabling the study of the heart in vivo, thus reducing the effect of autonomic dener-
vation. Heart rate was additionally analyzed with ex vivo optical mapping at E12.5, during which 
no Isoflurane anesthesia was used. SAN morphology (E12.5 till E17.5) was studied and volume 
estimations (E12.5 and E17.5) were performed. The expression profiles of genes in the SAN were 
studied with q-PCR in the samples of E17.5 collected with lasercapture microdissection. 
Generation of Vegf120/120 embryos
A routine breeding program was performed with mice heterozygous for the 120-isoform 
of the Vegf gene (Vegf+/120) kindly received form Professor Carmeliet [9], more than 10 times 
backcrossed. This resulted in WT (Vegf+/+), heterozygous (Vegf +/120) and mutant embryos with the 
over-expression of the Vegf 120-isoform (Vegf120/120) and no expression of Vegf164 and Vegf188 as 
described previously [10]. The day after the breeding was considered E0.5. 
ultrasound recording protocol 
Ultrasound recordings were performed using the Vevo770 ultrasound system (VisualSonics, 
Toronto, Canada), with a 40 MHz transducer. The embryos were studied longitudinally at E14.5 
and 17.5. The ultrasound examination at E12.5 was performed separately in pregnant mice as 
examination at this stage resulted in embryonic mortality at E17.5. In order to trace back an 
individual embryo at subsequent stages (E14.5 and E17.5) of development the maternal bladder 
was used as reference point. The first embryos positioned next to the left and right sides of the 
bladder were assessed. 
The ultrasound protocol was performed as described previously [18]. In short, Pregnant Vegf+/120 
mice were anesthetized with 1.5% Isoflurane (induction with 5% Isoflurane) via a cone-shaped 
nose mask. During the experiments maternal vital signs were monitored continuously. Echo-
doppler recordings over the atrioventricular valves of the embryos were performed to evaluate 
fetal heart rates (Figure 1A). Additionally, functional data were derived on passive or early fill-
ing (E-peak), atrial contraction or late filling (A-peak), diastolic filling time (DFT), isovolumetric 
contraction time (IVCT), ejection time (ET) and isovolumetric relaxation time (IVRT). Myocardial 
performance index (MPI) was calculated as (IVRT + IVCT)/ET. 
Ultrasound assessments were completed <30 min to limit a possible negative effect of 
Isoflurane on the function of the embryonic heart. Following the ultrasound experiment of 
E12.5 or E17.5 the pregnant mouse was sacrificed by cervical dislocation and the embryos were 
harvested. 
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Offline analyses of the echocardiographic recordings were performed blindly using Visual 
Sonics analytical software. The ultrasound measurements were performed in 28 WT embryos 
(E12.5: N = 11, E14.5 = 15, E17.5 = 12) and 14 Vegf120/120 embryos (E12.5 N=4, E14.5 = 6, E17.5 
= 7). WT embryos in this study were also included in the previously published reference series 
[18]. Heterozygous embryos did not show differences compared with WT in morphology or 
echocardiographic parameters and were therefore excluded from further analysis.
optical mapping
Optical mapping was performed at E12.5. To exclude any effect of anesthesia, optical mapping 
was also performed in a series of embryos that did not undergo previous anaesthesia during 
echocardiography (WT N=8 and Vegf120/120, N=7). Prior to optical mapping, embryos were de-
capitated and the thoracic region containing the heart was stained with the voltage sensitive 
dye di-4-ANNEPS for 5 min in Tyrode solution as described previously [20, 21]. Briefly, hearts 
were allowed to equilibrate in warm (37 ±0.5°C) oxygenated Tyrode solution before mapping 
using the Ultima-L mapping setup (SciMedia, Costa Mesa, CA, USA). Analysis of the recordings 
was performed using the BV-Analyzer software (Brain Vision). The time point of the maximum 
upstroke velocity determined the activation time points, which were defined as dF/dtMAX. The 
initial atrial activation point was determined by analyzing the total activation pattern of the 
atria and determining the location of the first atrial signal. The same was done for the ventricular 
activation pattern. The RR-interval was calculated as the time in milliseconds (ms) between two 
initial atrial activation points (Figure 1B). With this interval, heart rate in beats per minute (bpm) 
was calculated. Atrioventricular (AV) conduction time was determined by subtracting the first 
activation time point in the atria from the same point in the ventricles and then subtracting the 
total atrial activation time.
Harvesting of Vegf120/120 embryos
After fetal ultrasound and optical mapping, embryos were harvested and their tails collected 
for routine genotyping procedures as described previously [10]. Thoraxes were fixed in 4% 
paraformaldehyde phosphate (PFA) buffer pH7.4 for 24-48 h, after which they were stored in 
70% alcohol and embedded in paraffin, followed by the preparation of 5 μm sections for im-
munohistochemistry and 10 μm sections for lasercapture and quantitative real time-polymerase 
chain reaction (qPCR) analysis
Immunohistochemistry 
Routine immunohistochemical staining procedures were performed as described previously 
[22] using antibodies against Troponin-I, isoform 2 (TNNI2) (1/800, SC-15368, Santa Cruz Biotech-
nology Inc., Dallas, USA) and NKX2.5 (1/4000, SC-12514 Santa Cruz Biotechnology Inc., Dallas, 
USA) to study myocardial contributions; HCN4 (1/1000,APC-052 , Alomone Labs, Jerusalem, 
Israel) the highest expressed sodium/potassium channel in the SAN [23]; the gap junction 
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channels Connexin40 (1/100, SC-20466, Santa Cruz Biotechnology Inc., Dallas, USA), Connexin43 
(1/250, C-6219, Sigma-Aldrich Chemie) and Connexion45 (1/250, SC-7676, Biotechnology Inc., 
Dallas USA); the autonomic nerve markers Tyroxin Hydroxylase (1/500, PA-14679, Fisher Emergo 
BV, Landsmeer, The Netherlands) and Ncam (1/8000, AB-5032, Chemicon, Temecula, USA); the 
endothelial marker Pecam-1/CD31 (1/4000, Sc-1506-R, Santa Cruz Biotechnology Inc., Dallas, 
USA). The secondary antibodies used were either 1/200 goat anti-rabbit biotin (BA-1000, Vector 
Laboratories, Burlingame, USA) and 1/66 goat serum (S1000, Vector Laboratories, Burlingame, 
USA) in PBS-Tween-20 or 1/200 horse anti-goat biotin (BA-9500, Vector Laboratories, Burlingame, 
USA), and 1/66 horse serum (S-2000, Vector Laboratories, Burlingame, USA ) in PBS-Tween-20. 
For immunofluorescent stainings, Alexa Fluor 488 Donkey Anti-Rabbit IgG (1/200, A-21206, 
Invitrogen, Molecular Probes, Eugene, USA, A-21206) and Alexa Fluor 555 Donkey Anti-Goat IgG 
(1/200, A-21432, Life technologies Carlsbad, California, USA, A-21432) were used. To amplify non-
fluorescent stainings ABC-reagent (PK-6100, Vector Laboratories, Brunschwig Chemie) was used 
Figure 1. Lower heart rate in Vegf120/120 compared with Wild type embryos.
Blindly analyzed measurements of fetal echocardiography (A) and optical mapping (B). A significantly lower heart 
rate was observed in Vegf120/120 compared with wild type (WT) embryos with echocardiography at E12.5, E14.5 and 
E17.5 (C). Optical mapping analysis at E12.5 confirmed the lower heart rate (D), with a trend towards a longer atrio-
ventricular (AV) time (E) and no difference in atrial (F) and ventricular (Vent.) activation times (G). MS = milliseconds.
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and for visualization, 3-3’di-aminobenzidin tetrahydrochloride (DAB, Sigma-Aldrich Chemie, 
USA) was used. Counterstaining was performed with 0.1% haematoxylin (Merck, Darmstadt, 
Germany). For fluorescent staining, nuclei were stained with DAPI (1/1000, Life technologies, 
Carlsbad, California, USA ) and the slides were mounted with Prolong gold (Life technologies, 
Carlsbad, California, USA).
morphometry of the sinoatrial node
SAN volume estimations were performed in 4 WT and 4 Vegf120/120 embryos at E12.5 and in 4 
WT and 10 Vegf120/120 embryos at E17.5. Morphometry was based on the Cavelieri’s principle as 
described by Gunderson and Jensen in 1987 [42] and applied in our previous studies [24]. Briefly, 
regular spaced (49mm2) points were randomly placed on the TNNI2 and HCN4 positive and 
NKX2.5 negative stained SAN cells. The distance between the subsequent slices was 0.025mm 
in E12.5 embryos and 0.035mm in E17.5 embryos. Olympus microscope was used with a 400× 
magnification objective for E12.5 embryos and 200× for E17.5 embryos. To assess a possible ef-
fect of VEGF120 over-expression on cardiac size and to relate SAN volume changes to myocardial 
volume changes, the total ventricular myocardial volumes were estimated at E12.5 and E17.5, 
with distances between the subsequent slices ranging from 0.075mm to 0.150mm, 100mm2 
points and a 40× magnification objective. The SAN myocardium / ventricular myocardium ratio 
was calculated to exclude an effect on overall myocardial volume change. Furthermore, the si-
nus venosus myocardium, i.e. the NKX2.5 negative myocardium [25, 26], was calculated at E12.5, 
using 0.025mm slice distance, 100mm2 points and a 400x magnification. 
Lasercapture microdissection and qPCR of sinoatrial node
To study the genetic profile of the SAN, quantitative real time-polymerase chain reaction (qPCR) 
was performed using the SAN tissue of E17.5 embryos. The material was collected using laser-
capture microdissection with a PALM microlaser system (PALM MCB, Bernried, Germany). After 
fixation for 24 h in 4% PFA and embedding in paraffin, sections of 10μm were cut, mounted 
on polyethylene naphthalate membrane-coated slides (Zeiss, Gottingen, Germany) and im-
mediately dehydrated with xylene for 10 min. SAN and ventricular tissues were dissected and 
collected in adhesive caps (Zeiss, Gottingen, Germany). The SAN was defined as the bulging 
structure at the medial side of the entrance of the cardinal vein into the right atrium, containing 
a SAN artery (supplemental Figure 1). Six to eight sections with the SAN material of one embryo 
were collected. RNA was isolated from the tissue using the RecoverAll Total Nucleic Acid Isolation 
Kit from Ambion (Foster City, California, USA, 1975) according to the manufacturer’s protocol. 
cDNA was synthesized by using the iScript cDNA synthase kit from Biorad (Berkely, California, 
USA, 170-8891). For internal negative control no Reverse Transcriptase reactions were carried 
out, all according to protocol. qPCR was performed in 5 WT and 5 mutant samples (Vegf120/120) for 
Hcn4, Hcn1, Tbx5, Tbx3, Nkx2.5, Vegf, Cx40, Cx43 and Cx45, with RT² SYBR® Green qPCR Mastermix 
(330500) using the CFX96 Fast Real-Time PCR System with the use of Bio-Rad CFX Manager 3.1 
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software. Each reaction was carried out in triplicate for each sample. All samples were processed 
using a nested qPCR approach. In short, samples underwent a first round of PCR using the first 
primer set for 15 cycles at 55°C for product-specific pre-amplification. Then, a second round of 
amplification was carried out using one of the previous primers with a newly designed primer 
specific for the pre-amplified product. A list of the gene-specific primers used is provided in the 
data supplementary 2. Relative gene expression was normalized to Gapdh to compensate for 
the differences in the RNA input.
Statistics
The SPSS software program (version 20.0 IBM SPSS, Chicago, Illinois) was used for statisti-
cal analysis. Data are presented as mean ± standard deviation. Differences between WT and 
Vegf120/120 embryos were analyzed with the independent sample t-test in case of normal distribu-
tion and with the non-parametric Mann-Whitney U-test when data was not normally distributed. 
A P<0.05 was considered to be statistically significant.
RESuLTS
Experiments were aimed to detect differences in function and morphology of the developing 
cardiac inflow tract including the SAN between WT and Vegf120/120 embryos. Below firstly ob-
servations in function and morphology of the SAN in wild type (WT) versus Vegf120/120 embryos 
are shown. Subsequently other inflow tract abnormalities are described. The main quantitative 
parameters are presented in Table 1. 
Functional assessment of the sinoatrial node: results obtained from high frequency 
ultrasound and optical mapping 
Heart rate was assessed with high frequency ultrasound during developmental stages. Figure 
1C shows that heart rates were lower in Vegf120/120 as compared with WT at all stages examined: 
E12.5 (52±17 bpm versus 125±31 bpm, p<0.001), E14.5 (123±37 bpm vs 160±29 bmp p=0.024) 
and E17.5 (177±30 vs 217±34 bmp, p=0.017). No irregular heart rhythms were observed during 
Table 1. Quantitative measured parameters (with N) at different stages.
WT Vegf120/120 Significance
Heart rate (bpm) (high frequency ultrasound)
E12.5 125±31 (11) 52±17 (4) p<0.001
E14.5 160±29 (15) 123±37 (6) p=0.024
E17.5 217±34 (12) 177±30 (7) p=0.017
Heart rate (bpm) (optical mapping) E12.5 116±8 (8) 81±5 (7) p=0.003
SAN volume (mm3)
(morphometry)
E12.5 0.0018±0.00017 (4) 0.0011±0.00014 (4) p=0.029
E17.5 0.006±0.0008 (4) 0.003±0.0007 (10) p=0.002
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echocardiographic studies. As VEGF is involved in the promotion of sympathetic innervation 
[27], differences in heart rate may be attributed to a disturbed autonomic innervation of the 
SAN. Based on TH, expressed in the sympathetic nerve system and NCAM, a more general 
nerve marker no differences between Vegf120/120 and WT embryos were observed in size and 
number of the autonomic ganglia as well as the peripheral nerve patterns (Supplementary 3). 
To further exclude potential autonomic effects and a possible role of Isoflurane anesthesia, opti-
cal mapping was performed in ex vivo hearts at E12.5. The decreased heart rate in Vegf120/120 
embryos compared with the WT was confirmed with optical mapping (81±5 bpm vs 116±8 
bpm; p=0.003, Figure 1D). No differences in heart rate were observed between embryos that 
underwent embryonic echocardiography with anesthesia and those that were directly used 
for optical mapping. Additionally, the measurements showed a tendency towards a prolonged 
atrioventricular (AV) interval in Vegf120/120 embryos when compared with WT (119±12 ms vs 94±6 
ms; p=0.072) (Figure 1E). Total atrial activation times and patterns were not disturbed in Vegf120/120 
embryos as compared with WT (5.4±0.54 ms vs 5.1±0.48ms; p=0.713, Figure 1F). Total ventricular 
activation times and patterns were also normal in Vegf120/120 embryos (4.2±0.53 ms vs 3.4±0.18 
ms; p=0.126, Figure 1G). 
morphological analysis of the sinoatrial node: results obtained from histological 
examination and morphometry 
To assess possible causes of the reduced heart rate observed by echocardiography and optical 
mapping, the morphology of the SAN was studied ex-vivo. Myocardialization of the sinus veno-
sus progresses during development and at E12.5 in WT embryos the myocardial sleeve around 
the cardinal veins covers nearly (± 90%) of the circumferential wall. There is a large putative right 
SAN (TNNI2 and HCN4 positive, NKX2.5 negative) at the entrance of the right cardinal vein and 
also a smaller left SAN at the entrance of the left cardinal vein, as described previously [25]. In 
Vegf120/120 mutant embryos at E12.5 the myocardial sleeve and the right SAN are also present. 
No evident difference in the length of the sleeves covering the cardinal vein was observed and 
total sinus venosus myocardium volume, was not significantly different between Vegf120/120 and 
WT (E12.5 0.0055±0.001 mm3 vs 0.0079±0.002 mm3, p=0.179). At stages E14.5 and E17.5, when 
ventricular septation is completed, a clear right-sided SAN could be detected in WT with a single 
SAN artery. In Vegf120/120 embryos at E17.5 the SAN was shortened and positioned more cranial 
compared with WT embryos. The expression patterns of TNNI2 (Figure 2D and 2G), and HCN4 
(Figure 2E and 2H) were unaffected, as in previous stages. Strikingly, PECAM staining showed 
large vascular structures in the SAN of mutant embryos, as compared with the single SAN artery 
in WT embryos (Figure 2F and 2I). 
As the SAN in the Vegf120/120 embryos appeared smaller during morphological examination, 
morphometry was performed. The SAN in the Vegf120/120 embryos were significantly smaller at 
E12.5 (0.0011±0.00014 mm3 vs 0.0018±0.00017 mm3 p=0.029) and at E17.5 (0.003±0.0007 mm3 
vs 0.006±0.0008 mm3 p=0.002) compared with WT (Figure 2A). Additionally, the ventricular myo-
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cardial volume measurements were performed to exclude an overall decrease of myocardium. 
At E12.5 no significant difference was observed between Vegf120/120 and WT embryos (0.23±0.03 
mm3 vs 0.26±0.02 mm3). At E17.5 a non-significant trend towards a smaller volume of the 
Vegf120/120 embryos was seen (1.53±0.35 mm3 vs 1.32±0.14 mm3) (Figure 2B). However compared 
with WT the SAN myocardium/ventricular myocardium-ratio was smaller in Vegf120/120 embryos 
at E12.5 (0.0081±0.0002 vs 0.0044±0.0003, p=0.029) and E17.5 (0.0041±0.0017 vs 0.0023±0.0004, 
p=0.004) (Figure 2C). 
Examination of cellular coupling in the sinoatrial node: results of  
immunostaining and qPCR
The next step in the analysis was aimed at studying the expression profile of the SAN, with 
emphasis on connexins. As VEGF can increase the fast conducting CX43[13], the expression 
Figure 2. Smaller volume and less compact sinoatrial node with extensive vasculature in Vegf120/120 embryos.
Morphometric analysis showed a smaller sinoatrial node (SAN) volume at E12.5 and E17.5 (A) and no difference 
in ventricular myocardial volume at E12.5 and E17.5 (B). The ratio between SAN and ventricular myocardium was 
significantly smaller in Vegf120/120 embryos at E12.5 and E17.5 (C). Morphologic analysis of the SAN with staining for 
TroponinI, HCN4 and PECAM. The SAN (black dotted line) is situated at the medial side of the entrance of the right car-
dinal vein (RCV) into the right atrium (RA). The SAN appears less compact with extensive vasculature (black arrows) in 
Vegf120/120 embryos (G-I) compared with WT control (D-F). * = p <0.05, ** = p <0.01. AO = aorta, PT = pulmonary trunk.
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of CX43 in Vegf mutants was studied. In both WT and Vegf120/120 embryos CX43 was clearly ex-
pressed in the ventricles (Figure 3). In E17.5 WT embryos CX43 was also expressed in the atria 
and myocardium surrounding the cardinal veins, but not in the SAN itself, that was separated 
from the working myocardium by a TNNI2 negative zone of tissue, corresponding to the previ-
ously described fibrotic conduction barrier [28] (Figure 3). By contrast, in Vegf120/120 embryos C43 
expression extended over this conduction barrier and was observed in the caudal part of the 
SAN (Figure 4). 
In order to endorse the observed result, qPCR at E17.5 SAN tissues was performed. The primers 
for several known genes mandatory for SAN development Hcn4, Hcn1, Nkx2.5, Tbx3 and Tbx5, 
were included, as well as primers for Connexin40 (Cx40), Cx43 and Connexin45 (Cx45) (Figure 5). 
One Vegf 120/120 sample was excluded because of the presence of Nkx2.5, suggesting that atrial 
myocardium was dissected instead of the SAN. The other samples were used for analysis, and 
showed no significant difference in the SAN markers Hcn4, Hcn1, and Tbx3, or in Tbx5 (Figure 
Figure 3. Unaffected Connexin43 ex-
pression in ventricular myocardium.
No difference was observed in expres-
sion level of Connexin43 in the ventricle 
of wild type (A-C) and mutant (D-E) 
embryos (E17.5). In C and F TroponinI 
(TropI) is stained red, Connexin43 (Cx43) 
white and nuclei (DAPI) blue. 
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5). Interestingly, Cx43 was detected in 40% of WT and in 100% of the Vegf120/120 embryos and 
levels of Cx43 were distinctly increased in Vegf120/120 embryos. The Cx43 level in the ventricle 
was the same in mutants and WT embryos in accordance with the observed protein expression 
patterns (Figure 3B and E). Cx40 was equally expressed in WT and mutant embryos. Cx45 showed 
Figure 4. Overexpression of Connex-
in43 expression in the sinoatrial node of 
Vegf120/120 embryos.
In a E17.5 wild type embryo CON-
NEXIN43 (CX43) is expressed in the wall 
of the cardinal vein (white arrow in A), 
but not in the SAN (B-D), whereas in a 
Vegf120/120 embryo the CX43 continues 
from the cardinal vein wall into the 
caudal part of the SAN (E-H). Tropo-
nin (Trop-I) is stained red, Connexin43 
(Cx43) white and nuclei (DAPI) blue. 
White arrows in H point at CX43 expres-
sion in the SAN. 
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Figure 6. Underdeveloped atrioventricular cushion in Vegf120/120 embryos.
In a WT embryo at E17.5 the leaflets of the left atrioventricular valve have developed into thin structures (asterisks 
in B), whereas the AV valve in the Vegf120/120 embryo is plump (asterisks in D). Moreover a partial AVSD is seen in the 
Vegf120/120 embryo (black arrow in D). RA= Right Atrium, RV = Right Ventricle, LA = Left Atrium, LV = Left Ventricle IAS= 
interatrial septum.
Figure 5. q-PCR of genes in SAN reveals an 
increase of Connexin43 in Vegf120/120 versus 
wild type embryos
Q-PCR of genes in SAN samples of wild type 
and Vegf120/120. Error bars depict standard er-
ror of the mean. Values given under the graph 
show the percentages of samples in which 
expression of the gene was detected.
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variability in both WT and mutant embryos. Samples with high expression of Cx43 showed low 
expression of Cx45 and vice versa.
As local differences in VEGF levels have been described in Vegf120/120 embryos [10], the total 
VEGF expression (i.e. the sum of all isoforms) was also studied. With immunohistochemistry 
stainings no detectable differences in VEGF staining in the SAN was observed between mutants 
Table 2. Phenotype of Vegf120/120 embryos in which ultrasound was performed at both E14.5 and 17.5. AV= atrio-




Sub-aortal VSD, overriding aorta and small PT 4 
Sub-aortal VSD, overriding aorta, normal PT 2
Absent ductus arteriosus 5
Plump AV valve 5
AVSD 1
Figure 7. Working model: proposed mechanism of bradycardia in Vegf120/120 embryos.
In Vegf120/120 embryos, increased Connexin43 causes more electrical coupling and ionic shift between neighboring 
cells in the sinoatrial node (SAN). This results in prolongation of the loading time (i.e. time to depolarization) of the 
SAN cells. Connexin43 crossing the conduction barrier also results in reduced isolation (and increased electrical cou-
pling) of the SAN from atrial myocardium. The prolonged loading time of cells in the SAN and reduced isolation of 
the SAN, may lead to bradycardia. Moreover, the increased vascularization causes reduced volume and compaction 
of the SAN, which may also lead to reduced intrinsic automaticity and bradycardia. 
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and WT embryos. With qPCR total Vegf expression was detectable in one out of five WT embryos 
and in four out of five mutants, suggesting a net overexpression of VEGF.
Analysis of congenital anomalies at the inflow tract of the heart  
in Vegf120/120 embryos
To assess structural cardiac abnormalities specifically at the inflow tract of the heart, serial 
sections were examined. As previously described [10], at the level of the outflow tract (OFT), 
Vegf120/120 embryos showed phenotypes varying from normal to a tetralogy of Fallot (Table 2). 
At the level of the inflow tract, large and dysplastic atrioventricular valves were observed in five 
embryos and a partial AVSD in one case (Table 2, Figure 6). Pulmonary veins drained at a normal 
position in all mutant embryos. Although the interventricular foramen should have closed at 
stage E14.5, VSDs could be visualized by echo at both E14.5 and E17.5 in Vegf120/120 embryos 
(Supplementary movie 1). The E/A ratio, a diastolic function parameter reflecting the flow over 
the AV valve caused by passive (E) and active (A, reflecting atrial contraction) filling of the ven-
tricles, was studied. The embryo with an AVSD and plump AV valves had a lower E and A peak 
velocities compared with WT controls at E17.5 (Figure 1A). In normal hearts, the E/A ratio over 
the mitral and tricuspid valves increases between E14.5 and E17.5 [18], reflecting an improve-
ment of ventricular relaxation (diastolic function). The flow over the mitral valve was unaltered 
in Vegf120/120 embryos. In contrast, the E/A ratio over the TV did not show the same increase as 
was seen in the WT embryos (Vegf120/120 embryos from 0.31±0.05 to 0.34±0.07 between E14.5 
and E17.5 versus and increase from 0.31±0.04 to 0.48±0.05 in WT, p=0.03 at E17.5), indicating 
impaired right ventricular relaxation. The MPI, suggested to be an early marker of diastolic and 
systolic dysfunction [29], of Vegf120/120 embryos fell in the normal range of WT embryos (data not 
shown). The Vegf120/120 embryo that died between E14.5 and E17.5, had a low MPI (0.32 versus 
0.49±0.07 in WT), suggesting that the MPI is indeed a marker for poor prognosis. 
DISCuSSIoN
Congenital heart disease is often associated with conduction disorders, such as sinus node 
dysfunction, both before and after surgical correction[30, 2, 3, 4]. Furthermore, normal blood 
flow hemodynamics are required for cardiac development and a reduced heart rate may result in 
abnormal valve development in zebrafish [31]. Therefore normal function of the cardiac conduc-
tion system ensuring proper blood flow during early development is essential for cardiogenesis. 
In the current study, the role of VEGF in embryonic development of the inflow part of the heart 
was studied with emphasis on the function and morphology of the developing SAN.
Key findings of this study are: 1) Vegf120/120 embryos have a lower heart rate as detected by 
echocardiography and optical mapping; 2) the SAN in Vegf120/120 embryos is hypervascular-
ized, with smaller volume, and shows aberrant expression of gap junction channels with high 
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conduction velocity; and 3) besides the known OFT defects, Vegf120/120 embryos show abnormal 
inflow tract development including AVSDs and aberrant AV valve inflow patterns.
A role for VEGF in sinoatrial node function
Even though the anatomical shape of the SAN differs between species, in all species adequate 
function of the SAN requires: 1) Cells with pacemaker potential, expressing potassium/sodium 
channels, gap junction channels with low conductance (Cx45, Cx30.2 and Cx30) [32], lack of 
expression of high conductance gap junctions (Cx43) and specific intracellular Ca2+ dynamics 
[33] 2) Anatomical isolation of the SAN from the atrial myocardium by coronary arteries and 
connective tissue to prevent depression of the pacemaker automaticity from the resistive load 
of the atrial myocardium [28] 3) Autonomic innervation including sympathetic and parasympa-
thetic innervation, which in large mammals (human) is dominated by vagal tone and in mice by 
adrenergic stimulation [34] and 4) Presence of adequate pacemaker volume and both the head 
and tail components of the SAN. The latter is important, as both components have a different 
pacemaker potential (head is a faster pacemaker compared with the tail) and a shift in leading 
pacemaker activity can cause heart rhythm differences [28]. In the current study, impaired SAN 
function in Vegf120/102, reflected by a low heart rate observed with two independent techniques, 
suggests a role for VEGF in SAN development. The optical mapping data, confirming the lower 
heart rate, indicate that abnormalities in the conduction system of Vegf120/120 embryos are re-
stricted to the SAN.
Bradycardia in Vegf120/120 embryos due to less compact, hypervascularized node with 
a smaller volume 
In human elderly patients a decrease in theSAN volume has been suggested to contribute to a 
higher incidence of SSS [35], nevertheless little is known about the minimum volume required 
for an adequate pacemaker function. The reduction of the SAN volume can be caused by either 
diminished growth or increased decomposition of the SAN cells. Mutant mouse models of 
genes expressed in the posterior second heart field (including the Shox2, Podoplanin, Id2, Tbx3 
and Pdgfr-alpha mutant mouse embryos [5]), largely share a phenotype with hypoplasia of the 
cardinal (putative caval) vein myocardium, hypoplasia of the SAN, aberrant expression patterns 
of Connexins and NKX2.5 and sinus node bradycardia. VEGF is expressed in the sinus venosus 
myocardium, however in Vegf120/120 mutants no overt hypoplasia of sinus venosus myocardium 
was observed. Consequently a reduced contribution of the sinus venosus myocardium most 
likely is not the only cause of a smaller SAN volume. 
The extensive vascularization in the SAN of Vegf120/120 embryos is in line with previously de-
scribed irregular, tortuous and dilated capillaries in Vegf mutants [9] and with the fact that over-
expression of VEGF120 induces irregular and dilated vessels [36, 11]. As these vascular structures 
were not included in the measurements of the SAN volume, they could explain the decrease in 
the SAN volume. In the elderly a reduction in the SAN volume due to ischemia and fibrosis and a 
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change in the expressions of ion channels and gap junctions are considered a cause of SSS [37]. 
A similar effect may play a role in the Vegf120/120 embryos (Figure 7). Furthermore a prolonged 
corrected sinus nodal recovery time has been described in patients with SSS and a coronary 
anomaly [38], suggesting an impact of abnormal coronary distribution on the SAN. The abnor-
mal coronary arterial supply described in Vegf120/120 embryos might contribute to diminished 
development of the SAN.
Bradycardia in Vegf120/120 embryos due to over-expression of Connexin43
In the initial study reporting Vegf120/120 embryos, a decrease in Cx43 levels was observed in the 
ventricles of postnatal mutants with ischemic cardiomyopathy [9], which we did not observe. 
Possibly, a decrease in Cx43 in the ventricle only becomes present when ischemia escalates 
after birth. Total VEGF mRNA has been shown to be indifferent in Vegf120/120 embryos , but a 
local increase of VEGF has been observed in a.o. the OFT [10]. Even though the mRNA levels of 
VEGF were too low to detect in all embryos, the higher percentage of mutant embryos in which 
VEGF could be detected, suggest a net over-expression of VEGF in the SAN of mutants. Human 
VEGF165 is known to increase CX43 in vitro [13, 14]. Possibly, VEGF120 has a similar effect on Cx43 
in Vegf120/120 mutants. The effect might also be due to decreased expression of Vegf164 and Vegf188 
in Vegf120/120 mutants. Gap junctions consist of connexin protein complexes and play a role in 
communication and conduction between neighboring cells. The spontaneous depolarization of 
pacemaker cells (phase 4) is caused by the slow inward depolarization of the cell via “funny” cur-
rents. The slow velocity gap junctions (Cx45) cause poor electrical coupling to other cells in the 
SAN which is essential for fast repolarization and thus allows for high frequency depolarization, 
which keeps the cells in the lead. The poor electrical coupling to the surrounding myocardium is 
essential for the spontaneous depolarization, because the trigger is then only due to the funny 
current (channel related) and not due to ionic fluxes from the myocardium (gap junction related) 
[40]. Cx43 is a gap junction protein associated with fast conduction, mainly expressed in the 
working myocardium [41], which has a lower intrinsic automaticity as compared with the SAN. 
We propose that the increase of Cx43, observed in this study, improves electrical coupling in 
the SAN, causing a lower resistance for ions to move from one cell to another. This increases 
the loading time needed to repolarize individual SAN cells and thus decreases the frequency of 
depolarization (Figure 7).
This finding in mice is in agreement with a recent large genome-wide association study in hu-
man, where a genetic variant near the Cx43 gene is associated with variations in the resting heart 
rate [39], suggesting a role of Cx43 on the heart rate. Moreover conduction barriers to prevent 
the suppression of the pacemaker activity by the atrium, described as a sudden break of Cx43 
expression, are important for the normal SAN function, and in humans with the SAN dysfunction, 
areas of nodal to atrial continuity have been detected [40]. Expansion of Cx43 into the SAN, as 
observed in the Vegf mutants, can disturb this conduction barrier. Further electrophysiological 
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investigation of the SAN using high resolution optical mapping or micro-electrode arrays [41] is 
required to investigate a shift of pacemaker initiation within the SAN. 
Abnormal development of the cardiac inflow tract
In humans, VEGF has been associated with in- and outflow tract defects and the Vegf120/120 mouse 
model has previously been described with a tetralogy of Fallot phenotype. In the current study 
abnormalities in the endocardial cushion and atrioventricular valve development of Vegf120/120 
embryos, as well as AVSD, resembling the human phenotype, were observed. Of interest, sinus 
dysfunction is related to congenital heart diseases and has been described in patients with a.o. 
tetralogy of Fallot [3]. The same combination of CHD and sinus node dysfunction is observed 
in the VEGF mutant. Whether the impaired heart rate observed in our study contributes to ab-
normal valve development, as suggested in earlier studies conducted in zebra fish [31], requires 
further investigation. 
Limitations
Although the results of the current study suggest an influence of VEGF on the SAN molecular 
composition and function, it must be emphasized that the study is of a descriptive nature and 
future studies are required to investigate the exact cellular and molecular mechanism underly-
ing the bradycardia in Vegf120/120 embryos. Morphometry showed a smaller SAN at both early 
(E12.5) and late (E 17.5) developmental stages. Although it is likely that this is not different at 
E14.5, in the current study these measurements were not performed. qPCR was only performed 
at E17.5 due to limitations with sample size with the techniques used. Despite relatively small 
numbers, the sample size for analysis of the main outcome parameters (lower heart rate, smaller 
SAN size and expression of SAN proteins) was sufficient. Due to the positioning of the embryo it 
was not possible to measure Doppler flow over all four valves in all measured embryos. Therefore 
this study was insufficiently powered to draw a definite conclusion of valvular flow patterns.
CoNCLuSIoN
In conclusion, the results of the current study indicate a role of VEGF signaling in murine SAN 
development. The over-expression of VEGF results in bradycardia caused by a hypervascular-
ized SAN with small myocardial volume and compaction, overexpressing the fast conducting 
Connexin43 that is normally expressed in working myocardium (Figure 7). These observations 
indicate that VEGF is necessary for normal SAN development and function in mice. Although 
caution should be taken when extrapolating data from mouse study to human, disturbed VEGF 
signaling may as well explain the common occurrence of manifest or silent sinus node dysfunc-
tion in humans, as observed in selected groups of CHD patients. 
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Supplement figure 1. Lasercapture micro-dissection.
Examples are given of the drawn lasercapture border in a wild type (left) and mutant embryo (right).
Supplement figure 2. supporting information: primers used for q-PCR
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Supplement figure 3. Autonomic innervation.
NCAM stainings show similar appearance of the stellate ganglion (black arrows) in WT (A) and Vegf120/120 (B). Pe-
ripheral innervation of the sinoatrial node (SAN) appears similar in WT (C) and Vegf120/120 (D). AoA= Aortic arch, 
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Acquisition techniques related to 4D flow Magnetic Resonance Imaging (MRI) improved rapidly 
over the last three decades. Most importantly, a major improvement was the acceleration of the 
acquisition which resulted in a clinically feasible scan duration and led to more comprehensive 
use of 4D flow MRI in clinical research. This resulted in various new applications of 4D flow MRI for 
the evaluation of various physiologic and pathologic cardiovascular flow patterns. Visualization 
tools aim at displaying the direction and magnitude of blood flow velocity from 4D flow data, 
by using for instance a vector glyph or streamline representation or by constructing pathlines 
from particle tracing. Such tools are applied to provide insight in the temporal distribution of 
the three-dimensional flow velocity and enable the quantification of hemodynamic markers. 
These hemodynamic markers play an important role in the quantitation of abnormalities in 
cardiovascular blood flow patterns and the characterization of vascular and myocardial remodel-
ling which can possibly be used to predict pathology such as heart failure, aortic dissection or 
aneurysm or thrombus formation. This review focuses on the clinical use of 4D flow MRI and 
presents an overview of new applications of visualisation and quantification tools to describe 
physiologic and pathologic cardiovascular blood flow.
INTRoDuCTIoN
Over the last three decades, technology in cardiovascular magnetic resonance imaging (MRI) 
developed remarkably which contributed to the evolution of four-dimensional (4D) flow MRI 
from an imaging tool strictly limited to research environments into a clinically practical modality 
providing valuable disease-specific information. 4D flow acquisitions allow visualization and 
quantification of intra-cardiac blood flow and blood flow in the great arteries and veins, provid-
ing new insights in normal and pathologically altered blood flow patterns that were previously 
only suggested by computational fluid dynamics or in vitro simulations. In the current review, 
we will address important technical developments in cardiovascular MRI that contributed to the 
evolution of 4D flow, discuss the latest advances in acquisition tools and present an overview of 
current clinical applications in vascular, valvular and intra-cardiac blood flow visualization and 
quantification.
DEVELoPmENT oF FLoW ASSESSmENT WITH mRI: ToWARDS FAST AND ACCuRATE 
4D FLoW
After the commercial introduction of whole-body MRI scanners in the early 1980s, Moran was 
the first to describe in vivo two-dimensional (2D) imaging with one-directional velocity informa-
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tion for each voxel [1], by adding velocity-sensitive and velocity-compensated gradients to a 
standard gradient-echo pulse sequence. Bryant et al. [2] and van Dijk [3] demonstrated the use 
of motion-induced phase shifts to encode the magnitude and direction of blood flow velocity. 
The principle of velocity-encoding or phase-contrast imaging relies on manipulating the phase 
signal of spins moving in the direction along a magnetic field gradient in contrast to the phase 
of stationary spins, in such a way that the difference in phase between moving and stationary 
spins is proportional to the velocity of those moving spins. A velocity-sensitive gradient induces 
a phase shift proportional to the velocity, but other factors than motion (i.e., magnetic field 
inhomogeneity, eddy currents, concomitant gradient effects) which depend on B0 (i.e., the static 
magnetic field), induce additional phase shifts. By performing a subtraction of echoes from 
acquisitions using alternating velocity-sensitive and velocity-compensated gradient schemes, 
these additional phase shifts are eliminated and only phase shifts related to velocity remain. 
After image reconstruction, the accustomed phase images from phase-contrast MRI are ob-
tained, in which the grey value is linearly related to the velocity of blood flow. Typically, imaging 
is performed in a time-resolved manner [4], resulting in multiple phases during one average 
cardiac cycle. Data collection extends over multiple cardiac cycles and is synchronized to the 
patient’s ECG signal using either prospective [5] or retrospective gating [6]. With prospective 
gating, a trigger signal starts off data acquisition and data is collected over multiple heart beats 
at predefined time points of the cardiac cycle. Prior to acquisition, the heart beat interval is set 
in the acquisition protocol, determining the start of each trigger. Variations in the true heart 
beat during the acquisition may result in inaccurate acquisition timing, leading to inaccuracies 
especially in late diastolic flow assessment, or even missing flow assessment in this part of the 
cardiac cycle. With retrospective gating, data collection is performed continuously throughout 
the cardiac cycle and stored with the trigger signal. During image reconstruction, this recorded 
trigger signal is used to retrospectively assign the collected data to subsequent timings in the 
cardiac cycle. Since velocity-encoded imaging is not real-time and velocity images are recon-
structed from data acquired over multiple heart beats, therefore representing average velocities 
at specific time points in the cardiac cycle, alterations in the velocity over multiple heart beats 
cannot be picked up. 
Nowadays, 2D cine MRI with one-directional through-plane velocity-encoding is widely used 
in clinical protocols to assess the function of cardiac chambers and heart valves by evaluation of 
trans-valvular blood flow [7,8]. Intra-cardiac blood flow, however, is a complex three-dimensional 
and highly-dynamically-changing phenomenon which requires multi-dimensional imaging. 4D 
flow MRI is the term used for time-resolved three-dimensional (3D) three-directional velocity-
encoded MRI with data collected during several minutes but represented as one average heart-
beat. From this acquisition, the blood flow velocity is acquired in a 3D volume (e.g., covering 
the heart or the great thoracic vessels) by encoding the three individual vector components 
consecutively [9]. Visualization tools are required to display the multi-dimensional data such as 
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the time-dependent velocity vector field and quantification algorithms have been developed 
for hemodynamic analysis.
The first 4D flow MRI protocols involved a along acquisition time, which is the major drawback 
for introducing this technique in clinical practice [10,11]. Several improvements led to acquisi-
tion protocols which can provide good quality data acquired in less than 10-15 minutes. Ac-
celerated acquisition techniques using parallel imaging [12] or undersampling in k-t domain (k-t 
BLAST Broad-use Linear Speed-up Technique) [13] vastly reduced acquisition time. In contrast 
to conventional Cartesian read-out methods, algorithms for data read-out using Echo Planar 
Imaging (EPI) [14] or implementing radial [15] or spiral read-out trajectories [16] further con-
tributed to the reduction of acquisition times towards a clinically acceptable scan duration. The 
introduction of radial undersampling, known as VIPR (vastly undersampled isotropic projection 
reconstruction) [15] revealed the advantage of a larger area coverage, higher spatial resolution 
and improvement of hemodynamic analysis. 
Because scan time still exceeds a breath hold and respiratory motion may significantly degrade 
image quality, specific techniques have been developed to minimize breathing artefacts. Com-
monly used techniques are bellows reading [17], that corrects via registration of the excursion 
of the abdominal circumference, and navigator gating [18], based on diaphragm movement. In 
both cases, collected data are only included for image reconstruction when acquired during the 
time in the respiratory cycle when breathing motion is minimal. Rejection of data can be reduced 
to 20-40 % with adaptive k-space recoding [19]. The drawbacks of these types of respiratory 
compensation are that these methods are based on abdominal or long-liver movement instead 
of relying on heart movement, and the inaccuracy caused by the time delay between signal and 
movement [20]. To overcome these disadvantages respiratory self-gating is introduced, where 
k-space data of the heart is used to provide information about its movement [21].
Due to mentioned developments, it is currently possible to acquire whole-heart 4D flow data 
in under 10-15 minutes, with echo time 2-4 ms, repetition time 5-7 ms, spatial resolution 2-3 mm 
and temporal resolution 30-40 ms [22]. The implementation of these acceleration techniques 
however, led to a negative trade-off: increasing inaccuracies in velocity quantitation. Most nota-
bly are local phase offset errors, caused by eddy currents [23], Maxwell terms [15] and gradient 
field nonlinearity [24]. 4D flow acquisition implies volume coverage with consequently a larger 
anatomical area included than for conventional 2D flow acquisitions. Therefore, measurements 
are performed in areas further from the iso-center of the magnet where they are more prone 
to offset errors. During pre-processing, the major source of these errors should be taken into 
account and additional background correction methods have been developed, either by a 
phantom correction [25] or by using a plane-fitting correction algorithm based on the phase 
signal sampled in areas inside the acquired 3D volume with no velocity, in order to correct the 
position-dependent velocity offset [26,27].
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VISuALIZATIoN TECHNIquES
4D flow data represents the pulsatile time-resolved three-directional velocity distribution inside 
a 3D volume (i.e., the heart or great arteries and veins). Several image processing techniques 
are available to present this multi-dimensional data for qualitative visual interpretation, usu-
ally projecting velocity or flow as animations onto anatomical images presented in cine mode. 
Figure 1 illustrates three available and often-used visualization methods. A glyph (graphic sym-
bol) display of the velocity vector field represents the magnitude and direction of the velocity 
measured inside each voxel. Color coding or adjustment of the size of the vector glyph may be 
used to represent the velocity magnitude. Streamlines [28] are lines instantaneously tangent 
to the local velocity vector in each position at a specific time point and connected to all points 
along the direction of this line. Therefore, streamlines can be used to visualize the flow direction 
Figure 1. Three types of 4D flow visualization.
3-chamber orientation with velocity color coding (in cm/s). In panel A and D velocity vector glyph representation, in 
panel B and E streamline representation and in panel C and F pathline representation after forward (C) and backward 
(F) particle tracing. 4D flow MRI data was obtained with a 3T MRI scanner in a 9 year old healthy girl (informed consent 
was obtained from the parents) with a heart rate of 89 beats per minute. A-C represent the same mid-systolic phase 
(i.e., 136 ms after R-peak), D-F represent the same early diastolic phase (i.e., 409 ms after R-peak). In C and F, respec-
tively forward and backward tracing was performed with particles being released in the left ventricle at end diastole. 
LV left ventricle, LA left atrium, Ao aorta.
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only at this specific instant in time and do not represent the true pathlines of flow over time. 
Color coding can again be used to display the velocity magnitude [29].
Particle tracing is an often-used visualization tool to display the true pathline of flowing blood 
over time [30]. In particle tracing, virtual particles are positioned at a predefined position and 
time and subsequently released inside the 3D velocity field and then followed over time. The 
trajectory of the particles is calculated by either forward or backward tracing, by using the local 
velocity at each position and time point and calculating the next or previous position of this 
particle. Pathlines can be displayed over time with color coding either representing velocity 
magnitude or labelling the origin or destination of the particles in the flow field. The discretiza-
tion in time and space in combination with the quality of data defines the accuracy of particle 
tracing. When uncorrected, a particle near a physical border may dissipate through this border if 
the local velocity at a specific time point directs this particle towards the border and the distance 
covered over the time step exceeds the distance to the border. To check the quality of particle 
tracing, agreement in the particle count entering and leaving a volume should be verified [31].
Another line representation that is used for displaying flow is the streakline [32]. This line is 
constructed similarly to a pathline, with a virtual particle being released from a seed point inside 
a flow field. With streaklines, however, particles will be released continuously over time from 
the same seed point. At an instant in time, the positions of all consecutively released particles 
from the same seed point are connected to construct the streakline. Since streaklines are not 
representatives of the true pathline or velocity of blood flow, this type of visualization has not 
found widespread use in physiological hemodynamics. Isosurfaces are used as a visualization 
tool to cluster and segment flow structures. For example, vortical or helical flow can be displayed 
with an isosurface, clustering blood with identical vorticity or helicity together inside the flow 
field [33].
quANTIFICATIoN TECHNIquES
 Visualization techniques as described above aid in the qualitative interpretation of flow patterns 
in 4D flow data. In addition, quantification tools have been developed to assess hemodynamic 
markers from 4D flow data. Using particle tracing, a four-component evaluation of the intra-
cardiac blood flow has been introduced [31]. According to the moment of passing the LV relative 
to the cardiac cycle, the blood volume inside the LV at end diastole can be subdivided into four 
functional components: 1. direct flow, which is the amount of blood that enters the LV during 
diastole and is subsequently ejected through the aorta in the next systole; 2. retained inflow, 
which is the amount of blood that enters the LV during diastole but is not ejected in the next 
systole; 3. delayed ejected flow, which is part of the blood already present inside the LV during 
diastole but leaves the LV during the next systole; 4. residual volume, which is the amount of 
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blood that was not part of the blood entering during diastole and is not ejected in the next 
systole, and therefore resides in the LV for more than two cardiac cycles. Using particle tracing 
and color coding, the four components in intra-cardiac blood flow are labelled and the distribu-
tion can be followed over time [31]. 
From local velocity and flow rate, the kinetic energy of flowing blood can be calculated. Stroke 
volume multiplied by the blood density represents the mass m of flowing blood. The kinetic 
energy of this blood flow is then calculated by 0.5mv2, with v being the mean velocity. Another 
parameter representing energy of blood flow that is often used is the turbulent kinetic energy 
[34]. Turbulence is characterized by incoherent flow and rapid fluctuations in velocity, which 
cannot be picked up by the magnitude of velocity encoding. However, the standard deviation 
of the velocity distribution within each voxel can be assessed and this parameter is related to 
the turbulent kinetic energy. Another hemodynamic marker that is of high interest is the wall 
shear stress (WSS), as this shear stress affects vascular remodelling through its act on endothelial 
cells. WSS can be quantified [35,36] based on the assumption that a laminar condition exist 
in the boundary layer of the blood vessel, in which WSS is calculated by the wall shear rate 
multiplied by the blood viscosity, with the wall shear rate being the derivative of local velocity 
at the vascular wall. 
The aortic pulse wave velocity (PWV, i.e., the speed of the systolic pulse propagating through 
the aorta) is being used as a surrogate marker for aortic stiffness. PWV is calculated by measuring 
the transit time of wave propagation over a predefined segment of the aorta (Figure 2). Al-
though temporal resolution in 4D flow is limited, global PWV assessment in the total aorta using 
4D flow has been described [37]. High temporal resolution, required for accurate regional PWV 
assessment, can be achieved by combining multiple one-directional velocity-encodings [38].
Diastolic vortices are important phenomena in intra-ventricular blood flow patterns that can 
be evaluated with 4D flow (Figure 3). Vorticity describes the local rotation of fluid particles. A 
vortex represents a compact region of vorticity and forms when boundary layers separate, for 
instance distal to valve leaflets. Due to variance in speed in the shear layer, blood swirls and may 
separate from the boundaries, forming a compact vortex [39]. During early (E) and late (A) filling, 
a circular vortex ring is formed from the tips of the mitral and tricuspid valve leaflets, causing 
minimal loss in kinetic energy [40]. The vortex ring formed in the left ventricle is suggested to 
form a channel that prevents spreading of the inflow jet and loss of momentum to convective 
deceleration [41]. Additionally, the vortex ring contributes to the redirection of flow towards the 
aorta and possibly aids mitral valve closure [42] and prevents thrombus formation [43]. Various 
parameters have been suggested to characterize vortices and their association with systolic 
and diastolic function. With Echocardiographic studies (using contrast or vector flow mapping) 
found a relation between abnormal left ventricular function and vortex size, intensity and posi-
tion [44,45]. The vortex formation time (VFT), introduced by Gharib et al. [46], is a parameter 
computed from the equations for trans-mitral flow and ejection fraction and has been proposed 
as an indicator for cardiac health and diastolic function with suggested prognostic value in 
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predicting heart failure [47]. In contrast, Stewart et al. demonstrated no association between VFT 
and diastolic function [48]; they postulated that the vortex pinches off the mitral valve already 
before E-peak, leading to an abrupt deceleration of the velocity propagation. Since VFT is based 
on the assumption that the vortex is only completely formed at E-peak, they concluded that VFT 
is not useful as an indicator for cardiac function. 
Figure 2. Regional aortic pulse wave velocity assessment.
Two combined high-temporal one-directional in-plane velocity-encoded MRI acquisitions, performed with 3T MRI 
scanner in a 44 year old healthy male volunteer (informed consent was obtained). In A, in-plane velocity is displayed 
in a mid-systolic phase of a double-oblique sagittal view of the aorta, using a velocity vector glyph representation 
with color coding (cm/s). In B, velocity-time curves are displayed, sampled at 200 equidistantly-spaced positions 
along the 40 cm long centerline of the aorta, starting from the aortic valve to the abdominal aorta. From these 
velocity-time curves, the relation between sampling position and the transit-time for velocity wave propagation can 
be obtained, which defines the regional pulse wave velocity.
Figure 3. Visualization of the diastolic vortex in the left ventricle distal to the mitral valve.
Obtained with a 1.5T MRI scanner in a 45 year old male patient with ischemic cardiomyopathy (informed consent 
was obtained). In A, a 4-chamber orientation with streamline representation and velocity color coding (in cm/s) is 
presented and in B, a vorticity isosurface display, segmenting the ring-like structure of the vortex. LV left ventricle, LA 
left atrium, RV right ventricle, RA right atrium.
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Figure 4. Streamline visualization of left ventricular inflow.
Velocity color coding (in cm/s) of 4D flow MRI data, displaying the early diastolic inflow in a 4-chamber orientation, 
obtained with a 3T MRI scanner in a 33 year old healthy male volunteer (A) and a 30 year old female patient with 
a corrected atrioventricular septum defect (B) (informed consent was obtained in both subjects). The dotted line 
represents the anatomical annulus of the left atrioventricular valve. In A, an apically-directed inflow is visualized, in 
contrast to the laterally-directed inflow (B) in the patient, due to restricted opening of the valve. Peak inflow velocity is 
visualized 1-2 cm distal to the anatomical annulus, at the location of the valve leaflets. LV left ventricle, LA left atrium, 
RV right ventricle, RA right atrium.
Figure 5. Streamline representation of atrioventricular regurgitation.
Velocity color coding (in cm/s) of 4D flow MRI data in a 4-chamber orientation, obtained with a 3T MRI scanner in a 
16 year old female patient with a corrected atrioventricular septum defect and recurrent regurgitation in both left 
and right atrioventricular valves (solid arrows) during follow-up (informed consent was obtained from the patient and 
parents). A represents an early systolic phase (i.e., 34 ms after R-peak at heart rate of 61 beats per minute) and B rep-
resents mid-systolic phase (i.e., 201 ms after R-peak). Note the dynamically-changing direction of the regurgitant jets, 
illustrating the need for dynamical adaptation of measurement planes to the flow direction throughout the cardiac 
cycle. Due to turbulence at the regurgitant orifice, intra-voxel spin coherence is absent leading to dispersion of phase 
signal, especially notable at early systole at the left atrioventricular valve (A, dotted arrow). Therefore, quantification of 
regurgitant flow is usually performed 1.5 – 2 cm proximal to the valve, inside the atrium. Retrospective valve tracking 
at left and right atrioventricular valve resulted in an assessment of mean effective forward flow volume of 95 ml per 
cardiac cycle, and regurgitant fractions of 11% at the left atrioventricular valve and 15% at the right atrioventricular 
valve. LV left ventricle, LA left atrium, RV right ventricle, RA right atrium.
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From intra-cardiac blood flow, transvalvular stroke volumes and regurgitation can be as-
sessed, describing valve and chamber function. Retrospective valve tracking was introduced to 
transvalvular velocity mapping, with the measurement plane following the valve plane and the 
angulation adapting to the blood flow direction, to accurately quantify blood flow through any 
of the four heart valves obtained from one single 4D flow acquisition [49,50].The high velocity 
regurgitation jet is usually analyzed in a plane inside the atrium distal to the valve plane, in order 
to avoid underestimation of regurgitation velocity due to phase dispersion from turbulent flow. 
This 4D flow approach with retrospective valve tracking was proven to be more accurate for 
transvalvular velocity mapping than conventional 2D one-directional velocity-encoded (VE) MRI 
using a fixed acquisition plane [49,50]. From transvalvular velocity mapping, parameters such as 
cardiac output, ejection fraction, the effective forward flow volume, peak flow rate, peak velocity, 
retrograde flow and regurgitation fraction can be assessed. 
Besides quantification of flow volume,  the trans-atrioventricular flow rate graph allows as-
sessment of diastolic function analysis. From the flow rate graph, usually the following diastolic 
function parameters are determined: early (E) and late or atrial (A) filling rates, E/A ratio, E-peak 
acceleration and E-peak deceleration duration. When 4D flow data extents to the left atrium, 
wave form analysis of pulmonary venous inflow, another indicator for diastolic function, may be 
assessed when velocity sensitivity and temporal resolution allow [51].Kumar et al. defined the 
fractional propagation parameter as the ratio between the longest jet stream of early diastole to 
the length of the entire ventricle [52]. The flow propagation velocity Vprop is another marker used 
for classifying diastolic function; Vprop describes the speed of the early filling wave propagation, 
which is driven by a pressure gradient between atrium and apex [53]. From the intra-ventricular 
inflow in combination with streamline visualization, the inflow propagation can be evaluated 
[54], albeit no 4D flow approach has been able to provide sufficiently high temporal resolution, 
required for assessing the transit time of blood flow waves over a relatively short propagation 
distance inside the left ventricle.
Moreover, retrospective positioning of measurement planes in a 4D flow dataset of thoracic 
vessels allows accurate flow quantification, giving access to various hemodynamic parameters 
such as, antegrade and retrograde flow, peak velocity, wall shear stress and kinetic energy. With 
this approach, the pressure drop over a valve stenosis can be estimated using the equation of 
Bernoulli and accurate peak velocity assessment at both sides of the valve. However, accurate 
velocity depiction in a high-grade stenosis might be difficult, as phase dispersion due to turbu-
lent flow makes assessment of high peak velocities impossible. Furthermore, pressure gradients 
can be estimated from the intra-cardiac velocity field when using the Navier-Strokes equation. In 
this approach, it is assumed blood to be an incompressible Newtonian fluid and velocity to have 
zero variation (i.e., no turbulence) [55].
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APPLICATIoNS
In the following section, we will review the current status of 4D flow applications in clinical 
research and discuss promising results already obtained by applying the visualization and quan-
tification tools that were described above. We will review first applications of 4D flow for evaluat-
ing intra-cardiac flow patterns in the atria and ventricles, followed by blood flow quantification 
across atrioventricular valves and finally, in the thoracic vessels.
Flow patterns in the atria
The left atrium is a conduit and reservoir which directs the inflow of blood from the four pulmo-
nary veins towards the mitral valve during diastole and collects blood during systole. Visualization 
of 4D flow data revealed vortical flow in the left atrium during systole and diastole. This vortical 
flow is mainly formed from blood coming from the left pulmonary veins, while the blood from 
the right pulmonary veins passes along the vortex [56]. In the right atrium, a vortex is formed, 
rotating in an anti-clockwise direction [57]. In healthy volunteers, more and longer vortices and 
higher velocities were found in younger than in older individuals [58], which could be related 
to a decreased atrial compliance and late active (A-peak) filling becoming more dominant with 
ageing. The increased risk factor for thrombosis and systemic embolisms in patients with atrial 
fibrillation might partly be caused by disturbed flow. Preliminary results from Fluckiger et al. 
using 4D flow showed that patients with atrial fibrillation have lower atrial flow velocities and 
patients after treatment may reach similar velocities compared with age-matched controls [59]. 
In patients with mitral regurgitation, atrial vortices did not originate from the inflow through 
the (left) pulmonary vein, but from the regurgitation jet. Furthermore, a relation between mitral 
regurgitation fraction and left atrium turbulent kinetic energy loss was found [60]. 
Flow patterns in the left ventricle
Visualization techniques such as particle tracing have contributed to knowledge on the pathway 
of blood entering the ventricle through the atrioventricular valve and exiting through the aorta 
[57]. This pathway is assumed to be energy efficient and depends on multiple factors such as 
chamber shape, LV pressure, myocardial function and valve function. Changes in the cardiac 
flow pathway may influence cardiac function. Using computational fluid dynamics, simulated 
changes in flow direction have shown to reduce the heart pumping efficiency by 10% [40]. 
Moreover, it is suggested that changed hemodynamic forces act upon cardiac adaption through 
epigenetic mechanisms [61]. In an early study by Mohiaddin and colleagues, 4D flow was used 
to describe altered flow patterns in patients with dilated left ventricles. In normal subjects, the 
diastolic inflow through the mitral valve is directed towards the apex while in patients with di-
lated left ventricles, the inflow is directed towards the lateral wall, giving rise to a well-developed 
circular flow pattern [62]. Another study using 4D flow to describe LV inflow in patients with 
diastolic dysfunction showed that the high velocity inflow did not reach as far into the ventricle 
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as in healthy controls [52]. Figure 4 shows a laterally directed inflow in a patient who underwent 
correction for atrioventricular septum defect at early age, compared with a healthy control. 
The four-component evaluation of the intra-cardiac blood flow (i.e., direct flow, retained flow, 
delayed ejected flow and residual volume) in combination with particle tracing has provided 
unique insight in altered systolic and diastolic flow in patients with heart failure [63]. In patients 
with compensated heart failure, not only a decreased amount direct flow was observed, but also 
the kinetic energy of direct flow at end diastole was reduced. Furthermore, in a patient with a 
dilated cardiomyopathy, increased retained flow was described and related to increased kinetic 
energy loss of the retained flow [64]. The amount of residual volume potentially may predict 
intra-chamber thrombus formation.
Despite the high potential of 4D flow for evaluating intra-cardiac flow patterns, not much has 
been reported yet on vortex analysis in left ventricular flow patterns using 4D flow MRI. Foll et al. 
[58] used 4D flow with particle tracing and velocity vector fields to semi-quantitatively calculate 
vortex numbers and measure vortex duration and area based on the 2- and 4-chamber view and 
they observed smaller vortices in the base of the LV in women compared with men. Further-
more, Toger et al. quantified vortex volume [65] extracted from 4D flow and described smaller 
volumes in patients with ischemic cardiomyopathy. Further studies using 4D flow are required to 
standardize vortex description and quantification and detect clinical relevant parameters.
Flow patterns in the right ventricle
Despite the increasing interest in the right ventricular function, particularly in congenital heart 
disease, little is known about right ventricular (RV) fluid dynamics. This is mainly due its complex 
anatomy and function and difficulties to visualize the RV in 3D with echocardiography. Only 
recently, a computational fluid dynamics model was suggested to simulate right ventricular flow 
[66]. Fredriksson et al. [67]used 4D flow in combination with particle tracing and four-component 
evaluation to describe differences in LV and RV blood flow distribution and kinetic energy in 
healthy volunteers. Diastolic characterization of RV vortices has been so far only reported in vivo 
using echocardiography in dogs [68]. Kheradvar and Pedrizetti [39] depicted the complexity of 
the vortex in the right ventricle. In patients with a corrected Tetralogy of Fallot (TOF), more, and 
pathological vortices were observed in the right atrium and ventricle using 4D flow [69,70]. 
Transvalvular flow quantification
As was described above, 4D flow allows reliable and reproducible transvalvular flow assessment 
at each of the four heart valves when retrospective valve tracking is implemented [50]. Accurate 
quantification of valve regurgitation is clinically important as the regurgitation fraction is an 
indicator for morbidity and mortality and therefore a determinant for surgical decision making. 
Assessment of regurgitation with 2D one-directional through-plane VE MR is still routine clini-
cal practice, however, correlation between flow volumes at consecutive valves is lacking. With 
a 4D flow approach, conservation of mass has been described between the inlet and outlet 
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of cardiac chambers, a requirement for accurate quantitation of regurgitant volumes [71,72]. 
Several studies applied 4D flow with retrospective valve tracking in various patient groups, such 
as patients with functional mitral [73,74] or aortic valve insufficiency [75], patients with ischemic 
cardiomyopathy [76] and patients after correction of TOF [71]. These studies compared their 
flow results either with Doppler echocardiography or MRI planimetry, and concluded that 4D 
flow with retrospective valve tracking was superior to conventional 2D one-directional VE MRI 
for assessment of valve patency, regurgitation fraction and effective forward flow. Especially, 
quantification of eccentric jets is challenging with echocardiography [77]. Figure 5 shows an 
example of a 16 year old patient, corrected for atrioventricular septum defect at early age, 
who underwent a 4D flow evaluation as a part of follow-up cardiovascular MRI examination. 
Streamline visualization revealed multiple eccentric regurgitant jets over the atrioventricular 
valve, dynamically changing its orientation during systole. With 4D flow, multiple measurement 
planes were adjusted perpendicular to the regurgitation jet(s) throughout systole allowing reli-
able quantification of the regurgitation fraction. 
While the gold standard in detecting intra-cardiac shunt remains echocardiography, a new 
visualization technique (i.e., volume-rendered stereoscopic velocity fusion visualization) based 
on 4D flow showed improvement of detection of shunts with MRI [78]. Moreover, volumes of 
shunts can be more accurately estimated when using 4D retrospective valve tracking approach 
in describing the forward flow through the cardiac chambers.
Classification of diastolic filling parameters obtained from trans-atrioventricular flow rate 
graphs in patients with ischemic heart failure using 4D flow showed excellent agreement with 
Doppler echocardiography, superior to conventional 2D one-directional VE MRI [79]. It should be 
taken into account that temporal resolution (0.8 ms) used in echocardiography is vastly superior 
to MRI. This might interfere with accurate assessment of peak velocity. Furthermore, with MRI, 
flow rate graphs are usually used for diastolic function testing in contrast to the velocity-time 
graphs with echocardiography. Also, with echocardiography, diastolic parameters are assessed 
at the tip of atrioventricular valves and measurement performed at annulus level, as done in MRI 
calculations, are known to result in changes in E/A ratio [80]. Therefore, new reference values for 
classifying various types of diastolic dysfunction should be defined and applied when using 4D 
flow.
Flow patterns in the thoracic vessels 
Early 4D flow MRI studies have contributed to understanding blood flow in the aorta [81,82]. 
During systole, the normal blood flow in the aorta forms an anti-clockwise helix in the ascending 
aorta and clockwise helix in the aortic arch. Quantification of helicity is possible by combining 
velocity vectors with vorticity [83]. The highest velocity is found in the ascending aorta. During 
diastole, mild retrograde flow is visualized, which is important for perfusion of the coronary 
arteries. Regional differences of wall shear stress and oscillatory shear index are found in the 
healthy aorta, which might explain why specific locations are vulnerable for atherosclerotic 
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plaque formation or for dissection [84]. Several studies using 4D flow MRI revealed pathological 
blood flow in diseased aortas, such as coarctation of the aorta [85] or dissection (Figure 6). Fur-
thermore, 4D flow can be used to describe pathology and hemodynamics within the abnormal 
vessel due to valvular pathology. Patients with bicuspid aortic valves, who frequently develop 
aortic aneurysms, show aberrant helical flow patterns in the ascending aorta [83]. Whether this 
abnormal flow leads to aneurysm formation or whether the abnormal flow is a consequence of 
abnormal aorta wall structure and luminal size remains a debate. Other studies on aberrant heli-
cal flow in aortic aneurysms suggest additional value of 4D flow in prediction and prevention of 
aneurysms [86,87]. Sigovan et al. found a correlation between eccentric flow jets in patients with 
aortic valve diseases and local increased wall shear stress and aortic dilatation [88]. Figure 7 gives 
an example of a patient with aortic valve stenosis leading to an eccentric outflow jet, helical flow 
and aberrant laminar velocity and wall shear stress. Furthermore, in patients with aortic stenosis, 
the turbulent kinetic energy is high at the site of the stenosis and can be related with irreversible 
pressure loss [89]. When the stiffness of the aorta increases due to atherosclerosis, hypertension 
or connective tissue disorder such as the Marfan syndrome, an increased pulse wave velocity has 
been described as a precursor of aortic disease and related to end-organ damage [90,91]. Ab-
normal flow with altered wall shear stress has been described in these patients at relatively early 
stages of disease [92]. In patients with Marfan syndrome, multi-directional velocity-encoding 
has been proposed for accurate PWV assessment regionally in the aorta [38], relating lumen 
dilatation to increased PWV [93]. Another application for 4D flow of the aorta is the evaluation of 
abnormal retrograde flow, which can lead to retrograde embolization into the branches of the 
Figure 6. 4D flow visualization of a type A aortic dissection in a 50 year old male patient with Marfan syndrome.
Obtained with 1.5T MRI. In A, a double-oblique sagittal maximal intensity projection of a contrast-enhanced magnet-
ic resonance angiogram of the aorta is presented (i.e., first-pass imaging of 25 mL contrast bolus Dotarem (Guerbet, 
Gorinchem, the Netherlands) with a molarity of 0.5 mmol/mL, intravenously injected at an infusion rate of 2 mL/s). 
The dissection is visualized from the aortic arch to the abdominal aorta. In B, 4D flow MRI data of a mid-systolic phase 
is presented with velocity color coding (in cm/s) in velocity vector glyph representation. In the descending aorta, the 
true lumen is displayed with high flow velocity and the false lumen with low velocity. Through-plane velocity map-
ping is performed at ascending (labeled by 1) and proximal descending aorta (labeled by 2 and 3) at the level of the 
pulmonary trunk (in C and E) and at the abdominal aorta (labeled by 4 and 5 in D and F). The true lumen (labeled by 
2 and 4) presents high pulsatile flow while the false lumen (labeled by 3 and 5) presents low flow.
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aorta causing embolic stroke [94]. Early detection of retrograde flow might become a prognostic 
factor for embolization.
Using 4D flow, the normal blood flow pattern in the pulmonary circulation revealed two 
counter rotating helices in the left and right pulmonary artery [95]. In contrast, this helical flow 
was not found in a patient with corrected transposition of the great arteries and aberrant in a 
patient with correction of abnormal venous return. From 4D flow data obtained in patients after 
correction of a Tetralogy of Fallot, an increased peak systolic velocity in the pulmonary trunk and 
abnormal vertical flow in the main pulmonary artery were revealed [70,71]. A recent 4D flow 
study presented a patient with pulmonary regurgitation and pulmonary artery stenosis, who 
had a larger pressure drop and energy loss in the pulmonary artery branches [96]. Although 
some retrograde pulmonary flow is normal, increased backward flow has been described in 
pulmonary hypertension. Furthermore, presence of vorticity in the pulmonary flow pattern was 
Figure 7. 4D flow visualization of the aortic outflow with different visualization techniques.
Velocity color coding (in cm/s) of the aortic outflow, by a velocity vector glyph representation (A and E), streamline 
representation (B and F) and pathline representation after forward particle tracing (C and G). 4D flow MRI data was 
obtained with a 3T MRI scanner in a 23 year old healthy female volunteer (A-C) (informed consent was obtained) and 
a 56 year old male patient with aortic valve stenosis and dilated aortic root, clinically referred for MRI. In the patient, 4D 
flow visualization revealed an eccentric aortic outflow jet distal to the valve stenosis (E-G) with an area of recirculat-
ing flow in the ascending aorta. Particle tracing revealed a strong helical flow pattern in the ascending aorta (G). The 
through-plane velocity profile was retrospectively reformatted at the level of the sinotubular junction (dotted line in 
A and E), and presented for a mid-systolic phase in panels D (volunteer) and H (patient). For the volunteer in D, an 
approximately laminar velocity profile was obtained, presenting a skewed parabolic profile with the maximal velocity 
shifted towards the inner curve (i.e., the left wall). The wall shear rate at the left wall was calculated at 37 s-1 and at the 
right wall 80 s-1. For the patient, backward flow was visualized in the dilated ascending aorta at the left wall, with a 
calculated wall shear rate of –144 s-1 and at the right wall of 241 s-1. LV left ventricle, Ao aorta.
1414DFlow MRI techniques
3.1
correlated with pulmonary hypertension and the duration of this abnormal pattern has been 
correlated with mean pulmonary artery pressure [97].
A unique patient group for the clinical application of 4D flow MRI constitute patients with 
a Fontan palliation of their congenital heart defect. The Fontan procedure is the treatment for 
patients with a univentricular heart where biventricular repair is not possible. Several surgical ap-
proaches have been developed to create the connection of the superior and inferior vena cava 
with the right and left pulmonary artery: the total cavopulmonary connection (TCPC). However, 
late complications frequently occur. Etiology and risk factors for complications, including pro-
tein losing entropathy (PLE), development of pulmonary arteriovenous malformations (PAVMs), 
thrombosis, stenosis and aneurysms, are largely unknown. Understanding of flow patterns in the 
Fontan circulation might advance knowledge in the etiology of these risk factors and contribute 
to improvement of surgical techniques. Recent work has successfully employed 4D flow for 
visualizing and quantifying the distribution of caval flow towards the right and left pulmonary 
artery [98,99]. An unequal distribution of blood flow is associated with pulmonary arteriovenous 
malformations [100]. Moreover, it is possible to demonstrate kinetic energy loss due to helical 
flow formation in the pulmonary arteries. As can be seen in Figure 8, altered flow patterns with 
Figure 8. 4D flow streamline visualization of the Fontan circulation.
Two patients who underwent surgery at the age of 5, during which a total cavopulmonary connection with an extra 
cardiac conduit (TCPC-EC) was made to connect the inferior (IVC) and superior vena cava (SVC) to both the left (LPA) 
and right pulmonary artery (RPA). In A, a 13 year old female patient is presented, with normal distribution of blood 
flow through the conduit without loss of kinetic energy. Stroke volumes and kinetic energy per heart beat: SVC 12 
ml and 0.12 mJ, IVC 18 ml and 0.09 mJ, LPA 16 ml and 0.10 mJ, RPA 15 ml and 0.12 mJ. Total volume at the inlet of the 
connection was 30 ml with a kinetic energy of 0.21 mJ, and the total volume at outlet was 31 ml with kinetic energy 
of 0.22 mJ. In B, a 15 year old female patient is presented, with an area of recirculating flow present in the connection, 
proximal to the LPA, resulting in significant kinetic energy loss. Stroke volumes and kinetic energy per heart beat: SVC 
21 ml and 0.25 mJ, IVC 34 ml and 2.0 mJ, LPA 26 ml and 0.41 mJ, RPA 29 ml and 0.18 mJ. Total volume at the inlet was 
55 ml with kinetic energy of 2.25 mJ, total volume at outlet was 55 ml with kinetic energy of 0.59 mJ, resulting in a 
total kinetic energy loss of 1.66 mJ. Prior to MRI, informed consent was obtained from the patients and their parents.
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related kinetic energy loss can be observed in patients with a similar extra cardial TCPC, possibly 
due to differences in geometry of the connection of the conduit to the pulmonary arteries.
CoNCLuSIoN AND FuTuRE PRoSPECTIVE
4D flow MRI acquisition techniques improved rapidly over the last three decades. Shorter scan 
duration made 4D flow applicable for clinical use. The concomitant development of visualization 
tools such as streamlines and particle tracing enriched knowledge on blood flow hemodynam-
ics. Intra-cardiac blood flow patterns (e.g., vortices) may possibly add to the diagnosis of diastolic 
dysfunction. Moreover, as increasing evidence arises that hemodynamics play an important role 
in vascular and myocardial remodelling, altered blood flow patterns can possibly be used to 
predict pathology such as aneurysm or thrombus formation and early therapy can be aimed at 
prevention of these pathologies. Besides qualitative interpretation of 4D flow data by visualiza-
tion techniques, quantitative tools are increasingly used. Further studies are required to evaluate 
which hemodynamic markers will be clinically relevant and in what way 4D flow can help to 
improve early detection of pathology and identify response to treatment.
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To evaluate trans-left atrioventricular valve (LAVV) blood flow and optimize left ventricular inflow 
quantification in healthy controls and patients after atrioventricular septal defect (AVSD) correc-
tion. 
materials and methods 
Twenty-five patients after AVSD correction and 25 controls underwent 4DFlow MRI. Using 
streamline visualization in four- and two-chamber views, inflow direction at early and late filling 
was defined at the annulus level and at the peak inflow velocity (PIV) level. Trans-LAVV flow 
volume and velocity were assessed from a static 2D-multiplanar-reformat (MPR), a 4D-MPR track-
ing LAVV annulus and a 4D-MPR tracking the PIV-level, angulated perpendicular to the inflow. 
Results
In patients, on average 9 more laterally directed inflow was found at the PIV-level compared 
with controls. In controls, 4DFlow velocity mapping with LAVV annulus tracking resulted in lower 
absolute error with aortic flow (3 (1–8) mL) than with static 2D-MPR (7 (4–16) mL, P ¼ 0.001). In 
patients, 4D-MPR tracking the PIVlevel, resulted in lower absolute error with aortic flow (2 (1–4) 
mL) than with 4D-MPR LAVV annulus tracking (6 (2–10) mL, P = 0.003).
Conclusion
Streamline visualization of 4DFlow MRI data revealed dynamic trans-LAVV inflow and more lateral 
flow after AVSD correction. Streamline visualization improved trans-LAVV flow quantification as 
the positioning and angulation of the measurement plane was optimized, allowing an accurate 
assessment of left ventricular inflow.
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INTRoDuCTIoN 
Quantification of blood flow over the atrioventricular valve (AVV) is essential in the evaluation 
of valve function and ventricular filling [1]. Left atrioventricular valve (LAVV) dysfunction and 
diastolic dysfunction are both indicators of cardiovascular morbidity and mortality [2]. Moreover, 
disturbances of ventricular inflow have been shown to reduce the effi- ciency of the heart pump 
[3]. After correction of an atrioventricular septal defect (AVSD), LAVV morphology is changed 
substantially [4], but limited data are available on the physiological consequences of altered 
ventricular inflow. 
Time-resolved 3D magnetic resonance imaging (MRI) with three-directional velocity-encoding 
(VE), termed 4DFlow, can be applied to obtain timedependent distribution of blood flow veloci-
ties in the cardiac chambers during the whole cardiac cycle. Streamlines are lines representing 
the blood flow direction at one instant in time, as these lines are tangent to the local velocity 
vectors, connecting at all points along the direction of these lines [5]. Moreover, they can be 
presented with color-coding according to velocity magnitude [6] and therefore allow localiza-
tion of the peak inflow velocities.
Blood flow over the atrioventricular valves can be quantified using a static 2D plane, which is 
commonly used in a clinical setting, but this approach has been shown to overestimate flow vol-
ume as the annulus plane moves through the static measurement plane [7]. With 4D retrospec-
tive valve tracking, blood flow over the atrioventricular valves can be quantified more accurately, 
with the measurement plane adapting to the valve motion, as was validated in phantoms and 
volunteers [8]. In these reports, valve tracking was used to follow the anatomical annular plane, 
assuming blood flow to be orthogonal to the annulus during LV filling. Errors in the location and 
angulation of the reformatting plane may affect flow assessment [9]. Furthermore, changes in 
inflow direction during the cardiac cycle may also affect the assessment of diastolic parameters 
derived from AVV flow, measured with echocardiography and MRI [10]. 
We hypothesize that knowledge of the LV inflow pattern, depicted with streamline visual-
ization in healthy controls and patients after AVSD correction, will aid the retrospective valve 
tracking procedure: by locating the peak inflow velocity near the tips of the LAVV leaflets and 
aligning the measurement plane perpendicular to the inflow direction, flow quantification may 
be improved. 
Subsequently, the purpose of our study was to characterize trans-LAVV blood forward flow in 
healthy controls and patients after AVSD correction using 4DFlow MRI with streamline visualiza-





The study was approved by the local Ethics Committee and written informed consent was 
obtained from all participants or their parents. Between October 2012 and July 2013, 28 patients 
with a history of corrected AVSD were prospectively and consecutively enrolled in the study from 
an available surgical database [11]. Patients younger than 8 years, with pacemaker dependency 
and/or Down syndrome were excluded. Twenty-five controls with a similar age with no history 
of cardiac disease were included for comparison. 
mRI 
Whole-heart 4DFlow was obtained using a 3T-MRI scanner (Ingenia, Philips Medical Systems, 
Best, The Netherlands) with maximal gradient amplitude of 45 mT/m for each axis and a slew 
rate of 200 T/m/sec. A combination of FlexCoverage Posterior coil in the tabletop with a dStream 
Torso coil was used, providing up to 32 coil elements for signal reception. In the majority of 
patients (21 out of 25), gadolinium contrast agent (0.015 mmol/kg body weight, Dotarem, Guer-
bet, Aulnay-sous-Bois, France) was administrated just before the 4DFlow acquisition. Velocity 
encoding of 150 cm/s was used in all three directions, spatial resolution 2.3×2.3×3.0–4.2mm, flip 
angle 10 °, echo time (TE) 3.2 msec, and repetition time (TR) 7.7 msec, resulting in a maximal true 
temporal resolution of 4 x TR = 31 msec. Parallel imaging was performed using SENSE with factor 
of 2 and echo planar imaging with factor 5 was used for acquisition acceleration. The commer-
cially available concomitant gradient correction and local phase correction filter were applied. 
The 4DFlow acquisition time was, for a typical heart rate of 60–80 beats per minute, on average 
8–10 minutes. Furthermore, a two-chamber view of the left ventricle, a four-chamber view as 
well as a short-axis stack of slices, to measure left ventricular volumes and compute the ejection 
fraction (EF), were acquired with a steady-state free-precession sequence with TE/TR 1.5/3.0; 
350mm field of view, 8 mm section thickness; 45 ° flip angle; spatial resolution 1.0×1.0×8.0mm, 
three signal averages and parallel imaging with SENSE factor 2. Manual contour segmentation of 
LV volume was performed on the short axis stack to compute EF (EF = LV end diastolic volume 
– LV end systolic volume / LV end diastolic volume). During all scans, free breathing was allowed 
and no respiratory compensation was performed, retrospective vectorcardiogram-gating was 
performed, and for all acquisitions 30 phases were reconstructed representing one average 
cardiac cycle. 
Image Analysis: Characterization of LAVV Forward Flow
Image analysis was performed using in-house developed Mass software. 2D streamlines were 
generated based on image pixels within the LV cavity exceeding a minimum velocity of 10 cm/s, 
defined as candidate seed points. Streamlines were computed by applying a simple Euler inte-
gration method in both forward and backward directions using a step size of 1 pixel dimension 
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and using bilinear image interpolation. Integration was terminated when either the velocity was 
below 10 cm/s, or the trace length reached a length of 80 screen pixels. To avoid visual clutter-
ing of the generated streamlines, images were displayed enlarged on the computer monitor 
and the distance between seed points was forced to be 20 screen pixels at minimum. Three 
angles were measured in the twoand four-chamber view to characterize the valve morphology 
and the inflow pattern: the angle between the annulus and long-axis (Fig. 1A, angle 1), the 
angle between annulus and inflow direction at annulus level (Fig. 1B, angle 2) and the angle 
between the inflow direction and a plane parallel to the annulus at the level of peak inflow 
velocity (PIV) (Fig. 1B, angle 3). Angle 1 and angle 2 were measured at E-peak and Apeak, while 
angle 3 was measured only at E-peak, as the highest inflow velocity appeared at the E-peak. 
The timepoints of E- and A-peak were defined based on the flow-time curve calculated from 
velocity mapping after retrospective valve tracking. Finally, to combine the effect of annulus 
movement and flow direction through the annulus, we calculated the inflow angle defined as 
Figure 1. Inflow angles.
Streamline representation with velocity color coding (in cm/s) of LV inflow pattern illustrates the measured angles 
in the four-chamber view. A: The angle between annulus and long-axis (angle 1), where the annulus was manually 
identified as the line between the septal and lateral attachment of the LAVV and the long-axis was recognized as the 
line through the center of the annulus and the apex. B: The angles between annulus and inflow at the annulus level 
(angle 2) and peak inflow velocity level (angle 3). C: The inflow angle calculated as the difference between long-axis 
and inflow (angle 1 – angle 2), at the annulus level in this example. D: The positioning of the two reformat planes 
are shown at the annulus level and at the PIV-level, angulated perpendicular to the inflow. Left ventricle (LV), right 
ventricle (RV), left atrium (LA), and right atrium (RA).
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the angle between long-axis and inflow at both levels (angle 1 – angle 2 and angle 1 – angle 3) 
(Fig. 1C). For these calculations, a positive value designates lateral inflow relative to the longaxis 
on the four-chamber view and anterior inflow relative to the long-axis on the two-chamber 
view. Intra- and interobserver variation of these angle measurements was tested by repeated 
analysis in 10 randomly selected controls and 10 patients. Two observers (E.C. with 2 years of 
cardiac MRI experience and J.W. with over 15 years of cardiac MRI experience) performed these 
analyses blinded for each other, with one observer (E.C.) performing the analyses twice with an 
interexamination time of 3 weeks.
Image Analysis: quantification of LAVV Forward Flow
LAVV velocity mapping was performed retrospectively. For comparison with the clinically used 
2D technique, a static fixed MPR was defined retrospectively as described previously on the 
annulus at the moment of end systole by an MRI technician (P.v.d.B.) with over 20 years of experi-
ence. For 4DFlow quantification, two MPR measurement planes were positioned retrospectively: 
one on the anatomical annulus and one at the level of PIV distal to the annulus and angulated 
perpendicular to the inflow direction, using streamline visualization (Fig. 1D). The 4DFlow quan-
tification analysis was performed by one observer (E.C.) with 2 years of experience in cardiac 
MRI and verified by one experienced observer with more than 15 years of experience in cardiac 
MRI (J.W.). Solely during systole, the reformat plane was positioned as previously described, 
either at the closed valve or, in case of regurgitation, 1–1.5 cm proximal to the valve inside the 
atrium, perpendicular to the jet [12]. Transvalvular flow velocity was calculated by subtraction 
of myocardial velocity in the throughplane direction, sampled in nearby myocardium, from the 
mean inflow velocity. Transvalvular flow volume was subsequently calculated by integrating the 
transvalvular velocity over the inflow area (ie, the flow rate) and then integrating over the cardiac 
cycle. Because we aimed to evaluate quantification approaches of left ventricular inflow only, 
the same regurgitation volume during systole as most optimally quantified was included in all 
three measurements. Finally, the flow volume at the aortic valve was assessed from the same 
4DFlow MRI data aligned on a coronal and sagittal aorta view [12], to evaluate correlation and 
agreement with trans-LAVV effective forward flow.
Statistical Analysis
Data analysis was performed using SPSS Statistics (v. 20.0 IBM SPSS, Chicago, IL) software. 
Variables were tested for normal distribution using the Shapiro–Wilk test. Continuous variables 
are expressed as mean ± standard deviation or median with interquartile range (IQR) where 
appropriate. Differences between patients and controls were determined using an unpaired 
T-test or Mann-Whitney-U-test. Differences in angles at E- and A-peak were tested with paired 
T-tests or Wilcoxon-Signed-Rank-test. Linear regression analysis and Bland-Altman analysis [13] 
were used to assess relation and agreement between LAVV effective forward flow and aortic 
flow. Intra- and interobserver variation was determined by the significance of differences be-
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tween measurements and the intraclass correlation coefficient for absolute agreement and the 
coefficients of variance. A p-value<0.05 was considered as statistically significant. For statistical 




Of 28 scanned patients, two were excluded because they had a restrictive LAVV ring placed 
around the annulus, made of paramagnetic material, which resulted in distortion of the MRI sig-
nal. One other patient was diagnosed with left isomerism and was excluded to avoid influence 
on inflow direction, due to atrial isomerism and different position of the heart. 4DFlow scans 
of the remaining 25 patients and 25 controls were visually inspected to be free from imaging 
artifacts and approved to be of adequate quality for image analysis. In all these patients and 
controls streamline visualization and trans-valvular flow quantification was possible. Patient and 
control characteristics are given in Table 1. Fifteen (60%) patients underwent correction of a par-
tial AVSD and 10 (40%) of a complete AVSD. Correction of the AVSD involved closure of the cleft 
of the LAVV in 21 (84%) patients. Ejection fraction was significantly lower in patients compared 
with controls (55% (IQR 53–58) versus 61% (IQR 58–66), P < 0.001) and regurgitation volume was 
higher in patients compared with controls (8 mL (IQR 5–12) versus 1 mL (IQR 0–2), P < 0.001).
Healthy Controls
The angle measurements are presented in Table 2. On the four-chamber view, the inflow angle 
was larger during A-peak, implicating a more lateral inflow direction (E-peak 12±9° versus A-
peak 17±7°, p=0.021). The difference in inflow angle between A- and E-peak ranged between 
–13 and 22. The difference between A- relative to E-peak correlated with age (R 0.573, P = 0.003). 
Table 1. Patient characteristics: Data are presented as mean ± standard deviation or median with interquartile range 
where appropriate. * indicates p<0.001. BSA = Body surface area, LVED = Left ventricular end diastolic volume, EF = 
Ejection fraction, AVSD = Atrioventricular septal defect, LAVV = Left atrioventricular valve. 
Controls (N=25) Patients (N=25)
Age (yrs) 17 (IQR 12–28) 22 (IQR 16–31)
male (N, %) 10 (40) 7 (28)
BSA (m2) 1.6 ± 0.3 1.7 ± 0.4
LVED/BSA (mL/m2 ) 87 ± 11 89 ± 16
EF (%) 61 (IQR 58–66) 55 (IQR 53–58)*
Regurgitation volume LAVV (mL) 1 (IQR 0–2) 8 (IQR 5–12)*
Time after surgical correction of AVSD (years) 19 ± 8
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On the two-chamber view, the inflow was more anterior relative to the long-axis at the A-peak 
(E-peak 6±9° versus A-peak 9±10°, p=0.034), with an intersubject range in difference from –14 
to 13. The difference between inflow angle at PIV-level and annulus level was not statistically 
significant (mean difference 1.8 with 95% CI –0.6-4.5°, P =0.145). Velocities and flow volumes 
are provided in Table 3. In controls, high correlation was found between aortic flow volume and 
LAVV effective forward flow volume assessed with the 4DFlow MPR tracking the annular level 
(R2 0.949, P < 0.001) and the 4DFlow MPR tracking the PIV-level and angulated perpendicular 
to inflow (R2 0.949, P < 0.001), while correlation with static 2D MPR was lower (R2 0.877, P < 
0.001). The absolute error with aortic flow in volunteers was smaller when 4D MPR tracking the 
annulus (3 (1–8) mL, P = 0.001) and tracking PIV-level angulated on the inflow (3 (2–5) mL, P < 
0.001) were used compared with the measurements with static 2D MPR (7 (4–16) mL). The mean 
difference between aortic flow volume and LAVV flow volume with 4D MPR tracking the annulus 
was 0.14 6 6.4 mL; 95% limit of agreement –12.4-12.7 mL and with 4D MPR tracking the PIVlevel 
and angulated on the inflow was –0.8 ± 4.6 mL; 95% limit of agreement –9.7-8.1 mL. The mean 
difference between aorta flow volume an LAVV flow from the static 2D MPR was higher with a 
mean difference of –10.1 ± 10.2 mL; 95% limit of agreement –30.0-9.9 mL (Fig. 2). 
Patients
The inflow angle measurements performed in the patients are presented in Table 2. On the 
four-chamber view, the difference in inflow angle between E-peak and A-peak at annulus level 
was not statistically significant (mean difference 3.5° 95% CI –12.9– 1.5°, P = 0.113); however, a 
large interpatient variation was observed (range –40° to 38°). On the two-chamber view, inflow 
direction relative to the longaxis was more posterior during the A-peak (E-peak 7±9° versus A-
peak 2±11°, p=0.009). In patients, the inflow direction at the PIV-level was more lateral compared 
with the inflow angle at annulus level (annulus 10±10° versus PIV-level 19±11°, p=0.003). In the 
Table 2. Inflow angles: angle measurements in the four-chamber view and two-chamber view in degrees at early 
(E) and late (A) filling. * (p < 0.05) and ** (p < 0.01) indicating statistical significant differences between patients and 
controls. Data are presented as mean ± standard deviation or median with interquartile range where appropriate.
Four-chamber Two-chamber
Controls Patients Controls Patients
E Annulus - long axis (angle 1) 95 ±3 98 ± 9 94 ± 6 101 ± 8**
Annulus - inflow at annulus (angle 2) 83 ±9 88 ± 8 89 ± 10 94 ± 8*
Inflow angle at annulus level (angle 1-2) 12 ± 9 10 ± 10 6 ± 9 7 ± 9
Distance between annulus and PIV-level (mm) 14 ± 6 15 ± 6 13 ± 5 16 ± 6
Annulus - inflow at PIV-level (angle 3) 84 (80–90) 77 (65–82)** 90 ± 7 92 ± 8
Inflow angle at PIV-level (angle 1-3) 10 ± 8 19 ± 11** 5 ± 7 9 ± 9
A Annulus - long axis (angle 1) 94 ± 4 102 ± 8** 98 ± 5 101 ± 8
Annulus - inflow at annulus (angle 2) 77 ± 8 85 ± 12** 89 ± 10 100 ± 8**
Inflow angle at annulus level (angle 1-2) 17 ± 7 16 ± 15 9 ± 10 2 ± 11*
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3.2two-chamber view, the difference in inflow angle between the two planes was not statistically significant (mean difference –2.3°, 95% CI –5.1–0.4°, P = 0.091). Flow volumes and velocities 
obtained at the two measurement positions are presented in Table 3. In patients, a higher cor-
relation was found between aortic flow and LAVV flow measurements performed at the PIV-level 
with 4D MPR angulated perpendicular to inflow direction (R2 0.972, P < 0.001) and with 4D MPR 
tracking the annulus (R2 0.877, P < 0.001) rather than with the static 2D MPR (R2 0.823, P < 0.001). 
The absolute error between LAVV forward flow and aorta flow was smaller in the angulated MPR 
at the PIV–level (2 (1–4) mL), compared with MPR tracking the annulus (6 (2–10) mL, P = 0.003) 
and the static 2D MPR (4 (1–9) mL, P = 0.004). The mean difference between aortic flow and 
LAVV flow was smaller when the angulated MPR on PIV-level was used (0.2±3.4 mL; 95%-limit 
of agreement -6.9-6.4mL), compared with the MPR tracking the annulus (4.4 ±7.2mL; 95%-limit 
of agreement -9.6-18.5mL) and the static 2D MPR (-3.0±9.0 mL; 95%-limit of agreement -20.7-
14.77mL).
Differences Between Patients and Healthy Controls
Differences in angle measurements between patients and healthy controls are given in Table 
2. At the annulus level, the difference in inflow direction between patients and controls was 
not statistically significant (mean difference 2.0°, 95% CI –3.6-7.5°, P = 0.483). However, at the 
PIV-level, inflow direction was significantly more lateral (controls 10 ± 8° versus patients 19 ± 11°, 
P = 0.002) (Fig. 3). On the two-chamber view, the difference in inflow angle was not statistically 
significant between patients and controls during E-peak at both measurement levels (annulus 
mean difference 1.1°, 95% CI –6.1–3.9°, P = 0.668 and the PIV-level mean difference –4.1°, 95% CI 
–8.6–0.4°, P = 0.072), but the inflow was more posterior in the patients during Apeak (controls 9 
± 10° versus patients 2 ± 11°, P = 0.019). 
Table 3. Comparison of velocities and flow volumes: differences between trans- left atrioventricular valve (LAVV) 
velocity mapping using the static 2D MPR during diastole and a 4D MPR tracking the annulus and tracking the Peak 
inflow velocity (PIV)-level and angulated perpendicular to the inflow direction. Data are presented as mean ± stan-
dard deviation or median with interquartile range where appropriate, with * (p < 0.01) and ** (p < 0.001) indicating 
statistical significance between measurements with static 2D MPR and on the 4D MPR tracking the annulus level 
compared with the measurements with 4D MPR tracking the PIV-level and angulated perpendicular to the inflow 














LAVV flow volume (mL) 87 ± 26** 77 ± 20 78 ± 20 72 ± 21 65 ± 19** 70 ± 20 
Absolute error LAVV flow with aortic 
flow (mL)
7 (4–16) ** 3 (1–8) 3 (2–5) 4 (1–9) * 6 (2–10) * 2 (1–4) 
Correlation LAVV flow with aortic 
flow (R2)
0.877 0.950 0.949 0.823 0.877 0.972
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Inter- and Intraobserver Variation
Interobserver coefficient of variation for angle measurements ranged between 3% and 8%, with 
an intra-class correlation coefficient higher or equal to 0.85 (P < 0.001). The mean differences 
ranged between 0.1° and 1.9° and none of these were statistically significant, except for the as-
sessment of the angle between two-chamber view annulus and long-axis (mean difference 1.9 
± 2.7°, P = 0.005). The intraobserver coeffi- cient of variation ranged between 3% and 7%, with 
an intraclass correlation coefficient higher or equal to 0.77 (P < 0.001) and differences ranged 
between 0° and 1.5° (Table 4). 
DISCuSSIoN
In this study, streamline visualization of 4DFlow MRI data was used to characterize and improve 
the quantification of trans-LAVV forward flow in healthy controls and patients after AVSD correc-
tion. The main findings of the current study are as follows: First, streamline visualization revealed 
a change in inflow direction between E- and A-peak in healthy controls and patients and a more 
laterally directed LV inflow in patients with corrected AVSD. Second, streamline visualization aids 
in optimizing the positioning and angulation of the measurement plane (ie, at peak inflow ve-
locity level and perpendicular to inflow direction) during retrospective valve tracking procedure, 
resulting in a more reliable assessment of trans-LAVV forward flow volume in patients. 
Quantification and characterization of transatrioventricular valve flow is important in the eval-
uation of ventricular and valvular function. In the healthy subjects, we observed a difference in 
Figure 2. Agreement between left atrioventricular valve (LAVV) forward flow and aorta flow using three approaches 
for MPR placement.
Bland–Altman graphs depicting agreement between aortic flow and effective forward flow over the LAVV with static 
2D MPR (A,D), 4D MPR tracking the annulus (B,E) and 4D MPR tracking peak inflow velocity (PIV)-level and angulated 
perpendicular to the inflow (C,F), measured both in controls (A–C) as well as in corrected atrioventricular septal defect 
(AVSD) patients (D–F).
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inflow angle at E- and A-peak in both the four-chamber as well as the two-chamber orientation, 
which is most likely explained by the incomplete opening of the LAVV during A-peak phase [14]. 
Our observations are in line with Fyrenius et al [10] and extend their observations by quantifica-
tion of the inflow angle. The high degree of intersubject variability correlated with age, where 
in younger patients the A-peak inflow was relatively more lateral compared with the E-peak. To 
investigate this further, a larger number of subjects and a broader age range is required. The 
intersubject variation in inflow angle, the difference between inflow angle at E- versus A-peak 
in both four- and two-chamber view implies that adjustment of the reformatting plane with 
4DFlow MRI in each patient and during the whole cardiac cycle is relevant for quantification and 
characterization of trans-atrioventricular valve flow. 
The observed dynamic changes in inflow direction during E- versus A-peak in healthy sub-
jects were statistically significant but small, with substantial intersubject variation. The clinical 
relevance of these findings needs to be investigated in future studies. The PIV-level was found on 
Figure 3. Lateral inflow after AVSD correction.
Streamline representation with velocity color coding (in cm/s) of the LV inflow pattern, illustrating the difference in 
inflow direction at E-peak inflow between a healthy volunteer (A) and a corrected AVSD patient (B), which presents 
with a more lateral inflow. The dotted line represents the annulus. Black arrow points in the direction of the inflow at 
the annulus level and the white arrow depicts the inflow direction at the peak inflow velocity (PIV)-level. C: A normal 
mitral valve with supple anterior leaflet of the mitral valve (AML). D: An AVSD before surgery with the ridged superior 
bridging leaflet (SBL), inferior bridging leaflet (IBL), and mural leaflet (ML); *the cleft. E: An AVSD heart after correc-
tion; the cleft between the SBL and IBL was closed (*). Left ventricle (LV), right ventricle (RV), left atrium (LA) and right 
atrium (RA), aorta (AO), interventricular septum (IVS).
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average 15–16 mm distal to the annulus, corresponding with approximately half of the diameter 
of the LAVV, suggesting that the measured peak velocity may be found near or at the tip of the 
LAVV leaflets. At this PIV-level, the inflow direction in patients was directed significantly more 
laterally. The altered inflow is presumably caused by the abnormal annulus shape and attach-
ment of the anterolateral papillary muscle as described in a previous echocardiography study 
in corrected AVSD patients [4] and by the restrictive mobility of the septal leaflet caused by 
the cleft closure during correction (Fig. 3). Future studies are needed to investigate whether 
regurgitation of the LAVV effects the inflow direction. 
Lateral inflow was previously found in patients with dilated LVs [15] and the altered flow pat-
tern in patients with dilated cardiomyopathy was related to an increased loss in kinetic energy 
[16]. In simulations with computational fluid dynamics, changes in eccentricity of the inflow jet 
have been shown to reduce the efficiency of the heart pump by 10% [3]. Further studies are 
required to investigate whether the aberrant inflow pattern after correction of AVSD, indeed, 
in addition to other factors, contributes to less efficient LV function. These insights may be 
valuable in changing surgical techniques to minimize leaflet restriction and, subsequently, the 
effect on LV function. The more lateral inflow direction in patients with a corrected AVSD should 
also be taken into account during Doppler echocardiography. Appleton et al [14] observed 
that in patients with a dilated LV, the inflow can be directed up to 20 more lateral, leading to 
changes in inflow velocity recording without proper alignment of the echo Doppler beam to 
peak velocity direction and level. This report and our observation of a more lateral inflow in 
patients after AVSD correction stresses the need for proper adjustment to the inflow direction 
using echocardiography. The higher flow volume measured in controls, using the static 2D MPR 
approach, confirms previously described overestimation of LAVV when a static plane is used, due 
to movement of the atrioventricular valve [17]. The overestimation of flow was not observed in 
the patients, which can be explained by reduced throughplane movement of the AV valve but, 
more important, a concomitant increased misalignment due to the observed angulated flow, 
which compensates the overestimation. 
Furthermore, in patients we found a higher accuracy in trans-LAVV flow quantification when 
measurements were performed at the PIV-level angulated to the inflow, with an underestima-
tion of flow when the measurement plane was tracking the annulus. This is possibly caused 
by the difficulty in defining the exact anatomical position and angulation of the annulus in 
patients with corrected AVSD and the increased deviation of the inflow angle in these patients. 
Furthermore, while the effect of intravoxel phase dispersion and partial volume on the measured 
vector components contributing to the velocity mapping procedure will not change when the 
reformatting plane is adjusted in a 4DFlow dataset, higher accuracy can still be achieved by 
reducing the number of voxels with such inaccurate velocity within the region of interest due 
to a better alignment of the measurement plane perpendicular to the flow [9]. The higher ac-
curacy stresses the importance of streamline visualization in 4DFlow quantification to optimize 
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positioning of the measurement plane. Further studies are required to investigate the impact of 
optimal positioning of the measurement plane in other congenital and acquired heart disease. 
Our study has some limitations. Streamline visualization of 4DFlow MRI data is projected onto 
two- and four-chamber views and subsequently used for manual angle measurements and 
adjustment of measurement planes and, therefore, anatomical information and streamline data 
originate from different scans. Streamlines are a representation of the instantaneous flow velocity 
field and do not visualize the actual timecontinuous pathway of blood particles as pathlines do. 
In the present study we aimed to use the streamline visualization of the inflow direction at each 
specific timepoint during diastole and use this to position the measurement plane (assessing 
flow volume as through-plane velocity times cross-sectional area) at each of these timepoints. 
However, future studies may focus on differences between streamline and pathline visualization 
and their effect on measurement plane positioning. Differences in heart rate and respiratory rate 
might have caused some inaccuracy. In the future, automatic positioning and adjustment of 
measurement planes to the inflow direction from single scan data might improve the reliability 
and reproducibility of inflow assessment. All scans were performed with free-breathing and 
4DFlow acquisition was performed without navigator gating in order to minimize acquisition 
time, because children were included in the study. However, image quality was adequate in all 
studies to perform offline velocity mapping and any possible effect of overestimation in flow 
volume due to area enlargement from breathing motion may be assumed to be equal in pa-
tients and controls. Local phase offset errors, which may lead to small systematic errors, should 
be taken into account [18]. During data reconstruction, the commercially available concomitant 
gradient correction and local phase correction filter were applied. Furthermore, measurements 
of peak velocity at the annulus level and at the PIVlevel were obtained from the same dataset at 
sampling positions relatively close to each other and, therefore, we may assume that a potential 
systematic error in velocity is almost equal for both sampling positions. Furthermore, for LAVV 
flow quantification, transvalvular velocity is calculated from local blood flow velocity relative to 
through-plane myocardial velocity and is therefore corrected for potential phase offset errors. 
CoNCLuSIoN
Streamline visualization of 4DFlow MRI data confirmed different inflow angle at early versus late 
filling in healthy controls, with substantial intersubject variation and a more laterally orientated LV 
inflow after AVSD correction. Using this visualization for optimizing the position of the measure-
ment plane, assessment of trans-LAVV blood flow proved to be more accurate and resulted in 
related changes in blood flow characteristics. Our findings have implications for the assessment 
of trans-LAVV flow, as they stress the importance of careful adjustment of echocardiography 
Doppler beam or MRI measurement plane in the assessment of the dynamic ventricular inflow 
and taking into account alterations caused by AVSD correction.
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Four-dimensional (3 spatial directions and time) velocity-encoded flow magnetic resonance im-
aging with quantitative particle tracing analysis allows assessment of left ventricular (LV) blood 
flow organization. Corrected atrioventricular septal defect (AVSD) patients have an abnormal left 
atrioventricular valve shape. We aimed to analyze flow organization in corrected AVSD patients 
and healthy controls. 
methods
A total of 32 patients (age, 25 ± 14 years), 21 after partial AVSD correction and 11 after complete/
intermediate AVSD correction, and 30 healthy volunteers (26 ± 12 years) underwent whole-
heart four-dimensional velocityencoded flow magnetic resonance imaging. Particle tracing in 
the 16-segment LV cavity model was used to quantitatively evaluate blood flow organization 
discriminating multiple components. 
Results
Patients showed a smaller percentage of direct flow compared with controls (30% ± 9% vs 44% 
± 11%; P < 0.001). In patients, more inflow was observed in the basal inferior segment (22% 
± 11% vs controls, 17% ± 5%; P = 0.005), with less direct but more retained inflow (ie, part of 
inflow that is not ejected from LV in subsequent systole). In patients, more inflow reached the 
midventricular level (68% ± 13% vs controls, 58% ± 9%; P < 0.001), most notably as retained 
inflow in the lateral segments. Subsequently, in patients, more (mostly retained) inflow reached 
the apex (23% ± 13% vs 14% ± 7%; P < 0.001), which correlated with early peak filling velocity (r 
= 0.637, P < 0.001). Patients with a corrected complete or intermediate AVSD presented with less 
direct flow (24% ± 8% vs 33% ± 8%; P = 0.003) and more apical inflow (30% ± 14% vs 18% ± 12%; 
P = 0.014) compared with a corrected partial AVSD. 
Conclusion
Multicomponent particle tracing combined with 16-segment analysis quantitatively demon-
strated altered LV flow organization after AVSD correction, with less direct and more retained 
inflow in apical and lateral LV cavity segments, which may contribute to decreased cardiac 
pumping efficiency.
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INTRoDuCTIoN
Atrioventricular septal defect (AVSD) covers a spectrum of heart anomalies with a common atrio-
ventricular junction and is generally corrected early in life. Patients with a corrected AVSD have 
an abnormal atrioventricular valve with different leaflets and position of the papillary muscles 
[1;2], influencing left ventricular (LV) inflow. The normal pathway of blood flowing through the LV, 
from inflow through the mitral valve towards ejection into the aorta, optimizes the efficiency of 
cardiac pumping [3]. MRI based streamline evaluation in corrected AVSD patient revealed a more 
lateral inflow direction [4], which may disturb the most efficient intra-ventricular blood flow or-
ganization [5] and may also affect cardiac pumping efficiency and eventually lead to ventricular 
remodeling [6;7]. An evaluation of the organization of intra-cardiac blood flow is possible with 
particle tracing [8] from four-dimensional (three spatial directions and time) velocity-encoded 
magnetic resonance imaging (4DFlow MRI). Particle tracing is a visualization approach based on 
calculation of pathlines of virtual particles seeded in a flow velocity field and followed over time 
and can be used as a tool to display LV blood flow organization [8]. Eriksson et al. [9] introduced 
a quantitative four-component analysis of LV flow discriminating 1) direct flow entering and exit-
ing the LV within the analyzed diastole and systole, 2) retained inflow entering during diastole 
but remaining in the LV during the following systole, 3) delayed ejection flow already present 
in LV prior to diastole but exiting the LV during the following systole and 4) residual volume 
present and remaining in the LV during the analyzed diastole and systole cardiac cycle. These 
functional distinct components are used to describe the blood flow organization [10] and were 
found disturbed in patients with heart failure [11]. As LV blood flow is a fundamental aspect of 
the cardiac function and plays a role in remodeling [12], further understanding of blood flow 
organization is paramount.
We aimed to use multi-component analysis from 4DFlow MRI and extend this with the 16-seg-
ment model introduced by the American Heart Association (AHA) [13] to quantitatively describe 
regional blood flow through the LV in healthy controls and patients after correction of a partial, 
intermediate or complete AVSD. Our hypothesis is that an altered inflow direction such as in 
corrected AVSD patients will disturb intra-cardiac flow organization.
mATERIALS AND mETHoDS
Study population
The study was approved by the local medical ethical committee and written informed consent 
was obtained from all participants or their parents. Thirty-four patients with a corrected AVSD, 
without contraindication for MRI, were prospectively enrolled from a surgical databases [14]. At 
our institution partial AVSD is corrected with a single patch and a complete and intermediate 
AVSD with two patches. One of the 32 patients had an associated aortic coarctation, which 
Chapter 3.3168
was corrected with an end-to-end anastomosis during correction of the (intermediate) AVSD 
. In one other patient a small commissurotomy was performed in the pulmonary vein during 
surgical correction of the (complete) AVSD. All patients had a balanced ventricular anatomy. Two 
patients were excluded from analysis as these patients underwent left atrial ventricular valve 
(LAVV) replacement with a Carpentier ring which will result in severe imaging artifacts on MRI. 
Twenty-one patients had a partial AVSD with shunt at atrial level and 11 patients a complete 
or intermediate AVSD with a shunt at atrial and ventricular level. For comparison 30 healthy 
controls within a similar age range and without history of cardiac disease were included. Patients 
and volunteers in this study were also included in a study reporting on quantification of flow 
over the left atrioventricular valve [4],vortex core analysis [15] and quantification of regurgitation 
[16] . Patients underwent echocardiography and ECG details were analyzed.
mRI acquisition
Between October 2012 and November 2013 all patients and healthy subjects underwent whole-
heart 4DFlow MRI on a 3Tesla MRI (Ingenia, Philips Medical Systems, Best, The Netherlands) with 
maximal gradient amplitude of 45mT/m for each axis and a slew rate of 200T/m/sec with the 
use of a combination of a FlexCoverage Posterior coil in the table top and a dStream Torso 
coil, providing up to 32 coil elements for signal reception. Typical volume for a whole-heart 
acquisition was 396mm (Right - Left) × 336mm (anterior-posterior) × 117mm (feet-head). Scans 
were performed with three-directional velocity-encoding of 150cm/s in all directions, spatial 
resolution 2.3×2.3×3.0-4.2mm3, flip angle 10°, echo time (TE) 3.2ms, repetition time (TR) 7.7ms, 
true temporal resolution 31ms, sensitivity encoding (SENSE) factor 2 in anterior-posterior direc-
tion and Echo Planar Imaging (EPI) was performed with a factor 5 and 30 phases reconstructed 
over one cardiac cycle. The temporal footprint was 14 seconds for a subject with a heartbeat 
of 60bpm [17]. 4DFlow acquisition duration was on average 8 minutes (range 5-12 minutes). 
Commercially-available concomitant gradient correction and local phase correction were ap-
plied from the software available on MRI system (Ingenia 3T MRI with Software Stream 4.1.3.0). 
Trans-LAVV flow analysis was performed using through-plane velocity mapping with the use of 
retrospective valve tracking as described previously [4]. Peak velocity during E-peak filling and 
A-peak filling was determined from the trans-LAVV velocity-time curves. A cine multi-2D short-
axis image set was acquired using steady-state free-precession sequence with TE/TR 1.5/3.0, 
350mm field-of-view, 45° flip angle, acquisition resolution 1.0×1.0×8.0mm3, which was used to 
obtain the LV volume after segmentation of the LV contours. Retrospective gating was used with 
30 phases reconstructed to represent one cardiac cycle. Free breathing was allowed without 
using motion compensation or respiratory triggering, and three signal averages were taken to 
suppress effects of breathing motions.
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Particle tracing
The workflow of the multi-component particle tracing evaluation of the LV flow organization is 
presented in Figure 1. The endocardial contours of the LV were manually traced in all slices at the 
phases of the largest and smallest LV volume, marked as respectively end-diastole (ED) and end-
systole (ES). Sphericity index of the LV was calculated as EDV/(π/6×long-axis at end-diastole3) 
[18], with EDV representing end-diastolic volume. The contours were transferred to the 4DFlow 
data set. To reduce a possible translation of the subject between the cine short-axis acquisition 
and the whole-heart 4DFlow acquisition, image registration was performed between the cine 
data set and the magnitude image of the 4DFlow data set for a single phase that visually showed 
the best depiction of the LV in the magnitude image. The registration was restricted to transla-
tion only. This registration result was then applied to all phases.
The 3D velocity data of the whole-heart 4DFlow acquisition was used for particle tracing algo-
rithm, using 4th order Runge-Kutta numerical integration to create pathlines. Each voxel inside 
the LV at the moment of end-diastole was considered to represent one seed point (i.e., one 
particle), with the exception of the voxels from the outermost layer at the endocardial border, 
which were removed to avoid any boundary effects. Pathlines of the particles were calculated 
by integration of velocity data over time: backward over the diastole and forward over systole. 
The positions of the particles were stored every 10 ms. Particles exiting the LV other than into 
the aorta or the left atrium were excluded from analysis. Next, the four-component evaluation 
was performed as introduced by Eriksson, however, in patients, particles exiting the LV and 
entering the atrium during systole (i.e., the regurgitation) were classified as a fifth component. 
Figure 1. Workflow of particle tracing. 
Contours of the left ventricle (LV) are manually segmented (green lines) on the short-axis images (A) in all slices (B). 
Subsequently, the LV is filled with particles at end-diastole (C). Forward (D) and backward (E) tracing are used to de-
tect the components of left ventricular flow (F). 
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We compared the amount of particles part of the LV inflow with the amount of particles part 
of the outflow of the LV to evaluate the consistency of the particle tracing. To evaluate regional 
LV blood flow, the LV cavity was subdivided into 16 segments similar to the AHA model (i.e. 
six segments at both basal and mid-ventricular level and four segments at apical level) [13]. 
Segments were created automatically after setting a reference point manually at the insertion 
point between LV and right ventricle in each slice, with the endocardial circumference of each 
segment per level equal in size. Subsequently, the pathway of all particles contributing to dia-
stolic inflow (i.e. direct flow and retained flow) was assessed. For each segment, the amount of 
inflow particles entering a segment from an upper level segment was counted relative to the 
total amount of inflow particles. Besides the total inflow, the distribution of direct flow (i.e. direct 
flow particles in a segment relative to total amount of direct flow particles) and retained flow 
(i.e. retained inflow particles in a segment relative to the total amount of retained inflow) was 
computed. Manual segmentation of contours took 7-12 minutes, subsequently the automated 
particle tracing procedure and automated quantification took 5-8 minutes per subject.
To evaluate whether the absolute error between inflow and outflow or the number of particles 
that were excluded, influenced the particle organization, the correlations between outcome 
parameters (i.e. componential proportions and percentage of particles in a segment) and the 
absolute error and the number of excluded particles were analyzed.
Statistical analysis
Data analysis was performed using SPSS Statistics (version 20.0 IBM SPSS, Chicago, Illinois) soft-
ware. Variables are expressed as mean ± standard deviation. We used mixed models to evaluate 
the differences between controls and patients to take account of the within-subject correlation 
Table 1. Subject characteristics. Data is presented as mean ± standard deviation. BSA = body surface area, BP = 
blood pressure, LVEDV = Left ventricular end-diastolic volume. * indicates significant difference between patients 
and controls p<<0.001. 
Controls Patients partial
AVSD (N = 21)
Patients complete
AVSD (N=11)
Age (years) 25 ± 14 29 ± 12 18 ± 8
BSA (m2) 1.7 ± 0.3 1.8 ± 0.3 1.6 ± 0.5
Heart rate (bpm) 70 ± 13 74 ± 12 78 ± 15
Systolic BP (mmHg) 112 ± 13 122 ± 20 113 ± 18
Diastolic BP (mmHg) 67 ± 9 69 ± 12 59 ± 7
Sphericity index 0.37 ± 0.06 * 0.56 ± 0.14 0.58 ± 0.14
LVEDV (mL) 146 ± 42 154 ± 27 158 ± 43
LVEDV / BSA (mL/m2) 87 ± 13 88 ± 15 97 ± 14
Stroke volume (mL) 89 ± 23 86 ± 17 85 ± 24
Ejection fraction (%) 61 ± 4* 56 ± 4 54 ± 8
Regurgitation fraction (%) - 12 ± 7 17 ± 11
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of the components, the 3 layers or 16 segments respectively. Subject groups and components/
layers/segments were modelled as fixed and subjects were modelled as a random effect (ran-
dom intercept). A first mixed model analysis was performed to compare differences in the four 
componential percentages between patients and controls. A second mixed model analysis was 
performed to assess the difference between controls and patients in particle percentage enter-
ing the three levels (i.e. basal, mid and apical). Third, a mixed model analysis was performed to 
analyze the distribution over the 16 segments. Mixed model analyses for layers and segments 
were performed for total inflow as well as direct flow and retained inflow.
RESuLTS
Study population
Patient characteristics are presented in Table 1. Patients were similar in age, heart rate and LV 
stroke volume when compared with the controls. All patients were in NYHA class 1 or 2. On 
echocardiography none were diagnosed with mitral stenosis. 14 (44%) patients presented with 
a right bundle branch block and six (19%) with some form of left bundle branch block
Validation
After exclusion of particles that secede from the LV other than into the aorta or LA, 79 ± 9% of 
the particles remained available for analysis. A significant, but small difference was observed 
between in- and outflow volume (inflow 59 ± 18 mL versus outflow 55 ± 15 mL, p=0.005, 
95% confidence interval of difference 1.2 to 6.5 mL). There was no difference in absolute error 
between in- and outflow volume between controls (8.2 ± 8.7 mL) and patients (7.8 ± 6.4 mL) 
(p=0.851, 95% confidence interval of difference -3.5 to 4.2 mL). No correlations were observed 
between componential proportions and absolute error or number of excluded particles. Simi-
larly, no correlation was observed between percentage of particles per segment and absolute 
error or number of excluded particles.
Inflow analysis
Patients had a smaller percentage of direct flow compared to controls (30±9% versus 44±11%, 
p<0.001), but a larger percentage of delayed ejection flow (22±6% versus 17±7%, p=0.014) and 
residual volume (21±7% versus 16±6%, p=0.004) (Figure 2). In patients 4±4% of particles was 
computed as regurgitation volume, no regurgitation was quantified in controls. Examples of 
multi-component analysis are shown in Figure 2 and supplemental Movie 1. Lower ejection frac-
tion was related to higher residual volume (volunteers r = -0.561 p=0.001 and patients r = -0.617 
p<0.001) and lower direct flow (volunteers r = 0.258 p=0.169 and patients r = 0.370 p = 0.037).
As shown in Figure 3, in controls and in patients the majority of all inflow particles enter the 
LV via the basal inferior, basal infero-lateral and basal antero-lateral segments. In patients a lower 
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Figure 3. Particle percentage per segment relative to the total inflow. 
* indicates significant (p<0.05) difference between patients (gray bar) and controls (black bar) based on mixed model 
analysis. The 16-segment model is presented in the right panels. RV = right ventricle. 
Figure 2. Example of left ventricular flow com-
ponents in a healthy control (A) and a correct-
ed AVSD patient (B). 
Pie charts of the componential proportions 
(%) in controls and patients with * indicating 
significant difference (p<0.05) between con-
trols and patients. 
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percentage of inflow particles was observed in the basal antero-septal segment (6±5% versus 
10±7%, p=0.018) and a higher percentage of inflow particles in the basal inferior segment 
(22±11% versus 17±5%, p=0.005). Dividing inflow into direct flow and retained inflow revealed 
that in patients the percentage of direct flow was lower in the basal level, especially in infero-
lateral and antero-lateral segments compared to controls (Figure 4 and Figure 5). In contrast, in 
patients the percentage of retained inflow was higher in the basal and mid infero-lateral and 
antero-lateral segments (Figure 5).
In patients, of all particles entering the LV during diastole, 68 ± 13% reached into the mid 
ventricular level, compared to 58 ± 9% in controls (p<0.001). In controls, at the mid-ventricular 
level, particles were more evenly distributed over all six segments. At mid-ventricular level in pa-
tients, the percentage of inflow particles was higher in the infero-lateral (21±11% versus 16±7%, 
p=0.003) and antero-lateral (16±11% versus 11±6%, p=0.005) segments. 
Subsequently, in the patients a higher percentage of inflow particles reached into the apex 
(23±13% versus 14±7%, p<0.001). Direct flow into the apex was not significantly different be-
tween patients and controls, whereas the retained inflow into the apex was significantly higher 
in patients (14±6% versus 7±3%, p=0.005). An example of a patient with increased lateral and 
apical flow compared to a healthy control is shown in Figure 4 and supplemental movie 2 and 3.
Patients with a corrected complete or intermediate AVSD presented with a lower percentage 
of direct flow (24±8% versus 33±8%, p=0.003) and more apical inflow (30±14% versus 18±12%, 
p=0.014) when compared to patients with a corrected partial AVSD. In patients no correlation 
was observed between sphericity index or LVEDV and componential proportions. The increased 
inflow into the apex correlated with early peak filling velocity (r = 0.637, p<0.001) in patients. In 
patients total apical flow correlated with delayed ejection flow (r = 0.631, p <0.001). 
DISCuSSIoN
The current study introduces multi-component particle tracing in the LV using 16 AHA segments 
[13] and applies this technique in patients that underwent atrioventricular valve surgery. In 
patients after correction of an AVSD we observed altered intra-cardiac blood flow as compared 
to healthy controls. Key findings of the study are 1) the direct flow fraction is significantly lower 
in patients compared to controls, whereas the percentage of delayed ejection flow and residual 
volume are larger; 2) In patients versus controls a larger percentage of retained inflow is directed 
towards the lateral segments, whereas the inflow in the basal lateral segments contains more 
direct flow in controls versus patients; 3) In patients versus controls more (retained) inflow is 
directed towards the apex during diastole. Finally, after correction of an intermediate or com-
plete AVSD a lower percentage of direct inflow was observed as compared to patients with a 
corrected partial AVSD.
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Figure 5. Particle percentage per segment relative to the total direct inflow and retained flow. 
* indicates significant (p<0.05) difference between patients (black bar) and controls (gray bar) based on mixed model 
analysis.
Figure 4. Flow component organization in the left ventricle during diastole.
In a healthy control (A and B) and a patient (C and D). In A and C all components are presented, in B and D only the 
inflow components. More lateral and apical (retained) inflow is observed in a patient after AVSD correction (D) com-
pared to the healthy control (B). 
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The LAVV in AVSD has a different leaflet shape and papillary muscle position [1;2]. Further-
more, during AVSD correction a ‘cleft’ in the anterior leaflet of the LAVV is closed, which prevents 
regurgitation, but can cause restricted opening of the valve [1;2;19]. Using 2D streamline vi-
sualization, a previous cardiac magnetic resonance (CMR) study showed a more lateral inflow 
direction in corrected AVSD patients [4]. Based on these observations, we aimed to study the 
effect of this altered inflow after AVSD correction on intra-cardiac flow organization. Particle 
tracing allows visualization of the pathlines of blood flow over time [8]. The multi-component 
analysis proposed and validated by Eriksson et al. [9] extended visualization of 4DFlow MRI by 
specifying destination and timing of flow. Combining the 16 AHA segment model to the multi-
component 4DFlow method enables quantification of the organization of the separate blood 
flow components regionally within the LV.
Healthy controls
Compared to previous studies, direct flow percentage in our volunteers (i.e. 44%) was slightly 
higher as observed in earlier studies from the same research group reporting on 6-12 healthy 
controls with age range 19-62 (i.e. 35-38%) [9;11;20]. Retained inflow was slightly higher, delayed 
ejection flow was similar and residual volume was lower (current study 16% versus 29-33% 
[9;11;20]). These studies were performed on a 1.5 Tesla MRI with Venc 100cm/s and other differ-
ences in acquisition protocol were a slightly larger echo time (3.7ms) and shorter repetition time 
(6.3ms) but a lower spatial resolution (3x3x3mm3) and true temporal resolution (50.4ms) than in 
our acquisition protocol. Additionally, no echo planar imaging was used but instead segmented 
k-space readout was used. Furthermore, navigator gating was used to compensate for breathing 
motion. These differences in acquisition protocol may contribute to the differences in compo-
nential proportions in healthy volunteers. Furthermore, the younger age of our patients might 
be a factor in the differences in results.Töger et al. used volume tracking of early filling blood 
at mid-diastole and end-diastole and observed a variety in inflow blood organization in the LV 
cavity, with a small percentage entering the apical level in healthy subjects [21]. Considering 
the complete diastole, for controls we obtained a similar result, with only 14 ± 7% of inflow 
entering the apical level. Vortex ring formation at the tip of the LAVV might play an important 
role in redirecting the flow towards the aorta [22]. Furthermore, a recent study showed pressure 
difference, not only between apical and basal level, but also between contralateral segments in 
healthy volunteers, which possibly influences blood, flow pathways [23]. The high percentage 
of particles in inferior, infero-lateral and anterolateral segments is in line with visually described 
flow patterns in the LV as reported by Eriksson et al. [9].
Corrected AVSD Patients
Patients with corrected AVSD had a reduced percentage of direct flow but increased delayed 
ejection flow, resulting in a similar stroke volume as in healthy controls, as was also observed in 
patients with dilated cardiomyopathy [11]. The increased portion of (mainly retained) inflow par-
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ticles flowing through the mid antero- and infero-lateral segments is in line with our previous re-
port using 2D streamline visualization, describing more lateral inflow in corrected AVSD patients 
[4] and can be explained by the restricted opening of the valve due to ‘cleft’ closure. Additionally, 
the offset between the inter-atrial and inter-ventricular septum in AVSD hearts may influence 
inflow direction. However numbers in current study were too small to study subgroups with 
different off-sets. A possible effect of the left bundle branch block observed in 6 patients cannot 
be ruled out, but we expect that this will predominantly influence ejection and not the inflow. 
Next to the lateral inflow, patients presented with an increase of inflow into the apical segments, 
which may be a result of lateral inflow. Possibly, abnormal formation of the vortex ring, which 
is suggested to redirect flow towards the aorta [22], at the tip of the LAVV in patients allows 
blood to propagate towards the apex. To further analyze the consequences of these altered 
intra-cardiac flow patterns we divided the inflow into direct flow and retained flow components 
and observed an increased percentage of particles entering the mid lateral segments. Also, the 
apical level contained significantly more retained inflow particles, i.e. particles that do not exit 
the LV during the next systole, which indicates that this lateral and apical flow is less efficient. 
Patients with a corrected partial AVSD showed fewer abnormalities in flow organization 
compared to patients with a corrected complete or intermediate AVSD. This suggests that the 
morphology of the common atrioventricular valve or the more comprehensive surgery needed 
to correct a complete or intermediate AVSD, requiring correction with 2 patches, enhances 
abnormal LV blood flow organization.
Clinical implications 
Blood flow in the LV should be directed from atrium towards aorta in order to pump in an ef-
ficiently [3;10]. In-vitro studies showed that abnormal lateral inflow, due to LAVV manipulation, 
resulted in over 10% less efficient cardiac pumping [5]. In the current study the abnormal blood 
flow was not related to LVEDV nor sphericity index, which suggests that the affected blood 
flow is most likely related to valve abnormalities instead of LV shape. During AVSD correction 
the surgeon has to close the cleft in the LAVV and sometimes performs approximation of the 
leaflets to prevent LAVV regurgitation. Aberrant blood flow after AVSD correction indicates that 
the surgeon should be aware that LAVV leaflet shape can influence blood flow organization. 
Furthermore, the increased apical flow in patients was related to increased early peak filling 
velocity, which implicates that care should be taken not to restrict the LAVV opening too much 
as this will result in higher peak velocities and subsequent altered intra-cardiac flow pattern.
Little is known about cardiac function long-term after AVSD correction and long-term follow-
up of these patients is needed to show the effect of disturbed LV blood flow organization on 
cardiac remodeling [6;7] and subsequent cardiac function. Our study was conducted in patients 
in NYHA class I or II with preserved systolic function, however already marked changes could 
be observed in intra-cardiac flow organization suggesting less efficient LV flow. The abnormal 
intra-cardiac flow organization without clinical signs or symptoms observed in the current 
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study, suggests that flow organization may be used as a subclinical parameter of impaired LV 
function. However, studies during stress or after serial follow-up are still needed to assess the 
consequences of this disturbed flow organization. 
In the adult population, mitral valve abnormalities are common and mitral valve surgery is 
advocated in asymptomatic patients with moderate to severe mitral valve regurgitation [24]. Re-
cently examples of aberrant inflow and vortex formation after mitral valve replacement or repair 
were shown in vivo using 2D echocardiography [25]. 3D particle tracing using flow component 
analysis with the 16-segment model as performed in the current study, may give further insight 
in the consequences of different types of LAVV surgery and its effect on LV flow organization and 
cardiac function.
Limitations
4DFlow acquisition was performed without navigator gating in order to minimize acquisition 
time, because children were included in the study. The particle tracing approach is considered 
to represent the true pathlines of blood flow over time, however changes in velocity magnitude 
and direction faster than the temporal and spatial resolution can detect, cannot be represented 
in the tracing algorithm. Moreover, free breathing without respiratory gating as applied in our 
acquisition protocol in combination with a low EPI readout to allow a higher temporal resolution 
in contrast to segmented k-space acquisition with navigator gating, may lead to errors in the 
position of all particles. However this error is expected to be similar in magnitude in patients 
and controls and the used 4DFlow acquisition with free breathing has been validated previously 
[26] and an earlier study in this patient group showed excellent internal validation between 
LV stroke volume from 4DFlow MRI and the LV stroke volume calculated with multi-slice cine 
balanced steady state free precession [16]. Also no imaging artefacts were observed from using 
EPI readout. Furthermore, data quality was considered adequate by comparing the inflow and 
outflow particle count. In each subject a number of particles was excluded in the evaluation as 
these particles seceded from the LV cavity. This might be due to inaccuracies in the LV contour 
segmentation or registration, or by the fact that during the tracing procedure, particles can 
‘cross’ the myocardial wall due to the limited time step used in the integration procedure and 
the discretization of the acquired data. However, neither the difference between in- and outflow 
nor the number of excluded particles had a correlation with componential proportion or particle 
percentage per segment. Moreover, there was no difference observed in validation between 
controls and patients. To reduce the number of particles crossing the myocardial wall, one layer 
of particles was excluded before the analysis. This may have caused an underestimation of lateral 
flow quantification. As patients in current study were (nearly) asymptomatic it was not possible 
to relate abnormal flow patterns to clinical parameters. This study is limited to the flow pat-
terns in the left ventricle, as most re-operations are needed because of abnormalities of the left 
atrioventricular valve and we have shown lateral inflow in the left ventricle in a previous study 
[4]. Furthermore, the widely used American Heart Association segmentation model of the left 
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ventricle enables assessment of regional flow distribution, which would be more challenging in 
the right ventricle which has a complex anatomy. In addition, the left ventricle is the systemic 
ventricle and one would expect disturbances of the left ventricular intracaviy flow organisation 
to have more profound impact on clinical status. Future studies are needed to evaluate the flow 
patterns in the right ventricle as well as right ventricle - left ventricle interaction.
CoNCLuSIoN
The current study shows the feasibility of the segmental quantification of different flow com-
ponents in the LV. This technique allows description of the normal inflow pathway and reveals 
more lateral and apical inflow in patients after AVSD correction. As retained inflow in the lateral 
and apical segments was significantly higher after AVSD correction, it is considered as less ef-
ficient. Whether the disturbed flow pattern has a negative effect on cardiac remodeling and 
cardiac function on the long-term remains to be established.
SuPPLEmENTAL mATERIAL
Supplemental digital contents are available for this chapter on www.investigativeradiology.com.
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Left ventricular (LV) inflow propagation velocity (Vp) is considered a useful parameter in the 
complex assessment of LV diastolic function and is measured by Color M-mode echocardiog-
raphy. The aim of current study was to develop an alternative method for Vp-assessment using 
high-temporal velocity-encoded magnetic resonance imaging (VE-MRI).
methods
A total of 43 patients diagnosed with ischemic heart failure (61±11years) and 22 healthy volun-
teers (29±13years) underwent Color M-mode echocardiography and VE-MRI to assess the inflow 
velocity through the mitral valve (mean inter-examination time 14 days). (Temporal resolution of 
VE-MRI was 10.8–11.8 ms) Local LV inflow velocity was sampled along a 4 cm line starting from 
the tip of the mitral leaflets and for consecutive sample points the point-in-time was assessed 
when local velocity exceeded 30 cm/s. From the position-time relation, Vp was calculated by 
both the difference quotient (Vp-MRI-DQ) as well as from linear regression (Vp-MRI-LR). 
Results
Good correlation was found between Vp-echo and both Vp-MRI-DQ (r=0.83 p<0.001) and 
Vp-MRI-LR (r=0.84 p<0.001). Vp-MRI showed a significant but small underestimation as com-
pared to Vp measured by echocardiography (Vp-MRI-DQ: : 5.5±16.2 cm/s, p=0.008; Vp-MRI-LR: 
9.9±15.2cm/s, p<0.001). Applying age-related cut-off values for Vp to identify LV impaired 
relaxation, Kappa-agreement with echocardiography was 0.72 (p<0.001) for Vp-MRI-DQ and 0.69 
(p<0.001) for Vp-MRI-LR.
Conclusion
High-temporal VE-MRI represents a novel approach to assess Vp showing good correlation with 
Color M-mode echocardiography. In healthy subjects and patients with ischemic heart failure, 
this new methods demonstrated good agreement with echocardiography to identify LV im-
paired relaxation. 
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INTRoDuCTIoN
Despite improvements in the treatment of cardiac diseases, the prevalence of systolic and dia-
stolic heart failure (HF) continues to rise [1]. Particularly, presence of LV diastolic dysfunction, with 
or without a concomitant LV systolic dysfunction, is associated with increased morbidity and 
portends poor prognosis [2,3]. Furthermore, subclinical LV diastolic dysfunction has been shown 
to be related to a high risk of progression to symptomatic HF and therefore an early detection of 
LV impaired relaxation might have important clinical implications for patient management [1].
LV diastolic function is influenced by several factors, such as LV geometry and myocardial 
relaxation properties, left atrial function, pericardial restraint, heart rate and rhythm [4]. Direct 
measurement of the LV pressure-volume relation is considered the gold standard for diagnosis 
of diastolic function [5,6], but such assessment is invasive and not available for most patients. 
Current recommendations for the evaluation of LV diastolic function consider echocardiography 
the method of choice for a non-invasive evaluation in clinical practice and a combination of 
various parameters is proposed [7]. A useful marker for the assessment of LV diastolic function 
with echocardiography is the LV inflow propagation velocity (Vp), a relatively load-independent 
parameter that records velocity information along a scan line from the mitral valve into the 
ventricle during early LV filling [8-11]. Vp can be measured with Color M-mode echocardiog-
raphy, which allows a high temporal resolution. It has been shown that the ratio of peak early 
filling velocity to Vp is directly proportional to LA pressure and therefore can be used to identify 
impaired LV relaxation by itself [12,13] or in combination with the isovolumic relaxation time 
[14]. Furthermore, while a Vp>50 m/sec is considered normal, in patients >30 year-old a Vp less 
than 45 cm/s has been suggested to identify LV impaired relaxation; in patients <30 year-old, this 
cut-off value is raised to 55 cm/s [10]. 
Recently, magnetic resonance imaging with high-temporal time-resolved velocity encoding 
(VE-MRI) has been also proposed for Vp evaluation [15], allowing for the assessment of the 
intra-cardiac blood flow velocities. The aim of the current study was to develop a high-temporal 
VE-MRI approach to measure Vp and to compare this method with Color M-mode echocardiog-
raphy in patients with ischemic HF and healthy volunteers.
mATERIAL AND mETHoDS
Subjects
Forty-three patients with ischemic HF consecutively referred for cardiac MRI and 22 healthy 
volunteers were included in this study. Valvular stenosis or a repaired/replaced valve was an 
exclusion criterion. Data on New York Heart Association (NYHA) classification and percentage 
of LV scarring based on delayed contrast enhancement MRI [16] were obtained by patient 
status review. To allow evaluation of a wide range of LV diastolic function, the mean age of the 
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healthy volunteers was substantially younger as compared to patients. Mean inter-examination 
time between echocardiography and VE-MRI was 14 days. The study was approved by the local 
ethical committee and written informed consent was obtained from all patients and volunteers. 
Data of this patient population has been published before [17-21] however none was related to 
Vp-evaluation.
Echocardiography
Transthoracic echocardiography images were acquired in the left lateral decubitus position 
using a commercially available system equipped with a 3.5 MHz or M5S transducer (Vivid 7-9, 
GE-Vingmed Ultrasound, Horton, Norway). Vp was measured as described by Garcia et al. [10] 
by a cardiologist with 10 years of experience, (NA) blinded with regard to the MRI results. In the 
apical 4-chamber view, with the use of Color Doppler, the M-mode cursor was aligned along the 
mitral inflow stream to record the early flow propagation velocity into the LV. Baseline shift was 
performed as needed to obtain a distinct border of the propagation velocity into the LV cavity 
(usually Nyquist limit around 30-40 cm/sec). During off-line analysis, the slope of the first ‘aliasing’ 
velocity (red to blue) was traced from the mitral valve plane to 4 cm distal in the LV (Vp in cm/sec) 
(Figure 1). In some cases, the slope of the aliasing area in the M-mode image flattens towards 
the top. In such cases, the measurement line was positioned along the steepest part of the area 
of aliasing. For each subject, Vp-echo was calculated from an average of three measurements.
mRI acquisition 
MRI patient data was collected using a 1.5 Tesla (T) MRI system (Intera, release 11 and 12; Philips 
Medical Systems, Best, the Netherlands) with 33 mT/m maximal gradient amplitude and 100 
mT/m/ms slew rate. A five-element cardiac coil placed on the chest was used for signal recep-
tion. A series of survey scans which included cine 2- and 4-chamber views and a multi-slice 
multi-phase short-axis set were acquired to measure LV volume and compute the ejection 
fraction (LV EF = (LV end-diastolic volume - LV end-systolic volume) / LV end-diastolic volume) 
with a steady-state free-precession sequence with typical imaging parameters: slice thickness = 
8 mm, field-of-view = 400×320 mm2, spatial resolution voxel size of 1.8×2.0×8.0 mm3, flip angle 
= 50°, echo time (TE) = 1.7 ms, repetition time (TR) = 3.4 ms, one number of signal averages 
(NSA) and no parallel imaging. Each slice was acquired using breath-holding in end-expiration. 
Retrospective gating was used, with 10% arrhythmia rejection, and for each slice, 1 average heart 
beat was reconstructed into 30 phases. Image analysis with manual contour segmentation for LV 
volume calculation was performed using in-house developed MASS software.
Subsequent non-segmented VE-MRI was performed in a 4-chamber view with single-
directional in-plane velocity encoding in phase encoding direction. This direction was visually 
angulated parallel to the LV inflow direction (i.e. parallel to the line from the opened mitral valve 
leaflets to the apex). The following typical imaging parameters were used: slice thickness = 8 
mm, field-of-view = 370×320 mm2, spatial resolution voxel size of 2.8×2.5×8.0 mm3, flip angle = 
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10°, TE = 3.4 ms, TR = 5.4 ms, NSA = 4 and no parallel imaging was used. Velocity sensitivity was 
set to 20 cm/s and retrospective gating was used. Acquisition was performed with free breath-
ing. The maximal number of phases was reconstructed, yielding an effective temporal resolution 
of approximately 6 ms (i.e., the true temporal resolution equals 2×TR = 10.8 ms).
Figure 1. Schematic representation of velocity propagation assessment with Color M-mode echo and velocity-en-
coded MRI. 
During offline analysis of echocardiography (panel A), the slope of the first ‘aliasing’ velocity (red to blue) is traced from 
the mitral valve plane to position 4 cm distal into the LV. On the velocity encoded MRI scan (panel B), a 4 cm scan line 
is defined starting from the position of the valve leaflets and in the direction of the LV inflow. 11 sample points (4 mm 
apart) are defined on this scan line and the point-in-time was recorded, starting from the onset of LV filling, when 
aliasing was reached for each consecutive sample point. The time points where aliasing occurs, are then displayed in 
a position-time graph (panel C). The slope of the line of the position-time relation, representing Vp, is calculated by 
two definitions: Vp-MRI-Difference Quotient (Vp-MRI-DQ), using the difference quotient (i.e. the slope of the straight 
line between the first point and the final recording that represents the inflow wave), and Vp-MRI-Lineair Regression 
(Vp-MRI-LR), using the slope which was calculated by linear regression from all included sample points along the scan 
line. Since the slope of the x-t relation flattens towards the top in this example, only measurement points along the 
steepest part of line are included and the last sample point most distally in the LV is disregarded. Due to the limited 
temporal resolution, consecutive sample points may present equal recorded times of aliasing in case of fast propaga-
tion, as is illustrated in the first 8mm distal to the valve (panel C).
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Volunteer data was acquired using a 3.0T MRI system (Ingenia, Philips Medical Systems, The 
Netherlands) with 45 mT/m maximal gradient amplitude and 200 mT/m/ms slew rate. A combi-
nation of FlexCoverage Posterior coil in the table top with a dStream Torso coil was used, provid-
ing up to 32 coil elements for signal reception. Similar to the patient data acquisition, a series 
of survey scans and a multi-slice multi-phase short-axis set were acquired with a steady-state 
free-precession sequence with typical imaging parameters: slice thickness = 8 mm, field-of-view 
= 350×350 mm2, spatial resolution voxel size of 1.5×1.5×8.0 mm3, flip angle = 45°, TE = 1.5 ms, 
TR = 3.0 ms, NSA = 3 and parallel imaging with SENSE factor 2. Free breathing was allowed. 
VE-MRI was performed with typical imaging parameters: slice thickness = 8 mm, field-of-view = 
320×260 mm2, spatial resolution voxel size of 2.5×2.5×8.0 mm3, flip angle = 10°, TE = 3.8 ms, TR 
= 5.9 ms (i.e., the true temporal resolution equals 2×TR = 11.8 ms), NSA = 1 and parallel imaging 
with SENSE factor 2. Velocity sensitivity was set to 30 cm/s and retrospective gating with 10% 
arrhythmia rejection, was used with maximal number of phases reconstructed and acquisition 
was performed with free breathing.
VP-quANTIFICATIoN BASED oN VE-mRI
The approach of inflow propagation evaluation with MRI has been modelled to the Color M-mode 
approach, i.e. a position-time (x-t) graph was constructed which displays for each consecutive 
sample point along the scan line from mitral valve towards the apex, the point in time when 
local inflow velocity exceeds the aliasing value of 30 cm/s. Similar to Vp-echo assessment from 
Color M-mode echocardiography, the slope of the straight line constructed from the x-t relation 
then represents Vp. Therefore, in the 4-chamber view velocity images, a scan line of 4 cm was 
manually indicated from the tip of the valve leaflets into the LV, parallel to the inflow direction. 
The velocity scale was set to a maximal inflow velocity of 30 cm/s. For volunteers, this aliasing 
threshold already has been set at the acquisition. For patient data, however, the maximal velocity 
sensitivity at acquisition was 20 cm/s. Therefore, using the MASS software, the display range of 
velocity values was first shifted from -20 cm/s – 20 cm/s into -10 cm/s – 30 cm/s. Equidistantly 
along the scan line, 11 sample points were defined, 4 mm apart. Starting at the onset of LV 
filling, the point-in-time was recorded when aliasing was reached for each consecutive sample 
point along the scan line. These time points were then transported offline into MS Excel (version 
2010) and displayed in a position-time graph. The slope of the line of the position-time relation, 
representing Vp, was calculated by two definitions: Vp-MRI-Difference Quotient (Vp-MRI-DQ), 
using the difference quotient (i.e., the slope of the straight line between the first point and the 
final recording that represented the inflow wave), and Vp-MRI-Linear Regression (Vp-MRI-LR), 
using the slope which was calculated by linear regression from all included sample points along 
the scan line. Similarly as in Color M-mode echocardiography in cases when the slope of the x-t 
relation flattens towards the top, only the measurement points along the steepest part of line 
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were included and sample points more distal in the LV were disregarded, both for Vp-MRI-DQ as 
well as for Vp-MRI-LR calculation.
Intra- and interobserver variation of MRI-DQ and MRI-LR were tested by repeated analysis in 
10 randomly selected controls and 10 patients. Two observers (EC with 2 years of cardiac MRI 
experience and JW with over 15 years of cardiac MRI experience), performed these analyses 
blinded for each other and the analyses was performed twice by the initial observer with an 
inter-examination time of two weeks.
To compare the signal-to-noise ratio (SNR) in patients versus volunteers, one observer (JW) 
measured SNR in the VE-MRI magnitude images at the moment of end-diastole, by placing 
circular sampling regions-of-interest of approximately 1 – 1.5 cm2 in the left ventricle (at the 
position of the end of the scan line, 4 cm distal to the mitral valve) and in the air near to the 
anterior chest wall. SNR was calculated by the ratio between the mean signal intensity sampled 
in the LV and the standard deviation of the signal intensity measured in air.
Statistical analysis
Continuous data were expressed as mean ± standard deviation (SD). Vp from VE-MRI was 
compared with echo Doppler using paired t-test, Pearson correlation and Bland-Altman analysis 
with 95% limits of agreement. [22] When using the cut-off value for Vp of 45 cm/s for subjects 
>30 years and 55 cm/s for subject <30 years to classify LV impaired relaxation, a cross-table 
was constructed to determine weighted kappa agreement (Fleiss-Cohen weighting) between 
both modalities [23]. Correlation and agreement were classified as excellent (>0.95), strong 
(0.95 – 0.85), good (0.85 – 0.70), moderate (0.70 – 0.60) or fair (>0.60). Intra- and interobserver 
variation was determined by the significance of differences between measurements and the 
intraclass correlation coefficient for absolute agreement and the coefficients of variation. SPSS 
for Windows version 20 (SPSS Inc., Chicago, Illinois) was used for statistical analysis and P < 0.05 
was considered significant.
RESuLTS
Characteristics of the patients and healthy volunteers, with parameters for left ventricular volume 
measurement obtained by standard short-axis MRI evaluation, are presented in Table 1. Delayed 
enhancement analysis in 42 patients showed a mean infarct size of 23±16% of the total LV myo-
cardial mass. Mean heart rate ± SD during VE-MRI for patients was 68 ± 14 bpm (range 45 – 104 
bpm), which resulted in mean VE-MRI acquisition time of 4 minutes 7 seconds (range: 2 minutes 
43 seconds – 5 minutes 17 seconds). For volunteers, mean heart rate ± SD during VE-MRI was 68 
± 13 bpm (range 53 – 103 bpm), which resulted in mean VE-MRI acquisition time of 1 minutes 
22 seconds (range: 54 seconds – 1 minutes 46 seconds). Heart rates between examinations were 
very similar and not statistically significantly different: mean heart rate in patients during during 
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echocardiography 69 ± 15 bpm (for comparison with VE-MRI p = 0.65). For controls, mean heart 
rate during echocardiography 67 ± 13 bpm (for comparison with VE-MRI p = 0.46). Heart rates 
between patients and controls were also not statistically significantly different (p=0.46). Analysis 
time for Vp-assessment from VE-MRI was 1–2 minutes. SNR measured in VE-MRI in patients was 
53 ± 36 versus 114 ± 77 in volunteers (p = 0.002). 
In Figure 2, correlation between Vp-echo and both VE-MRI-assessed markers (Vp-MRI-DQ 
and Vp-MRI-RL) is presented. Good correlation between both modalities was observed: linear 
regression analysis between Vp-echo and Vp-MRI-DQ Y = aX + b, with regression coefficients 
a = 0.81±0.07 and b = 6.1±4.6, r = 0.83, p<0.001. Linear regression between Vp-echo and Vp-
MRI-LR Y = aX + b, with regression coefficients a = 0.70±0.06 and b = 8.3±3.7, r = 0.84, p<0.001. 
Comparing both MRI markers, Vp-MRI-DQ showed significant but slightly higher values as 
compared to Vp-MRI-LR (mean difference 7.1±8.1cm/s, p<0.001), with excellent correlation: r 
= 0.941 (p<0.001). The agreement between Vp-echo and both VE-MRI markers is presented in 
Bland-Altman graphs in Figure 3. For both Vp-MRI-DQ and Vp-MRI-LR, a significant but small 
underestimation compared to Vp-echo was observed (Vp-MRI-DQ: 5.5±16.2 cm/s, p=0.008, 95% 
limits of agreement -26 to 37 cm/s; Vp-MRI-LR: 9.9±15.2cm/s, p<0.001, 95% limits of agreement 
-20 to 40 cm/s). As shown by the Bland-Altman graphs, the bias between Vp-echo and Vp-MRI 
becomes larger for higher values of Vp.
To identify LV impaired relaxation, age-related cut-off values were used (Vp<45 cm/s for 
subjects older than 30 years and Vp<55 cm/s for subjects younger than 30 years). A 26 year-old 
female volunteer showed a Vp-echo = 59 cm/s, a Vp-MRI-DQ = 48 cm/s and a Vp-MRI-LR = 45 
cm/s. All other volunteers showed Vp>55cm/s for Vp-echo as well as for both VE-MRI markers. All 
patients were older than 30 years. Applying the age-related cut-off values, good agreement was 
found between Vp-echo and Vp-MRI-DQ: kappa ± standard error (SE) = 0.72 ± 0.09, p < 0.001; 




Age (years) 29 ± 13 61 ± 11
Weight (kg) 65 ± 15 80 ± 11
Gender 68% male 72% male
Heart rate (bpm) 68 ± 13 68 ± 14
LV EF % 60.9 ± 4.8 29.6 ± 11.4
LV EDV (mL) 161 ± 37 295 ± 85
LV ESV(mL) 63 ± 19 213 ± 82




189VE-MRI to asses left ventricular inflow propagation velocity
3.4
moderate agreement was found between Vp-echo and Vp-MRI-LR: kappa ± SE = 0.69 ± 0.09, p < 
0.001 (Table 2). When using either VE-MRI measures of Vp to identify LV impaired relaxation, high 
values for sensitivity (Vp-MRI-DQ 88% with 95%-CI 71 – 96% and Vp-MRI-LR 88% with 95%-CI 71 
– 96%) and specificity (Vp-MRI-DQ 85% with 95%-CI 70 – 93% and Vp-MRI-LR 82% with 95%-CI 
67 – 91%) were found (Table 3).
Intra-observer analysis showed excellent intraclass correlation for both MRI-LR and MRI-DQ 
(0.97) with a coefficient of variation of 15% (Table 3). Mean difference in MRI-LR was -4.5cm/s 
95%-CI -9.0 – -0.6, p=0.05 and in MRI- DQ -3.0cm/s 95%-CI -7.2 – 1.2, p=0.15. Inter-observer 
analysis showed strong intraclass correlation for both MRI-LR (0.92) and MRI-DQ (0.95) with a 
coefficient of variation of 26% for MRI-DQ and 20% for MRI-LR (Table 3). Mean difference in 
MRI-LR was 2.5cm/s 95%-CI -5.5 – -10.4, p=0.53 and in MRI- DQ 0.5cm/s 95%-CI -5.5 – 5.6, p=0.99.
Figure 2. Correlation between velocity propagation.
Measured with Color M-mode echocardiography (Vp-echo) and MRI difference quotient (Vp-MRI-DQ) and MRI linear 
regression (Vp-MRI-LR).
Figure 3. Agreement between velocity propagation.
Measured with Color M-mode echocardiography (Vp-echo) and MRI difference quotient (Vp-MRI-DQ) and MRI linear 
regression (Vp-MRI-LR) presented in a Bland-Altman plot.
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DISCuSSIoN
In the current recommendations for LV diastolic function assessment, LV Vp is proposed as a rela-
tively load-independent parameter to identify LV impaired relaxation [8,10,11] and is reproduc-
ibly measured by Color M-mode echocardiography [12]. Even when multiple echocardiographic 
tests of LV diastolic function may be available, Vp-assessment may be useful in the identification 
of impaired LV relaxation in case other Doppler indices appear to be inconclusive [24].
In the present study, a high-temporal VE-MRI method has been introduced to assess Vp and 
compared to Color M-mode echocardiography. More specifically, two different approaches of Vp 
measurement by VE-MRI were assessed; one based on the difference quotient, calculated from 
the LV inflow wave propagation between two measurement points; and one based on the slope 
determined with linear regression from the wave propagation along multiple measurement po-
sitions. The first approach reflects more closely the analysis by Color M-mode echocardiography, 
whereas the second approach has been tested as potentially less noise-sensitive. We chose to 
model the method for MRI-Vp-assessment on the Color M-mode echocardiography approach, 
rather than evaluating wave propagation similar to arterial pulse wave propagation approaches 
[25,26] as the short intra-ventricular distance that is covered and the limited spatial and temporal 
Table 2. Cross-tables determining weighted kappa agreement (Fleiss-Cohen weighting) between Vp-measurements 
with Color M-mode echocardiography (Vp-echo) and MRI difference quotient (Vp-MRI-DQ) and MRI linear regression 
(Vp-MRI-LR). 
Vp-mRI-Dq
< 45/55 cm/s ≥ 45/55 cm/s
Vp-echo
< 45/55 cm/s 23 6
≥ 45/55 cm/s 3 33
Vp-mRI-LR
< 45/55 cm/s ≥ 45/55 cm/s
Vp-echo
< 45/55 cm/s 23 7
≥ 45/55 cm/s 3 32
Table 3. Intra- and inter-observer variability analysis. Vp-MRI-DQ = Velocity propagation MRI difference quotient, Vp-
MRI-LR = Velocity propagation MRI linear regression.
Intra-observer Inter-observer
Vp-mRI-Dq Vp-mRI-LR Vp-mRI-Dq Vp-mRI-LR
Intraclass correlation coefficient 0.97 (p<0.001) 0.97 (p<0.001) 0.92 (p<0.001) 0.95 (p<0.001)
mean difference with 95%-CI (cm/s) -4.5 (-9.0 – -0.6) -3.0 (-7.2 – 1.2) 2.5 (-5.5 – 10.4) 0.1 (-5.5 – 5.6)
P value 0.05 0.15 0.53 0.99
Absolute difference (cm/s) 7.1 ± 7.9 5.8 ± 7.4 11.9 ± 12.3 8.9 ± 7.5
Coefficient of variation 15% 15% 26% 20%
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resolution do not allow such evaluation. Vp-values obtained by both MRI approaches showed 
good correlation and agreement with Color M-mode echocardiography. However, Vp based 
on difference quotient calculation showed slightly better agreement and smaller bias when 
compared with echocardiography. This approach could be therefore proposed as a potential 
alternative method or as further confirmation to echocardiography in the assessment of LV 
diastolic function and identification of LV impaired relaxation. 
Although echocardiography remains the method of choice for the assessment of LV dia-
stolic function considering the high temporal and spatial resolution and the wide availability, 
VE-MRI could represent a valuable alternative in several patients referred for cardiac MRI for a 
comprehensive systolic and diastolic function evaluation. In patients with Duchenne muscular 
dystrophy for example, echocardiographic window may be poor in progressive disease, but Vp 
has been reported as an early marker of LV diastolic dysfunction [27]. Vp measured by VE-MRI 
could therefore serve as a useful tool in such cases when the echo measure is difficult to obtain. 
Similarly, Vp measured with Color M-mode echocardiography may be challenging in patients 
with dilated cardiomyopathy [13] or patients after atrioventricular valve surgery [28] due to lat-
eral mitral valve inflow ; in these patients the MRI acquisition plane can be adjusted to the inflow 
direction and provide a potentially more accurate assessment. However, MRI is not feasible in 
all patients: claustrophobia is occasionally a problem, and absolute contraindications include 
pacemakers, defibrillators, and cerebral clips. 
Several limitations of current study should be mentioned. VE-MRI is characterized by a 
lower temporal resolution as compared to Color M-mode echocardiography. Higher temporal 
resolution is possible by applying one-directional Fourier encoded M-mode [29], however, this 
technique was not available on our MRI platform. Especially for fast wave propagation, temporal 
resolution of VE-MRI may not be adequate to register Vp accurately. This explains the fact that 
agreement between MRI and Color M-mode echocardiography worsened for higher Vp values. 
However, around the proposed cut-off values of 45cm/s (>30 year-old) and 55cm/s (<30 year-
old), VE-MRI performs well for the identification of impaired LV relaxation with a good kappa 
agreement and high sensitivity and specificity. With VE-MRI an average heart beat is constructed 
from several minutes of recording, consequently variety in heart rate might cause errors. The 
time-resolved imaging approach of MRI is not feasible for detecting small-scale fluctuations 
in the temporal domain. However, variety in heart rate was minimized during the acquisition 
by excluding heart beats with more than 10% deviation of the average. Furthermore, due to 
logistical reasons, patients and volunteers were scanned using different scanners and field 
strengths, resulting in minor differences among some scan parameters and a more than twofold 
higher SNR for VE-MRI in volunteers versus patients. However, SNR of VE-MRI in patients was still 
adequate for Vp-assessment. Furthermore, it is not expected that the method of Vp-assessment 
will be affected by scanning at different field strengths. Finally, in the current study, only patients 
with ischemic heart failure were included. Vp-assessment with VE-MRI should also be evalu-
ated further in healthy controls to provide reference values and in different patient populations 
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such as heart failure patients with preserved ejection fraction, non-ischemic cardiomyopathy or 
congenital heart disease.
CoNCLuSIoN
This study showed the feasibility of a high-temporal VE-MRI approach for Vp-assessment, with 
a direct comparison to Color M-mode echocardiography. Good correlation and agreement 
was found especially for lower Vp-values which are related to impaired LV relaxation. VE-MRI 
represents therefore a potential valuable approach in the assessment of LV diastolic function.
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During normal left ventricular (LV) filling, a vortex ring structure is formed distal to the left atrio-
ventricular valve (LAVV). Vortex structures contribute to efficient flow organization. We aimed to 
investigate whether LAVV abnormality in patients with a corrected atrioventricular septal defect 
(AVSD) has impact on vortex ring formation.
methods
Whole-heart 4DFlow MRI was performed in 32 patients (age 26±12 years) and 30 healthy con-
trols (25±14 years). Vortex ring cores were detected at peak early (E-peak) and peak late filling 
(A-peak). When present, the three-dimensional (3D) position and orientation of the vortex ring 
was defined and the circularity index was calculated. Through-plane flow over the LAVV and 
the Vortex Formation Time (VFT) were quantified to analyze the relation of vortex flow with the 
inflow jet. 
Results
Absence of a vortex ring during E-peak (controls 0% versus patients 19%, p=0.015) and A-peak 
(controls 10% versus patients 44%, p=0.008) was more frequent in patients. In 4 patients, this was 
accompanied by a high VFT (5.1-7.8 versus 2.4±0.6 in controls) and in another two patients with 
abnormal valve anatomy. In patients compared with controls, the vortex cores had a more an-
terior and apical position, closer to the ventricular wall, with a more elliptical shape and oblique 
orientation. The shape of the vortex core closely resembled the valve shape and its orientation 
was related to the LV inflow direction. 
Conclusion
This study quantitatively shows the influence of abnormal LAVV and LV inflow on 3D vortex ring 
formation during LV inflow in corrected-AVSD patients compared with controls.
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BACKGRouND
Patients with an atrioventricular septal defect (AVSD) require corrective surgery early in life to 
prevent pulmonary overflow and heart failure. As compared with the normal mitral valve, the 
mural (posterior) leaflet of the left atrioventricular valve (LAVV) is smaller and the anterolateral 
papillary muscle is positioned more lateral in AVSD hearts [1;2]. Furthermore, the presence of a 
single papillary muscle and double-orifice are described [3]. Moreover, surgical correction of an 
AVSD, including closure of the ‘cleft’, may result in restricted opening of the LAVV [4] and a more 
lateral inflow [5], which might affect efficiency of cardiac blood flow in the left ventricle (LV). 
Survival after surgical correction is excellent in current era, but re-operation rate due to valve 
regurgitation is high [6;7]. Long-term follow-up data on cardiac function or exercise capacity 
after AVSD correction is lacking. However, deterioration of cardiac function and NYHA-class is 
described during pregnancy, when cardiac flow increases [8]. 
Recently, the formation of a vortex within the LV during diastole was related to the inflow area 
through the mitral valve in healthy subjects [9]. The formation of vortex structures, (i.e. compact 
regions of swirling blood flow) in LV blood flow patterns during diastolic filling has recently 
emerged as a potential novel index for characterizing efficient LV blood flow and evaluating 
cardiac chamber (dys)function [10]. During LV filling, a vortex ring structure distal to the mitral 
valve leaflets and enclosing the inflow jet is observed. This vortical flow is considered an ef-
ficient mechanism for transporting a significant portion of LV filling volume towards the aorta 
[11], minimizing energy loss and helping mitral valve closure [12;13]. Recently, three-directional, 
three-dimensional (3D) and time-resolved velocity encoded MRI(4DFlow MRI) has been intro-
duced to assess vortex ring formation during LV filling in vivo [9], because it has the advantage 
of a 3D evaluation of the vortex ring. 
Given the relation between the vortex ring properties and the mitral valve morphology and LV 
inflow [9;14-17], we hypothesized that LAVV abnormalities and associated abnormal lateral inflow 
[5] after surgical AVSD correction may result in disturbed vortex flow during LV filling. Therefore, 
we used 4DFlow MRI to identify and quantitatively characterize the geometrical properties and 
anatomical location of vortex ring cores during early and late LV filling, allowing quantitative 




The study was approved by the ethical committee of the Leiden University Medical Center and 
written informed consent was obtained from all participants or their parents. Thirty-two patients 
with a history of corrected-AVSD were prospectively enrolled from a surgical database [18]. 
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Thirty controls with a similar age without history of cardiac disease were included for compari-
son. Patients and controls in the current study were previously reported in studies with the aim 
to characterize and quantify diastolic trans-atrioventricular flow [5;19]. Twenty-four of the 30 
healthy controls were reported in a study providing reference values for 3D vortex flow in the LV 
flow [9]. None of the previously published papers addresses vortex formation in corrected AVSD 
patients. For clarity we will use the term left atrioventricular valve (LAVV) in patients and controls, 
instead of referring to mitral valve in healthy subjects and LAVV in patients. 
magnetic Resonance Imaging acquisition and analysis
Whole-heart 4DFlow was obtained on a 3T MRI scanner (Ingenia, Philips Healthcare, Best, The 
Netherlands) with maximal gradient amplitude of 45mT/m for each axis and a slew rate of 
200T/m/sec, using a combination of FlexCoverage Posterior coil in the table top with a dStream 
Torso coil, providing up to 32 coil elements for signal reception. Imaging details have been re-
ported elsewhere [5]. In short, a 3D volume acquisition of the heart was performed with velocity 
encoding of 150cm/s in all three directions, spatial resolution of 2.3×2.3×3.0-4.2mm3, 30 cardiac 
phases were retrospectively reconstructed to represent one average heartbeat, with a maximal 
true temporal resolution of 31ms. Furthermore, to quantify LV volumes and ejection fraction, a 
left 2-chamber and 4-chamber cine view and a short-axis cine stack of slices, was acquired with 
steady-state free-precession (SSFP) sequences as reported elsewhere [5].Spatial resolution was 
1.0×1.0×8.0mm3 and also for these acquisitions, 30 phases were retrospectively reconstructed. 
All acquisitions were performed with free breathing and no respiratory motion control. The cine 
SSFP acquisitions were all performed with 3 signal averages to suppress breathing artefacts. 
After manual segmentation of LV endocardial boundaries, the LV end-diastolic volume (LVEDV), 
end-systolic volume (ESV) and ejection fraction were calculated. Sphericity index of the LV was 
calculated as LVEDV/(π/6×long-axis at end-diastole3).
A 3D vortex core analysis based on the Lambda2-method
Using the image analysis workflow as described previously [9], the cores of vortex structures 
within the LV blood flow during diastole as acquired from the 4DFlow MRI data were identified 
by a single observer using the Lambda2-method [20]. In short, the Lambda2-method is a fluid-
dynamics-based method that uses the gradient properties of the velocity field to identify vortex 
cores in the flow. For each subject, the vortex cores were identified at the early (E-peak) and late 
(A-peak) filling, defined from the below described trans LAVV flow quantification, and visualized 
as isosurfaces. 
Qualitative visual inspection of the shape of detected vortex cores was performed to deter-
mine whether a 3D ring-shaped vortex core was present, defined as a vortex core with a donut-
like (torus) shape (Figure 1). If a vortex ring core was detected during E-peak and/or A-peak, its 
3D position (in normalized cylindrical coordinates), orientation and shape were quantitatively 
characterized as illustrated in Figure 1. 
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Trans- left atrioventricular valve flow
Trans-LAVV flow was quantified using the 4DFlow MRI data and retrospective valve tracking [21]. 
From the through-plane LAVV velocity map, a flow-time curve of the LAVV flow was computed 
and E-peak and A-peak were defined. The early LV filling fraction was calculated as (E-wave inflow 
volume / total inflow volume) × 100%. To study the association with diastolic vortex formation, 
LAVV and inflow characteristics were evaluated. The inflow area and peak velocity during E-peak 
were quantified at the level of peak inflow velocity. The peak velocity inflow angle (i.e. angle 
between long-axis and inflow direction) at E-peak was measured using streamline visualization 
of the flow velocity field on the four-chamber view as previously described [5].
Figure 1. 3D-quantitative vortex core parameters. 
The cylindrical position of the vortex core center (asterisk in a) was defined using longitudinal (L), circumferential 
(C), and radial (R) coordinates relative to LV (A,B). L and R were normalized relative to the LV long-axis length and the 
radius of the LV endocardial cavity respectively. The orientation angle was defined relative to the long-axis (C)(sept = 
septal side, lat = lateral side). Circularity index (CI) was defined as the ratio between longest- (D1) and shortest diam-
eter (D2) (D). (modified after Elbaz et al. JCMR (16))
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Vortex formation time index
The Vortex Formation Time (VFT), a dimensionless index previously proposed to quantify the 
process of vortex progression during early filling [23], was determined using the formula: VFT = 
(Vavg×Eduration) / D, based on the average speed of the blood flow during the early filling period 
(Vavg), the duration of the E-filling (Eduration) and the maximum diameter (D). The D dominator was 
computed at E-peak from the area of the LAVV flow, measured on the velocity map after retro-
spective valve tracking at peak velocity level (i.e. tip of the valves). The diameters was calculated 
as D = 2 Area/π  , assuming the inflow area to be circular.
Statistical analysis
Data analysis was performed using SPSS Statistics (version 20.0 IBM SPSS, Chicago, Illinois). 
Variables were tested for normal distribution using the Shapiro-Wilk test. Continuous variables 
are expressed as mean ± standard deviation (SD) and as median with inter-quartile range (IQR) 
where appropriate. Differences between presence of E-peak and A-peak vortex ring core were 
tested with a Pearson Chi-Square test. Differences between patients and controls and subjects 
with and without E-peak vortex ring core were performed with an unpaired T-test or Mann-
Whitney-U-test. Correlation between inflow direction, LV volume and vortex position parameters 
were assessed with linear regression analysis (Pearson’s r). 
RESuLTS
Patient characteristics
Characteristics of patients and healthy controls are presented in Table 1. Of 32 patients, 1 had a 
double-orifice LAVV [3], 1 had a single papillary muscle [3] and another patient was known with 
dextrocardia. In patients compared with controls, mean LV ejection fraction was lower, diastasis 
was shorter and LV sphericity index was higher. 
Presence of 3D vortex cores during E-peak and A-peak
In all controls, during peak E-filling, a quasi-ring-shaped vortex core was identified distal to the 
mitral valve in the LV blood flow pattern (Figure 2). In 26 (81%, p=0.015) patients, such compact 
3D vortex ring core distal to the LAVV was identified during peak E-filling. The shape of the 
detected 3D vortex ring cores in patients was more frequently deformed, albeit the vortex cores 
were still compact and recognizable (Figure 2). 
Visually, the shape of vortex core tended to resemble the shape of the inflow area over the 
LAVV as observed on the through-plane velocity maps (Figure 2). In six patients (19 %) (Table 2), 
no E-peak vortex ring core was detected, instead only a complex irregular vortex shape was pres-
ent. The six patients included the patient with a double-orifice LAVV (Figure 3) and the patient 
with a single papillary muscle. The other 4 patients without an E-peak vortex ring core had a 
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small LAVV area, higher peak velocity and VFT deviating more than 2SD (VFT = 5.1, 5.5, 7.4 and 
7.8) (Table 2) from controls (2.6±0.6). The other patients with an E-peak vortex ring core had a 
mean VFT of 2.4±0.6, which was very similar to the controls. The LV shape parameters LVEDV 
and sphericity index, of the six patients without E-peak vortex, still fell within the ranges of the 
patients with an E-peak vortex ring core.
At peak A-filling, an asymmetrical compact vortex ring core formed at the basal LV level in 
27 controls (90%) but only in 19 (59%, p=0.006) patients. Details of patients with and without 
A-peak vortex ring core are presented in Table 3. Patients and controls without an A-peak vortex 
ring core had shorter diastasis (14±17ms) as compared with patients and controls with an A-
peak vortex ring (109±85ms, p<0.001). 
quantitative 3D parameters of vortex ring cores and association with the LAVV and 
LV characteristics
The circumferential, longitudinal and radial position, orientation and circularity index were 
quantified for all detected vortex ring cores. During E-peak and A-peak the center of the vortex 
ring core was positioned more anterior (lower circumferential value), closer to the apex (higher 
Table 1. Characteristics of healthy controls and patients. LVEDV = Left ventricular end-diastolic volume, BSA=body 
surface area, LAV=left atrial volume, LV=left ventricle, LAVV=left atrioventricular valve, VFT=vortex formation time, * 
excluding two cases without A-peak † indicates p<0.01, ‡indicates p<0.001.
Controls Corrected-AVSD patients
Age (years) 23 (13-38) 26 ± 12
male (%) 14 (46) 9 (28)
Heart rate (bpm) 68 (60-78) 76 ± 13
Diastasis (ms) 116 ± 89 26 (0-67) * †
Type AVSD - 21 (66%) partial 11 (33%) complete or intermediate
Time after surgical correction (years) 20 ± 9
Stroke volume LV (mL) 89 ± 23 85 ± 19
LVEDV (mL) 146 ± 42 155 ± 33
LVEDV / BSA (mL/m2) 87 ± 13 91 ± 15
LV Sphericity index 0.37 ± 0.06 0.57 ± 0.14 ‡
Inflow area (cm2) 9.2 ± 2.0 8.5 ± 2.5
Peak velocity (cm/s) 94 ± 15 93 (77-145)
VFT index 2.6 ± 0.6 2.4 (1.9-3.1)
Blood pressure systolic (mmHg) 112 ± 13 119 ± 20
Blood pressure diastolic (mmHg) 67 ± 9 67 ± 12
E/A ratio peak flow rate 2.5 ± 0.8 2.1 (1.7-2.6) *
Early filling fraction (%) 76 ± 5 73 ± 13 
Ejection fraction (%) 61 ± 5 56 (52-58) ‡
LAVV regurgitation (%) - 14 ± 8 
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Figure 2. Shape of vortex core corresponds with the inflow area. 
Vortex cores depicted on reformat planes of through-plane flow at peak inflow velocity (B, E, H, K) during early (E-
peak) and late (A-peak) filling in a healthy control (A-F) and a patient (G-L). LA = Left atrium, LV = Left ventricle. Sept 
= septal side.
Figure 3. Patient with a double-orifice LAVV showing two separate inflow jets.
Streamlines (color coding representing velocity magnitude) show two inflow jets (white arrow A). The vortex core had 
a complex shape (B), but fitted with streamlines (C). Through-plane flow analysis showed two jets in the LAVV (dotted 
line in D). Positioning the streamlines (E) and vortex core (F) on top of the velocity map shows that a core is formed 
around both jets. LA = Left atrium, LV = Left ventricle. Ant = anterior.
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longitudinal value) and closer to the LV wall (higher radial value) in patients compared with 
controls (Table 4). 
In healthy controls, the vortex orientation ranged from 55-88°, while in patients, the vortex 
orientation showed a wider range (14-134°). Three patients had a vortex orientation angle larger 
than 90° (i.e. 102°, 115° and 134°), indicating a reversed orientation of the ring (Figure 4) with the 
lateral side of the vortex being positioned towards the apex, in contrast to the controls where the 
septal side was positioned more apical. In patients with non-reversed vortex ring cores (orienta-
tion <90°), cores were in a more tilted position (50±20°) as compared with the controls (71±9°, 
p<0.001) (Figure 5). During A-peak, the vortex ring core orientation was in a non-reversed more 
Table 2. Characteristics of the 6 patients without a vortex ring core during E-peak or A-peak. Bpm = beats per minute, 
ms = milliseconds, LAVV = left atrioventricular valve, cm = centimeter, s = second, VFT = vortex formation time
Pt 1 Pt 2 Pt 3 Pt 4 Pt 5 Pt 6
Age 10 23 20 36 12 32







Partial Complete Complete Complete 
dextro-
cardia
Regurgitation % 10 23 20 36 12 32
Heart rate (bpm) 76 78 96 114 60 62
Diastasis (ms) 24 0 No A-peak No A-peak 0 0
Early filling fraction (%) 61 80 100 100 81 88
Area LAVV (cm2) 9.2 8.4 6.0 5.1 4.6 4.6
Peak velocity (cm/s) 58 110 144 158 146 155
VFT 1.6 2.5 5.1 5.5 7.8 7.4
Table 3. Characteristics of controls and patients with a vortex ring core present during E-peak. Bpm = beats per min-
ute, ms = milliseconds, LAVV = left atrioventricular valve, cm = centimeter, s = second, VFT = vortex formation time.
Controls with E- 
and A-peak ring
Controls with only 
E-peak ring
Patients with E- 
and A-peak ring
Patients with only 
E-peak ring
N 27 3 19 7
Age 26 ± 13 11 ± 2 26 ± 14 28 ± 8




Regurgitation % - - 12 ± 8 13 ± 6
Heart rate (bpm) 67 ± 10 95 ± 7 72 ± 12 80 ± 4
Diastasis (ms) 128 ± 86 7 ± 13 81 ± 79 22 ± 18
Passive filling fraction (%) 76 ± 5 79 ± 2 72 ± 11 68 ± 10
Area LAVV (cm2) 9.5 ± 1.9 6.4 ± 0.8 8.8 ± 2.5 9.3 ± 2.3
Peak velocity (cm/s) 93 ± 16 105 ± 4 92 ± 15 94 ± 28
VFT 2.6 ± 0.6 2.6 ± 0.2 2.4 ± 0.6 2.4 ± 0.5
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tilted position in all patients compared with controls (54±21° versus 72±6°, p=0.001). During 
both E-peak and A-peak, vortex ring cores were less circular in patients compared with controls 
(Figure 5) (Table 4).
In patients, vortex ring core orientation angle relative to the LV long-axis showed a significant 
correlation with the inflow angle (E-peak r=0.41, p=0.037 and A-peak r=0.62, p=0.005), inflow 
area during E-peak (r = 0.47, p=0.015) and LVEDV (E-peak r=0.61, p=0.001 and A-peak r=0.54 
p=0.017). In controls no significant correlations were found between orientation angle and 
inflow angle, inflow area or LVEDV. In patients, sphericity index of the LV did not show a relation 
with vortex ring core characteristics. Ejection fraction did not correlate with vortex ring core 
Figure 4. Reversed orientation of the vortex ring core in a corrected AVSD patient. 
Healthy control (A) and patients (B). LA = Left atrium, LV = Left ventricle.
Table 4. Quantitative vortex core characteristics as presented in Figure 1 at E-peak and A-peak in controls and pa-
tients. * Including patients with a non-reversed orientation (N=23). Inclusion of all patients (N=26) gives a mean 
orientation of 58 ± 29, p=0.037. 
Controls (N=30) Patients (N=26) P value
E-peak Circumferential 90 ± 26° 70 ± 21° 0.003
Longitudinal 0.19 ± 0.04 0.23 ± 0.07 0.015
Radial 0.26 ± 0.07 0.33 ± 0.08 0.001
Orientation 71 ± 9° 50 ± 20° * <0.001 *
Circularity Index 0.80 ± 0.08 0.70 ± 0.13 0.002
Controls (N=27) Patients (N=19)
A-peak Circumferential 106 ± 27° 80 ± 28° 0.003
Longitudinal 0.15 ± 0.05 0.19 ± 0.05 0.004
Radial 0.20 ± 0.08 0.32 ± 0.14 0.002
Orientation 72 ± 6° 54 ± 21° 0.001
Circularity Index 0.63 (0.59-0.69) 0.60 ± 0.10 0.115
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Figure 5. Example of a vortex 
core during E-peak in a patient 
and a control. 
Streamline visualization (color 
coding represents velocity mag-
nitude) shows a more lateral 
inflow direction in the patient 
(F) compared with the control 
(B). The vortex core has a more 
tilted orientation (G) and ellipti-
cal shape (H) in the patient as 
compared with the healthy con-
trol (C-D). LA = Left atrium, LV = 
Left ventricle. 
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presence or characteristics. In patients, no significant correlation (p=0.97) was found between 
regurgitation fraction and vortex orientation.
DISCuSSIoN 
This study, for the first time, quantitatively describes the effect of LAVV abnormalities and abnor-
mal LV inflow on 3D vortex ring formation in LV blood flow patterns during early and late filling, 
in patients with surgically corrected LAVV valves compared with healthy subjects. These findings 
highlight the close relationship between AVV morphology and LV filling characteristics, with LV 
vortex formation. Previous studies on vortex formation in the presence of LAVV abnormalities 
were performed in vitro, or were based on 2-dimensional analysis using echocardiography.
The current report provides an in vivo 3D analysis using 4D flow MRI. Key findings are as fol-
lows: (1) Absence ofvortex ring formation is more frequent in corrected-AVSD patients and is 
related to LAVVabnormalities (single papillary muscle and double-orifice) and a narrow LAVV 
diameter concomitant with high inflow velocities evidenced by a high VFT. (2) If a vortex ring 
core is present in corrected-AVSD patients, it has a different position, a more elliptical shape, and 
an oblique orientation compared with controls, and these differences correlate with LV inflow 
direction.
Absence of vortex ring core related to valve morphology and VFT 
In the normal heart, adequate suction, correct shape of the valve leaflets and normal electrical 
conduction allow vortex ring formation during LV filling [23]. In our study, 6 patients did not 
develop a vortex ring. One of these patients had a double-orifice LAVV, resulting in two inflow 
jets as is also seen after edge-to-edge repair. Absence of a ring in this patient is in agreement 
with computational fluid dynamics (CFD) studies simulating edge-to-edge repair, resulting in 
abnormal vortex formation with increased energy loss and decreased LV filling efficiency [24]. 
Another patient without vortex ring formation had a single papillary muscle, stressing the con-
tribution of the papillary muscles to the shape of the vortex ring [25]. 
Both cases underline the influence of morphological LAVV abnormalities on vortex formation. 
Next to two patients with abnormal anatomy, 4 other patients were observed without E-peak 
vortex ring formation. These four had a VFT more than 2 SDs higher, compared with the patients 
with an E-peak vortex ring core and controls. The VFT index, studied in vitro and in vivo, is known 
to have an optimal value range defining efficient vortex formation [22;26]. In patients with mitral 
stenosis, higher values of VFT have been related to absence of a well-formed vortex ring result-
ing in increased energy dissipation [27]. In the current MRI study, the VFT values in controls were 
lower than the reported range (3.5-5.5) measured with echocardiography [22]. This might be 
due to differences between modalities [28] and their definition of valve diameter measurement. 
However, the markedly higher VFT values in patients with an absent vortex ring confirms that 
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patients with a narrow LAVV diameter and higher peak velocity develop abnormal vortex flow 
[22,26]. In addition, VFT measurements were comparable and not significantly different between 
controls and patients when an E-vortex ring core was present. Absence of a separate A-peak 
vortex ring core was related to the shorter diastasis in patients similarly to what is reported in 
healthy controls [9]. 
Vortex ring formation related to LAVV and LV characteristics
In normal hearts, a vortex ring forms at the tip of the LAVV [29], with the septal side positioned 
towards the apex due to the unbalanced shape of the leaflets (i.e., longer anterior and shorter 
posterior leaflet) and interaction with LV wall [23,29]. The visual similarity between the 3D shape 
of the vortex ring core and the (abnormal) LAVV orifices (i.e. LAVV inflow area) in this study 
illustrates the impact of the abnormal LAVV on vortex ring formation. Moreover, the observed 
correlation between disturbed vortex characteristics and altered inflow area and direction, 
indicates an influence of abnormal valve and inflow on vortex ring formation. Our findings are 
in agreement with CFD experiments [16], 2D echocardiography analysis in human [17;30] and 
an MRI study in sheep [31] showing that LAVV repair and replacement are related to unnatural 
vortex formation. Aside from the impact of the valve abnormalities, the correlation between 
vortex ring orientation and LVEDV shows an impact of LV size on vortex formation. This finding 
is in agreement with the relation between LVEDV and vortex size observed in patients with 
dilated cardiomyopathy [32]. In current study, no relation was found between vortex ring core 
characteristics and sphericity index, as was described in a previous study using vortex filling 
fraction [11]. However, absence of such correlation might be due to the narrow range in spheric-
ity index of patients in the current study. In addition no relation was found with the ejection 
fraction, which was close to normal in all patients. Consequently a possible impact of a restrictive 
LV, remains to be investigated.
Clinical implication
During AVSD correction, the common atrioventricular valve is separated and the cleft is closed. 
During surgical correction of an AVSD surgeons have to minimize valve regurgitation, without 
causing valve restriction. Even though the shape of the vortex will not be the main concern 
of the surgeon during correction of an AVSD, awareness of the effect of valve surgery on the 
formation of vortices in the LV blood flow is important, as changes in vortex formation might 
affect blood flow efficiency. Similar consideration accounts for LAVV surgery in other congenital 
and acquired heart disease. 
These results do not preclude the possibility that the aberrant vortex formation is a coping 
mechanism of the heart and has a favorable effect on cardiac function. However, CFD studies 
have shown increased energy dissipation in cases with a disturbed LAVV shape and abnormal 
vortex flow formation [14-16] and reduced efficiency of the heart pump in patients with a higher 
VFT index [33]. A reversed vortex resulted in an increased energy dissipation level compared with 
Chapter 3.5208
a normally oriented vortex [15]. Whether the aberrant vortex formation also results in clinical 
relevant changes in flow efficiency in corrected AVSD patients remains to be investigated during 
long-term follow-up data of this patient group. 
In the current study, global diastolic and systolic functions were within normal ranges, how-
ever vortex ring characteristics were significantly different in patients compared with controls. 
This finding may suggest that vortex formation provides a more sensitive indication of disturbed 
diastolic function than do conventional functional parameters, and confirms the suggested role 
of vortex analysis as early predictor of diastolic dysfunction [34]. In patients with unbalanced 
AVSD the inflow direction may play a role in LV growth as well [35]. Analysis of vortex formation 
in unbalanced AVSDs can potentially contribute to predicting LV growth and decision making 
for bi-ventricular repair.
The disturbed vortex formation observed at rest may become more pronounced during 
exercise or pregnancy when cardiac blood flow increases. Future studies are needed to analyze 
flow organization in situations with increased cardiac flow, such as during exercise. Furthermore, 
disturbed vortex ring formation might influence shear stress which serves as an epigenetic fac-
tor in cardiac remodeling [13]. Therefore, future long-term studies have to reveal if abnormal 
vortex formation affects energy loss or cardiac pumping efficiency, and/or may serve an early 
predictor for poor cardiac outcome [30]. 
Study Limitations 
Absence or presence of a vortex ring was scored visually, however a previous study [9] showed 
that vortex detection can be done with low inter- and intra-observer variation. In the current 
study, the absence of vortex formation was further confirmed by the significant high VFT which 
is in line with previous work. 4DFlow MRI has the disadvantage of a relatively long scan duration 
(8-10 minutes), and is associated with relatively high costs compared with echocardiography. 
Vortex core analysis was limited to the E-peak and A-peak, subsequently no data was available 
on the timing, forming and disappearance of the vortex cores. Parameters of diastolic and sys-
tolic function of patients were all close to normal reference values, which made correlation with 
clinical parameters difficult. LV inflow angle was measured on a 2D plane but was compared 
with a 3D-determined vortex orientation. If a vortex ring core was not elliptical, the circularity 
index was computed by approximating an ellipse around the deformed vortex shape. This ap-
proximation might not fully capture or characterize the deformed vortex ring shape.
CoNCLuSIoN
Quantitative 3D vortex analysis of early- and late-filling vortex ring formation revealed a disturbed 
vortex ring formation in patients after correction of an AVSD. This disturbance is characterized by 
either absence of a formed vortex ring or alterations in the geometric properties and location 
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of the formed rings. These findings were associated with abnormal LV inflow and morphology 
of the LAVV in the studied patients. Using 3D analysis, the current in vivo study quantitatively 
confirms the relation between LAVV abnormalities and altered vortex ring formation in the LV. 
Our findings highlight the close relationship among AVV abnormalities. In addition, they create 
awareness of the influence of AVV abnormalities and AVV surgery on LV vortex formation. The 
exact implications of abnormal vortex formation and possible increased energy loss and cardiac 
remodeling, owing to aberrant vortex formation, needs further investigation. 
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 Chapter 3.6
Characterization and quanti cation of 
dynamic eccentric regurgitation of the left 
atrioventricular valve after atrioventricular 
septal defect correction with 4DFlow 
cardiovascular magnetic resonance and 
retrospective valve tracking
Emmeline E. Calkoen, Jos J.M. Westenberg, Lucia J.M. Kroft, Nico A. Blom, 
Mark G. Hazekamp, Marry E. Rijlaarsdam, Monique R.M. Jongbloed, 





To characterize and directly quantify regurgitant jets of left atrioventricular valve (LAVV) in pa-
tients with corrected atrioventricular septal defect (AVSD) by four-dimensional (4D)Flow Cardio-
vascular Magnetic Resonance (CMR), streamline visualization and retrospective valve tracking. 
methods
Medical ethical committee approval and informed consent from all patients or their parents 
were obtained. In 32 corrected AVSD patients (age 26±12 years), echocardiography and whole-
heart 4DFlow MRI were performed. Using streamline visualization on 2- and 4-chamber views, 
the angle between regurgitation and annulus was followed throughout systole. On through-
plane velocity-encoded images reformatted perpendicular to the regurgitation jet the cross-
sectional jet circularity index was assessed and regurgitant volume and fraction were calculated. 
Correlation and agreement between different techniques was performed with Pearson’s r and 
Spearman’s rho correlation and Bland-Altman analysis.
Results
In 8 patients, multiple regurgitant jets over the LAVV were identified. Median variation in regurgi-
tant jet angle within patients was 36°(IQR 18–64° ) on the 2-chamber and 30°(IQR 20–40°) on the 
4-chamber. Regurgitant jets had a circularity index of 0.61±0.16. Quantification of the regurgita-
tion volume was feasible with 4DFlow CMR with excellent correlation between LAVV effective 
forward flow and aortic flow (r=0.97, p<0.001) for internal validation and moderate correlation 
with planimetry derived regurgitant volume (r=0.65, p<0.001) and echocardiographic grading 
(rho=0.51, p=0.003). 
Conclusion
4DFlow CMR with streamline visualization revealed multiple, dynamic and eccentric regurgitant 
jets with non-circular cross-sectional shape in patients after AVSD correction. 4DFlow with ret-
rospective valve tracking allows direct and accurate quantification of the regurgitation of these 
complex jets. 
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BACKGRouND
After correction of an atrioventricular septal defect (AVSD), regurgitation of the left atrioventricu-
lar valve (LAVV, i.e. the left part of the common atrioventricular valve after correction, connecting 
the left atrium with left ventricle) is common. Up to 11% of the patients with corrected AVSD re-
quire surgery of the LAVV during follow-up [1], and according to the grown-up congenital heart 
disease (GUCH) guidelines of the European Society Cardiology (ESC) surgical correction of LAVV 
regurgitation should be considered in asymptomatic patients with moderate to severe LAVV [2]. 
Therefore, reliable quantification of LAVV regurgitation is important for clinical decision-making.
Echocardiography is most commonly used to evaluate mitral valve or LAVV regurgitation, but 
echocardiographic quantification of the regurgitation is based on several assumption, such as a 
cross-sectional circular shape of the jet and a static occurrence and position of the jet through-
out systole. In adult patients with mitral regurgitation of diverse origin, poor inter-observer 
agreement has been described for echocardiographic grading of mitral valve regurgitation 
using proximal isovelocity surface area (PISA) and vena contracta methods in cases of eccentric 
regurgitant jets, with non-circular cross-sectional shape or for non-pansystolic regurgitation [3, 
4]. Also in patients with corrected AVSD, quantification of LAVV regurgitation with echocardiog-
raphy has shown poor inter-observer agreement, possibly caused by the eccentric and multiple, 
non-circular characteristics of the jets [5]. Consequently, in patients after AVSD correction or 
patients with complex mitral valve regurgitation, no accurate reference method is available to 
assess LAVV/mitral valve regurgitant volume and fraction; for such cases, a combination of ap-
proaches is suggested [6, 7].
Four-dimensional (4D) Flow Cardiovascular Magnetic Resonance (CMR) allows visualization 
and reliable, validated and direct quantification of mitral valve flow using retrospective valve 
tracking perpendicular to inflow and regurgitant jet with the opportunity to perform internal 
validation [8, 9]. However, this approach has not been applied in patients after AVSD correction. 
We hypothesize that the dynamics and shape of the regurgitant jets after AVSD correction 
are not in accordance with the assumptions on which the currently available direct quantifica-
tion techniques are based. Furthermore, we hypothesize that 4DFlow CMR with retrospective 
valve tracking allows direct and accurate quantification of LAVV regurgitation by tracing the 
regurgitant jet(s) throughout systole with good internal validation of LAVV flow with aortic flow. 
Therefore, the purpose of the current study was to characterize and directly quantify regurgitant 
jets of the LAVV in patients with corrected AVSD by 4DFlow CMR, streamline visualization and 




The study protocol was approved by the medical ethical committee of the Leiden University 
Medical Center and informed consent was obtained from participants or their parents. Inclusion 
criteria were a history of AVSD correction and compatibility for MRI (age above 8 years, no-
pacemaker dependency, non-Down syndrome). Thirty-four patients were prospectively enrolled 
between October 2012 and October 2013 from an available surgical database [1]. Twenty-five 
out of the thirty-four cases have been previously reported [10]. This prior article focussed on the 
optimal CMR quantification of diastolic left ventricular inflow, whereas in the current manuscript 
we report on regurgitation during systole. Two cases were excluded because of a history of LAVV 
replacement. To assess grading of LAVV regurgitation, patients underwent echocardiography 
and 4DFlow CMR. Transthoracic echocardiography images were acquired using a commercially 
available system equipped with a 3.5MHz transducer (Vivid 9, GE-Vingmed Ultrasound, Horton, 
Norway). A senior paediatric cardiologist (MR) with over 25 years of experience in echocardiogra-
phy of congenital heart defects, visually classified/graded the regurgitation as none/trace, mild, 
moderate or severe, blinded for the 4DFlow results [5]. 
magnetic Resonance Imaging 
A 3T CMR system (Ingenia, Philips Medical Systems, the Netherlands) with maximal amplitude of 
45mT/m for each axis and a slew rate of 200T/m/sec, with a combination of FlexCoverage Pos-
terior coil in the table top with a dStream Torso coil, providing up to 32 coil elements for signal 
reception was used. Whole-heart 4DFlow was performed with velocity-encoding of 150cm/s 
in all three directions, spatial resolution 2.3×2.3×3.0mm3, flip angle 10°, echo time (TE) 3.2ms, 
repetition time (TR) 7.7ms, true temporal resolution 31ms, SENSE factor 2 in anterior-posterior 
direction and Echo Planar Imaging with a factor 5. No segmented k-space acquisition was used. 
Mean acquisition time of the 4DFlow scan was 8 minutes (range 5-11 minutes). Commercially-
available concomitant gradient correction and local phase correction filter were applied, from 
the software available on MRI system (Ingenia 3T MRI with Software Stream 4.1.3.0). Just prior 
to the 4DFlow acquisition, in the majority (26 out of 32) of patients Gadolinium contrast agent 
(0.015mmol/kilogram body weight, Dotarem®, Guerbet, Aulnay-sous-Bois, France) was admin-
istrated, for other clinical evaluations. Furthermore prior to contrast administration, cine 2D left 
2-chamber, 4-chamber, coronal and sagittal aorta views and a cine muli-2D short-axis stack of 
slices were acquired, using steady-state free-precession sequences with TE/TR 1.5/3.0, 350mm 
field-of-view, 45° flip angle, acquisition resolution 1.0×1.0×8.0mm3. Retrospective gating was 
used with 30 phases reconstructed to represent one cardiac cycle. Free breathing was allowed 
without using motion suppression, three signal averages were taken to suppress effects of 
breathing motion.
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magnetic Resonance Image analysis
Image analysis was performed by one observer (EC) with two years of experience in CMR and 
verified by two observers (JW and LK) with over 15 years of experience in CMR. Image analysis 
was done using in-house developed Mass software (Leiden). Left ventricular end-diastolic vol-
ume (LVEDV) and end-systolic volume (LVESV) were calculated by planimetry: the endocardial 
border was manually traced at end-diastole and end-systole in short-axis slices, the enclosed 
areas were calculated, multiplied by slice thickness and summed over all slices. Ejection fraction 
(EF) was calculated as EF = (LVEDV-LVESV)/LVEDV. The maximum left atrial volume (LAV) was 
calculated according to the biplane area-length from the 2- and 4-chamber view using the for-
mula (8/3π × Area(4-chamber) × Area(2-chamber))/(shortest atrial length). Atrial and ventricular 
volume were indexed for body surface area (BSA) according to Du Bois formula [11]. To assess 
the dynamics of the LAVV regurgitant jet, the jet direction was visualized using streamlines 
[12], in two orthogonal stacks of parallel cine multiplanar reformatting planes (MPRs) in 2- and 
4-chamber orientation, constructed from the magnitude gradient-echo images. At each phase 
during systole, the MPR with the largest regurgitant jet projection was used to measure the 
angle between the jet and the valve annulus (Figure 1). Prior to velocity mapping, the source 
velocity images were checked for aliasing artefacts. In case aliasing occurred in the region of 
interest, phase unwrapping was performed in the source images. Retrospective valve tracking 
was performed to assess trans-LAVV and aortic flow volumes as described previously [9]. In the 
presence of LAVV regurgitation, the reformatting plane was positioned perpendicular to the 
regurgitant jet, 1–2cm proximal to the valve throughout systole, to avoid sampling in an area 
with phase dispersion due to turbulent flow at the orifice of the regurgitation (Figure 2) [13]. 
In case of multiple regurgitant jets with different directions, a separate reformatting planes 
was constructed for each jet. The total regurgitant volume was determined by summing the 
regurgitant volume of each of the jets. To assess the shape of the regurgitant jet, the circular-
ity index of the jet at the phase of maximum regurgitant flow was calculated as the shortest 
diameter/longest cross-sectional diameter (Figure 2). To determine diastolic inflow volume 
during diastole, the MPR plane was positioned perpendicular to the inflow direction (Figure 2) 
and tracking the valve. Transvalvular flow velocity was calculated by subtraction of myocardial 
velocity in through-plane direction from the mean velocity measured over the inflow area [14]. 
Transvalvular flow volume was subsequently calculated by integrating the transvalvular velocity 
over the inflow area (i.e., the flow rate) and then integrating over the cardiac cycle (Figure 2E). 
In case of aliasing, phase unwrapping of the original data set was performed in the source data 
using in-house developed software. The phase unwrapping algorithm uses the linear relation 
between image grey value and the velocity scale between -Venc and +Venc to recalculate 
velocity values exceeding this scale in wrapped areas [15]. Regurgitant fraction was calculated 
as the ratio between regurgitant volume and total flow volume over LAVV×100%. For internal 
validation, the effective forward flow over the LAVV was compared with the aortic flow volume. 
Aortic flow volume was assessed from a similar retrospective valve tracking procedure at the 
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aortic valve, obtained from the same 4DFlow acquisition. For comparison of 4DFlow derived 
regurgitation volume with a conventional CMR quantification technique, regurgitation volume 
was also quantified as the difference between planimetry-derived stroke volume (LVEDV-LVESV), 
based on short-axis images minus aortic flow, derived from the 4DFlow acquisition. 
Figure 1. Multiple dynamic eccentric regurgitant jets.
In one subjects in 4-chamber (A, C, E) and 2-chamber (B, D, F) view during early- (34 ms) (A,B), mid- (201 ms) (C,D) and 
late (302 ms) (E,F) systole (total RR 984ms). The jet starts nearly perpendicular to the annulus (A, B), but changes to a 
more lateral (C) and anterior direction (D). A second jet was observed in late systole (E). Black dots show the annulus 
plane and the white dots the plane perpendicular to the jet. In plane C and D, the angle measurements are illustrated 
between annulus and regurgitant jet.
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Statistical Analysis
Variables were tested for normal distribution using the Shapiro-Wilk test. Continuous variables 
are expressed as mean ± standard deviation (SD) and as median with inter-quartile range (IQR) 
where appropriate. Linear regression analysis and Bland-Altman analysis [16] were performed 
to assess agreement between LAVV effective forward flow and aortic flow. Correlation between 
left atrial and ventricular volume with regurgitation volume was assessed with linear regression 
analysis (Pearson’s r). Spearman’s regression analysis (rho) were used to assess correlation be-
tween regurgitant flow volume measured on 4DFlow CMR and visual grading of regurgitation. 
Data analysis was performed using SPSS Statistics (version 20.0 IBM SPSS, Chicago, Illinois).
RESuLTS
Patient characteristics are presented in Table 1. Twenty-one (66%) patients underwent correc-
tion of a partial AVSD and 11 (34%) patients underwent correction of a complete AVSD at a 
median age of 52 (IQR 8–100) months. Patients were examined 20±9 years after correction. 
4DFlow CMR data of all 32 patients were visually inspected to be of sufficient quality for image 
analysis and streamline visualization and trans-valvular flow quantification was possible. In one 
Figure 2. Example of flow quantification.
With retrospective valve tracking in a patient with the reformatting plane (white line) adjusted to the inflow during 
diastole (A) and perpendicular to the regurgitant jet during systole (C) with through-plane velocity of inflow (B red 
contour indicates LAVV flow, green contour traces a region within the free wall of the left ventricle for background 
correction) and the non-circular regurgitant jet (CI = 0.67) (D). In E the flow curve. 
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patient aliasing occurred in the regurgitation jet and phase unwrapping was performed. Of 32 
included patients, 2 patients underwent re-operation of the LAVV due to regurgitation. Mean 
left ventricular EF was 55±5% and 30 (94%) patients were categorized NYHA class I and two 
(6%) patients NYHA class II. Using echocardiography, LAVV regurgitation was classified based on 
visual grading as none to trace in 3 patients, mild in 15 patients and moderate in 14 patients. 
Dynamics of LAVV regurgitation 
In 26 patients, the LAVV regurgitant jet(s) were visualized with streamlines. The six patients 
(including the 3 patients with none to trace LAVV regurgitation) in whom the LAVV regurgitant 
could not be visualized with streamlines were quantified with a low regurgitation volume (1–
4ml). In 8 (31%) patients, multiple LAVV regurgitant jets were observed (Figure 1). All regurgitant 
jets were dynamic with changes in the jet angle during systole. Minimal and maximal angle of 
the jet showed large variation between patients (Table 2 and Figure 3), with a lateral orientation 
of the jet on the 4-chamber view and various orientation on the 2-chamber view. The median 
difference between minimal and maximal LAVV regurgitant jet angle within patients was 36° 
(IQR 18–64° ) on the 2-chamber and 30° (IQR 20–40°) on the 4-chamber. Cross-sectional jets areas 
were non-circular (Figure 2D), as evidenced by a circularity index of 0.61±0.16. No differences in 
jet dynamics were observed between the patients with partial AVSD and complete AVSD. 
quantification of LAVV regurgitation 
Using 4DFlow CMR with retrospective plane tracking and streamline visualization, mean LAVV 
regurgitant volume was 11±6 ml and mean regurgitant fraction was 14±8%. Excellent correla-
Table 1. Patient characteristics. Data are presented as mean ± standard deviation or median with interquartile range 
where appropriate. *Indicates p<0.05. BSA = Body Surface Area, BMI = Body mass index, LVEDV = Left ventricular end 
diastolic volume, LAESV = Left atrial end systolic volume, EF = Ejection Fraction, LV = Left ventricle, NYHA class = New 
York Heart Association classification, AVSD = Atrioventricular septal defect. 
Patients
N 32
male (N, %) 9 (28%)
Age (years) 26±12
BSA (m2) 1.7±0.3
BmI 23 (IQR 19–29)
LVEDV / BSA (ml/m2) 91±15
LAESV / BSA (ml/m2) 45±11
EF LV (%) 55±5
NyHA class 30 (94%) class I, 2 (6%) class II
Type AVSD 21 (66%) partial, 11 (34%) complete
Age surgery (months) 52 (IQR 8–100)
Time after surgery (years) 20±9
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tion (Pearson’s r=0.97, p<0.001) and agreement (mean difference 0.3±4.0 ml, p=0.69, 95%-limit 
of agreement -8.0;8.6ml) was observed between aortic flow and LAVV effective forward flow 
(Figure 4). Correlation of the regurgitation volume derived from direct 4DFlow CMR with the 
combined method of planimetry - aortic flow method was Pearson’s r=0.65 (p<0.001) (Figure 5). 
Correlation between planimetry (stroke volume) and aortic flow plus regurgitation fraction was 
Pearson’s r=0.90. Regurgitant flow volume correlated with LAV relative to BSA (Pearson’s r=0.53, 
p=0.002) and LVEDV relative to BSA (Pearson’s r=0.44, p=0.016) in 30 patients with a corrected 
AVSD who did not underwent re-operation. Correlation between visual grading and 4DFlow 
CMR assessment of 4DFlow regurgitation volume was rho=0.51 (p=0.003) and of regurgitation 
fraction rho=0.63 (p <0.001) (Figure 6A,B). 
Figure 3. Schematic representation of the regurgitant jet angle in 2- and 4-chamber view. 
The median (black arrow) and interquartile range (dark grey) of the minimal and maximal regurgitant angles are 
presented. LA= left atrium, LV=left ventricle, RA=right atrium, RV=right ventricle. 
Table 2. Regurgitant jet angle (degrees) on 2- and 4-chamber view. Data are presented as median with interquartile 
range 
minimal angle maximal angle Angle difference
4-chamber view 50° (IQR 37-85°) 77° (IQR 58-112°) 30° (IQR 20-40°)
2-chamber view 63° (IQR 42-90°) 116° (IQR 81-133°) 36° (IQR 18-64° )
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Figure 4. Correlation and agreement between aortic flow and net LAVV flow.
Correlation (A) and agreement (B).
Figure 5. Correlation and agreement between regurgitant volume based on planimetry minus aortic flow and regur-
gitant volume based on direct quantification from 4DFlow data.
Correlation (A) and agreement (B).
Figure 6. Correlation between regurgitation classification based on visual echocardiography and CMR quantification. 
Mean and standard deviation of the quantitative measurements per visually scored regurgitation grade are given: A: 
regurgitation volume based on 4DFlow CMR and B: regurgitation fraction based on 4D flow CMR.
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DISCuSSIoN
The key findings of current study were as follows: First, in patients with corrected AVSD, LAVV 
regurgitant jets are dynamic, eccentric and have a non-circular cross-sectional shape. Second, 
it is feasible to directly quantify LAVV regurgitation using 4DFlow CMR and retrospective valve 
tracking with excellent internal validation with aortic flow and this approach showed moderate 
correlation with the planimetry-based CMR approach.
In patients after AVSD correction, recurrent regurgitation of the LAVV is common and associ-
ated with leaflet prolapse, rest cleft, large annular area and a different position of the papillary 
muscle [1, 17]. Reoperation incidence due to LAVV regurgitation is as high as 11%. The ESC GUCH 
guidelines recommend surgical correction in case of moderate or severe LAVV regurgitation in 
symptomatic as well as in asymptomatic patients with signs of LV volume overload. Recommen-
dations are however largely based on level C evidence (consensus of opinion of the experts and/
or small studies, retrospective studies, registries). Clear indications for and timing of intervention 
remain debatable in this patient group, in part based on difficulties in the reliable assessment of 
the amount of LAVV regurgitation [18]. 
Little is known about the natural history or predictive value of chronic LAVV regurgitation in 
patients with corrected AVSD. Adult patients with asymptomatic chronic organic mitral valve re-
gurgitation show a high likelihood to develop cardiac symptoms and high incidence of mortality 
[19, 20, 21, 22]. Chronic mitral valve regurgitation can remain asymptomatic for years, due to the 
increase in left atrial and ventricular volume [23], which was also found in our study. Due to this 
compensatory mechanism ejection fraction can remain normal despite myocardial dysfunction 
[24]. However, left atrial enlargement is a predictor of mortality and atrial fibrillation in patients 
with chronic mitral valve regurgitation due to flail leaflets or mitral valve prolapse and should be 
considered in clinical decision making for mitral valve correction [25, 26, 27]. Prolonged volume 
overload eventually results in cardiac hypertrophy and contractile dysfunction, with impaired 
output, increased end systolic volume and pulmonary congestion. Because of the poor prog-
nosis of organic mitral valve regurgitation even in asymptomatic patients, early correction of 
organic mitral valve regurgitation should be considered according to adult guidelines [23]. 
Currently data on long-term outcome of patients with LAVV regurgitation after AVSD cor-
rection is lacking. This is complicated by the lack of a gold standard to quantify LAVV regurgi-
tation in these patients. Furthermore, not all suggested quantification techniques have been 
evaluated in children with LAVV regurgitation after AVSD correction and no established cut-off 
values are available for LAVV/mitral valve regurgitation severity in children [18]. The observed 
eccentric, dynamic, multiple, non-circular jets in the current study can explain the reported low 
inter-observer agreement found in previous studies evaluating LAVV regurgitation after AVSD 
repair [5], because quantitative echocardiography techniques are based on several assumptions. 
Eccentric regurgitant jets, in contrast to central jets, are in close contact with the mitral leaflet 
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behind the regurgitant orifice and impinged to the medial or lateral wall of the left atrium [28]. 
The adherence and deviation of the jet to the valve leaflets and atrial wall, the so-called Coand  
effect, causes up to 40% smaller color Doppler jet areas and leads to underestimation of ec-
centric jets with visual grading [29]. Vena contracta measurements are based on the assumption 
that the jet has a circular cross-sectional shape and measurements from multiple jets cannot be 
added [4]. Furthermore, the PISA-method is based on the assumption of hemispheric symmetry 
of the velocity distribution [4]. Due to these drawbacks, no gold standard is available to quantify 
the regurgitation of these complex jets with echocardiography and grading of regurgitation 
remains relatively subjective. 
CMR offers non-invasive evaluation of atrial and ventricular dimensions and function with 
excellent reproducibly [30] within one comprehensive examination without geometric assump-
tions. Indirect quantification of LAVV regurgitation by subtracting the LAVV forward flow from 
the aortic flow has been shown feasible in patients with corrected AVSD [31]. Another approach 
to quantify LAVV regurgitation is the combination of planimetry-derived stroke volume with 
assessment of aortic flow volume [32]. However, both are indirect assessments of the regurgitant 
volume, and are not suitable in case of multiple valve lesions, such as aortic valve insufficiency 
or intra-cardiac shunts, such as a ventricular septal defect. Moreover, planimetry relies on ac-
curate contour definitions, with concomitant intra- and interobserver variability, and separate 
acquisitions are needed with possible differences in heart rate, possibly explaining the moderate 
correlation and variation between 4DFlow and the combination of planimetry- and aortic flow. 
4DFlow CMR can be used to directly quantify flow over the atrioventricular valves using retro-
spective valve tracking. This technique has been validated both in vitro and in vivo and proved 
to be accurate and reproducible [9]. 4DFlow CMR is independent of hemodynamic or geometric 
assumptions and it has the opportunity to retrospectively position the measurement plane 
according to flow direction during all phases of the cardiac cycle, and to use separate measure-
ment planes for each jet in case of multiple jets, which is not possible with echocardiography. 
Furthermore, using 4DFlow CMR the measurement area perpendicular to the regurgitant jet 
can be adjusted in case of a non-circular cross-section regurgitant jet area, which is not possible 
using echocardiography. Furthermore, 4DFlow CMR has the advantage of internal validation of 
flow volume consistency as was shown to be excellent in our study as well as in a recent study 
in patients with a congenital heart disease [33]. Internal validation with aortic flow was excellent 
in the current study, including patients with complex jets. However, no gold standard is avail-
able that could be used to validate the 4DFlow CMR and therefore, in vivo validation is difficult. 
Nevertheless, this is the first approach that allows direct quantification of the regurgitant volume 
without the use of assumptions in this patient group, including children, with challenging LAVV 
regurgitation jets. The prognostic value of 4DFlow CMR regurgitation quantification has not 
been studied. Future, long-term follow-up studies are required to investigate cut-off values of 
quantification of regurgitation with 4DFlow CMR, which might differ from available echocar-
diography values and how these need to be used in patient management. 
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In this study, we have to acknowledge some limitations. Although 4DFlow CMR data was 
acquired, jet angles were measured in 2D planes based on streamline projections. Streamlines 
represent velocity direction at each location at one instant in time only. By measuring jet angles 
at different phases of systole, however, we provide useful information on jet direction at specific 
time points. Analysis of 4DFlow CMR, with manual positioning of the measurement plane, is 
time-consuming and might be affected by observer variation. However, compared with conven-
tional 2D one-directional velocity-encoded CMR, additional analysis time consists only of time 
required for the valve tracking, which amounts to approximately 1–2 minutes per valve. Future 
technical advances may allow full automatic valve tracking and placement of the measurement 
plane perpendicular to the flow direction, which will reduce analysis time and also eliminate 
observer variation. Another limitation is that none of the studied patients were classified with 
severe regurgitation. Although we do not expect different results in these patients, future stud-
ies are needed to confirm regurgitant jet characteristics and the feasibility of quantification in 
patients with severe LAVV regurgitation after AVSD correction.
CoNCLuSIoN
4DFlow CMR with streamline visualization revealed multiple, dynamic, non-circular, eccentric 
regurgitant jets of the LAVV in corrected AVSD patients and enables direct quantification of the 
regurgitation of these challenging jets. The observed complex jets explicate the limitations of 
qualitative and quantitative assessment of LAVV in these patients with echocardiography [5, 18]. 
Quantification of LAVV regurgitation with 4DFlow CMR with retrospective valve tracking showed 
good internal validation and has the potential to be used as an adjunct to echocardiography 
for more comprehensive evaluation of LAVV regurgitation. Future studies in patient groups with 
congenital and acquired heart disease are needed to investigate the potential use of 4DFlow in 
evaluation of mitral valve/LAVV regurgitation and its effect on cardiac function during follow-up. 
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During ventricular systole, a compact recirculating flow pattern forms in the left atrial (LA) blood 
flow. We aimed to evaluate LA recirculating flow structures in healthy volunteers and patients 
with corrected atrioventricular septum defect (AVSD) with both none to mild and moderate left 
atrioventricular valve (LAVV) regurgitation with the use of 4DFlow MRI.
methods and Results
Data was obtained in eighteen controls (age 24±14 years) and eighteen corrected AVSD patients: 
nine (24±12 years) with none to mild regurgitation (<9%) and nine (21±13 years) with moderate 
regurgitation (>17%). In healthy controls, a single recirculating flow structure was visualized in 
the LA by streamlines (size 4.3±2.9mL) with a similar volume as the lambda2-extracted vortex 
core (3.9mL, IQR 3.0- 6.8 mL, p=0.27). In patients with regurgitation of the LAVV, two recirculating 
flow structures were observed in the LA, with opposing circulation direction. Recirculating blood 
flow contribution originated less frequently from the left pulmonary veins (LPVs) in patients 
with none to mild regurgitation (27±25%, p=0.023) and moderate regurgitation (6%, IQR 0-23%, 
p=0.002) compared with controls (49±21%).
Conclusion
Quantitative 3D analysis showed disturbed recirculating LA flow patterns in corrected AVSD 
patients with decreased contribution to the vortex cores from the LPVs. Furthermore, LAVV 




The left atrium (LA) has a reservoir function during ventricular systole when blood enters from 
the right pulmonary veins (RPVs) and left pulmonary veins (LPVs). During diastole, after opening 
of the left atrioventricular valve (LAVV), the LA serves as a conduit when blood flows from the 
RPVs and LPVs through the LA into the left ventricle. Efficient filling of the LA, contraction and 
draining into the ventricle contribute to adequate cardiac function [1]. 
Recirculating flow patterns and vortex formation are well described in the left ventricle 
and are known to contribute to efficient blood flow [2]. Recirculating flow in the LA has been 
described in healthy hearts during systole and mid-diastole based on streamline and pathline 
analysis from intra-cardiac blood flow velocity data. This phenomenon is suggested to play a 
role in preventing thrombus formation, preservation of LA flow momentum during ventricular 
systole and efficient diastolic left ventricular (LV) filling [1;3-5]. Previous studies suggest that the 
recirculating flow during ventricular systole mainly consist of blood originating from the LPVs. 
Blood flow from the RPVs was proposed to be directed along the inter-atrial septum towards the 
ventricle [1]. 
Regurgitation of the left atrioventricular valve (LAVV) has been a predictor for a poor clini-
cal outcome even in asymptomatic patients [6]. An increase in turbulent kinetic energy in the 
LA has been described around LAVV regurgitation jets [7]. Patients after atrioventricular septal 
defect (AVSD) correction often present with LAVV regurgitation [8] and the re-operation rate is 
as high as 28% [9]. Moreover, the regurgitation direction in corrected AVSD patients is lateral 
towards the ostia of the LPVs, though the direction varies dynamically during systole [10]. We 
hypothesize that the dynamic and eccentric regurgitant jet in these patients disturbs formation 
of normal LA recirculating blood flow patterns.
Novel 4DFlow MRI techniques allow 3D quantification of intra-cardiac flow patterns and 
vortex analysis [11;12]. Therefore, the aim of this explorative study was to evaluate flow patterns 
in the LA in healthy subjects and patients after AVSD correction with the use of 4DFlow MRI-
based visualization methods. In this study, normal flow behavior in the LA will be evaluated in 
healthy controls and in patients after correction of an AVSD correction. Furthermore, the effect 
of LAVV regurgitation on LA flow patterns will be studied by comparing left atrial flow patterns 
in patients with none-to-mild versus moderate LAVV regurgitation.
mETHoDS
Twenty healthy controls and twenty patients with a corrected AVSD were included. Patients were 
selected from a total group of 34 patients who underwent cardiac MRI. Selection was based on 
regurgitation grade: ten patients were selected with none to mild regurgitation (regurgitation 
fraction below 9%) and ten patients with moderate regurgitation (regurgitation fraction above 
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17%). Subjects with aliasing in LA velocity data were excluded. Informed consent was obtained 
from all patients and controls and/or their parents. Subjects and controls in the current study 
were also included in previous studies using 4DFlow MRI [10;12;13], but in none of these studies 
atrial flow patterns were evaluated. 
magnetic Resonance Imaging 
All subjects underwent whole-heart 4DFlow MRI on a 3T system (Ingenia, Philips Medical Sys-
tems, The Netherlands) with maximal amplitude of 45mT/m for each axis and a slew rate of 
200T/m/sec. A combination of FlexCoverage Posterior coil in the table top with a dStream Torso 
coil, providing up to 32 coil elements for signal reception was used, with the following acquisi-
tion settings: velocity-encoding of 150cm/s in all three directions, spatial resolution 2.3×2.3×3.0-
4.2mm3, flip angle 10°, echo time (TE) 3.2ms, repetition time (TR) 7.7ms, true temporal resolution 
(4×TR) 31ms, SENSE factor 2 in anterior-posterior direction and Echo Planar Imaging with a factor 
5. Retrospective VCG-gating was used with 30 phases reconstructed to represent one average 
heart cycle and free breathing without motion compensation was allowed. Commercially-
available concomitant gradient correction and local phase correction filter were applied from 
the software available on MRI system (Ingenia 3 T with Software Stream 4.1.3.0). Acquisition 
time of the 4DFlow scan with a heart beat 60-80bpm was typically 8-10 minutes. Cine 2D left 
2-chamber and 4-chamber views were acquired to quantify maximal left atrial volume according 
to the biplane area-length method (8/3π × Area(4-chamber) × Area(2-chamber))/(shortest atrial 
length).
Streamline evaluation of compact recirculating flow 
As regurgitation occurs during ventricular systole, flow patterns were evaluated during the 
reservoir function phases of the LA. Streamline display of the velocity field at any instant of 
time allows visualization of flow structures at a specific time point [14]. Streamline visualization 
using Mass software (LUMC, Leiden, The Netherlands) was used to assess and quantify compact 
recirculating flow structures in the LA. A stack of reformatted planes parallel to the 4-chamber 
view was analyzed with streamlines to visualize the flow pattern in the LA. The number of 
compact recirculating flow structures (i.e. where streamlines are circular and connected) was 
visually scored and the rotational direction with respect to the feet-head axis (clockwise or 
counter-clockwise) was determined (Figure 1A). A previous study showed that the vortex inside 
the atrium reached its largest volume just before the end of systole [1]. Therefore, the volume 
of the compact recirculating flow structure was measured two phases before end-systole. The 
compact recirculating flow structure was manually outlined in each axial slice and the areas 




Figure 1. Explanation of used methodology. 
Streamline visualization shows recirculating 
flow (dotted line in A) in clockwise direc-
tion with respect to the feet-head axis. The 
lambda2-method is used to extract the vor-
tex core (red in B). Vortex cores are filled with 
seeds (dots in C). Backwards particle tracing 
allows the distinction between flow from the 
right pulmonary veins (RPV) and left pulmo-
nary veins (LPV). RA = right atrium, RV = right 
atrium, LV = left ventricle. 
Figure 2. Differences in left atrial flow between healthy control and patient.
Healthy control (A-C) and a patient with 36% left atrioventricular valve regurgitation (D-F). Streamline visualization 
shows a single counter-clockwise (with respect to the feet-head axis ) recirculating flow structure in the control (ar-
row in A) compared with multiple recirculating flow structures in the patient (arrows in D). The vortex core in the 
patient is less compact and nearer to the atrioventricular valve (E). Backward tracing in the healthy control shows 
predominant contribution of the left pulmonary veins (LPVs) to the vortex core, whereas in the patient only contribu-
tion from the right pulmonary veins (RPVs) is observed (F). RA = right atrium, RV = right atrium, LV = left ventricle.
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Vortex detection in the left atrium and particle tracing
Three-dimensional (3D) vortex cores can be identified using the gradient properties of the 
4DFlow MRI data [12]. Vortex core detection was used to provide a more objective definition 
of the compact region of recirculating flow in the LA. Backwards particle tracing [15] was then 
used to distinguish respective contribution of the LPVs and RPVs to the detected vortex core. 
First, the LA was manually segmented on magnitude images of the 4DFlow scans. Subsequently 
the lambda2-method [12] was used to detect the vortex core from the velocity field two phases 
before end-systole. The 3D velocity data of the whole-heart 4DFlow acquisition was used for par-
ticle tracing algorithm, using 4th order Runge-Kutta numerical integration to create pathlines. 
To identify the origin of the recirculating flow, each voxel in the vortex core was designated as 
a seed point and backward particle tracing was performed until the start of systole. At the first 
phase of systole the particles were scored as 1) originating from LPVs; 2) originating from RPVs; 3) 
originating from LV (i.e., regurgitation); 4) particles already present in LA at start of systole (Figure 
1). Particles entering the LA from outside the heart and not part of the pulmonary venous flow 
or LV regurgitation were excluded and considered as tracing errors (i.e., particles crossing the 
myocardial wall due to the discrete time step or spatial discretization used in the integration 
algorithm or due to other sources of error such as imaging artifacts). Additionally, to calculate 
the contribution of particles originating from LPVs and RPVs to the whole LA volume, at the same 
phase (two phases before systole) the whole atrium was seeded with particles and backwards 
tracing was performed to the start of systole.
Retrospective flow quantification 
Using the same 4DFlow data set, retrospective valve tracking and through-plane flow mapping 
over the aorta and LAVV was performed. From aortic and LAVV flow-time curves the start and 
end of systole were determined as well as the regurgitation fraction [16]. Furthermore, the com-
bined flow through the superior and inferior LPVs and the combined flow through the superior 
and inferior RPVs was quantified by retrospectively placing measurement planes at the ostium 
of each pulmonary vein, perpendicular to the inflow direction into the LA as visualized with 
streamlines. A resultant flow-time curve was formed for the summed LPVs and RPVs and peak 
systolic (S) and peak diastolic (D) flow from the pulmonary veins was defined. Furthermore, the 
time to peak systolic flow was determined. 
Statistical analysis
Data are described as mean ± standard deviation or median (interquartile range) where ap-
propriate. Differences between patients and controls are calculated with an independent t-test 
or Mann-Whitney U test where appropriate. The within-subject difference were tested with a 
paired t-test or Wilcoxon signed-rank test where appropriate between 1) volume of the compact 
recirculating flow structure (defined by streamlines) and vortex core volume (defined using the 
lambda2-method) 2) the left atrial inflow volume defined with particle tracing and the total 
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trans-pulmonary vein inflow. Correlation between different flow volumes were evaluated with 
Pearson’s test.
RESuLTS
Visual grading of the 4DFlow scans revealed aliasing in the area of the LA in 2 controls and 
2 patients (1 with none to mild regurgitation and 1 with moderate regurgitation), who were 
excluded from further analysis. Characteristics of included subjects are described in Table 1. 





Patients with moderate 
LAVV regurgitation
Number 18 9 9
Age (years) 24 ± 14 24 ± 12 21 ± 13
male (%) 50 66 6




Age of surgery (months) 58 ± 55 69 ± 110
Time after surgery (years) - 19 ± 9 16 ± 8
Regurgitation fraction (%) - 5 ± 2 24 ± 6
Atrial volume (mL) 60 ± 31 74 ± 21 72 ± 24
Atrial volume / BSA (mL/m2) 34 ± 13 41 ± 8 48 ± 8 * 
LV Ejection fraction (%) 62 ± 4 57 ± 4 * 55 ± 8 *
Controls 
In the remaining 18 controls, a single counter-clockwise (with respect to the feet-head axis) 
compact recirculating flow pattern could be detected with streamline visualization during 
ventricular systole (Figure 2A). The manually segmented compact recirculating flow structure 
had a median volume of 4.3 ± 2.9mL when measured just before end-systole. These measured 
volumes showed modest correlation with total LA volume (r = 0.60, p = 0.009), but not with 
age (p = 0.73). In all controls, a vortex core could be detected with the lambda2-method in the 
LA. The median volume (3.9mL, IQR 3.0 – 6.8mL) was not different from the volume detected 
with streamlines (mean difference 0.51mL, p = 0.267 with 95%CI -0.7 – 1.7mL) and correlation 
between both volumes was r = 0.61 (p = 0.007). 
Backward tracing of the vortex core volume revealed a mean of 49 ± 21% of the total vortex 
volume originating from the LPVs, a median of 7% IQR 3 – 14% originating from the RPVs with a 
remaining mean of 40 ± 15% of the total vortex volume originating from blood particles already 
present within the atrium at the start of ventricular systole. 
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The flow from the four pulmonary veins could be separately detected and quantified in 15 
of 18 controls. In the remaining three controls, streamline visualization was not adequate to 
depict LA inflow at the ostium of all four veins respectively, and to perform retrospective flow 
mapping. For the remaining 15 controls, the combined flow from the four veins (38 ± 15mL) was 
comparable to the combined particle volumes of the LPVs and RPVs after seeding the whole 
atrium and backward tracing (36 ± 15mL) (mean difference -1.8 mL, p = 0.60, 95%CI -9.3 – 6.0 
mL). Pulmonary venous flow during ventricular systole in controls showed a right-left volume 
ratio of 1.2 ± 0.4. Peak velocity was significantly higher in the LPVs (54 ± 14cm/s) as compared 
with the RPVs (36 ± 11cm/s, p<0.001). Peak systolic flow rate was reached in the LPVs 195 ± 49ms 
and in the RPV 107ms IQR 87 – 175ms (difference p = 0.003) after the start of ventricular systole. 
Patients
All patients were in sinus rhythm, one patient previously underwent a cardioversion because 
of atrial fibrillation. In patients, the normal LA flow pattern was disturbed. Differences between 
both patient groups (none to mild regurgitation and moderate regurgitation) and the controls 
are presented in Table 2. 
Of the patients with none to mild regurgitation streamline visualization revealed a single 
recirculating flow pattern in the LA as seen in controls in 8 (89%) patients and two separate 
compact recirculating flow structures in 1 (11%) patient, with a regurgitation fraction of 9%. 
Total volume of compact recirculating flow patterns combined was 3.2 ± 2.0mL in the none to 
mild regurgitation group, which was not significantly different from the vortex core volume in 
controls (mean difference patients with none to mild regurgitation to controls 1.0 mL, p = 0.34, 
95%CI -1.2 – 3.3 mL). In patients with none to mild regurgitation, particles seeded from inside 
the vortex core originated less frequently from the LPVs compared with controls (27 ± 25%, p = 
0.023). Moreover, an increased contribution to the vortex core of blood already present in the 
LA at the start of ventricular systole was observed in patients with none to mild regurgitation 
compared with controls (57 ± 23%, p = 0.03). Using retrospective mapping, detection of flow 
from four separate pulmonary veins was possible in all patients with none to mild regurgitation 
and revealed a non-significantly different right-left volume ratio as described in controls (1.1 IQR 
0.9 – 1.6, p = 0.61). Peak flow velocity was similar in patient and controls in LPVs and RPVs (Table 
2). In patients with none to mild regurgitation, peak flow rate was reached later in the RPVs as 
compared with controls (mean difference -69ms, 95%CI -121 – -18ms, p = 0.01).
In contrast to the controls, in patients with moderate regurgitation, streamline visualization re-
vealed two or three separate compact recirculating flow structures in the LA in 8 (89%) patients 
(difference between patient groups p = 0.002) (Figure 2C). In patients with multiple recirculating 
flow structures, two structures could be detected around the regurgitant jet; one circulating in 
counter-clockwise direction and one in clockwise direction with respect to the feet-head axis. 
In 3 out of 9 patients with recirculating flow around the regurgitant jet, another (third) counter-
clockwise recirculating flow pattern was seen more cranially in the atrium. Total volume of com-
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pact recirculating flow patterns combined was 4.7 ± 3.4mL in the moderate regurgitation group, 
which was not significantly different from the vortex core volume in controls (mean difference 
patients with moderate regurgitation -0.4mL, p = 0.74, 95%CI -3.0 – 2.1 mL). In patients with 
moderate regurgitation, particles seeded from inside the vortex core originated less frequently 
from the LPVs compared with controls (6% IQR 0 – 23%, p = 0.002). A trend towards an increased 
contribution to the vortex core of blood already present in the LA at the start of ventricular 
systole was observed in patients with moderate regurgitation (62 ± 27%, p = 0.05) compared 
with controls. Pulmonary venous flow quantification, possible in five patients with moderate re-
gurgitation, revealed a non-significantly different right-left volume ratio as described in controls 
(1.3 ± 0.4, p = 0.90). Peak flow velocity was similar in patients and controls in the LPVs and RPVs 
Table 2. Differences between controls and the two patients groups. * indicate p < 0.05 as compared with controls. 
ˆ pulmonary vein right-left ratio only computed in cases with four pulmonary veins detected. Rotational direction is 
described with respect to the feet-head axis.






N 18 9 9
Streamlines Volume compact 
recirculating flow (mL)
4.3 ± 2.9 3.2 ± 2.0 4.7 ± 3.4
Rotational direction 100% single, counter-
clockwise
89% single counter-








clockwise and one 
clockwise 
Vortex core Volume vortex (mL) 3.9 
(IQR 3.0 - 6.8)
4.0
(IQR 3.3 - 6.8)
4.2 
(IQR 2.3 - 6.7)
Contribution LPVs (%) 49 ± 21 27 ± 25 * 6 
(IQR 0 – 23) *
Contribution RPVs (%) 7 
(IQR 3 – 14)
16 ± 15 17 
(IQR 4 – 31) 
Residual in atrium (%) 40 ± 15 57 ± 23 * 62 ± 27 *
Pulmonary 
venous flow 
Right-left ratio systolic 
volume ˆ
1.3 ± 0.3 1.1 
(IQR 0.9 - 1.6)
1.3 ± 0.4
Peak velocity LPVs (cm/s) 54 ± 14 46 ± 12 49 ± 17
Peak velocity RPVs (cm/s) 36 ± 11 33 ± 12 36 ± 12
Time to peak LPVs (ms) 195 ± 49 207 ± 53 242 ± 28 * 
Time to peak RPVs (ms) 107
(IQR 87 - 175)
201 ± 74 * 223 ± 61 *
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(Table 2). Systolic peak flow rate was reached later in the cardiac cycle in patients with moderate 
regurgitation compared with controls in both the LPVs (mean difference -48ms, 95%CI -84 – 
-12ms, p = 0.012) and the RPVs (mean difference -92ms, 95%CI -139 – -44ms, p = 0.001). Time to 
systolic peak flow rate in the LPVs was moderately correlated with the regurgitation fraction (r = 
0.49, p = 0.04) whereas timing of peak flow rate in RPVs was not significantly correlated. 
DISCuSSIoN
This explorative study provides new insights in blood flow characteristics in the LA in healthy 
controls and patients after AVSD correction with recurrent LAVV regurgitation, with the com-
bined use of streamline visualization, semi-automated vortex core detection and particle tracing 
of pulmonary venous flow of 4DFlow MRI data. Key findings of the study are 1) in controls, on 
average 49% of volume of the single compact recirculating flow structure in the LA originates 
from the LPVs, but also on average 7% contribution to the volume originating from the RPVs 
was observed; 2) in corrected AVSD patients with none to mild regurgitation and with moderate 
regurgitation, the LPVs contribute less to the vortex core and systolic peak flow was reached 
later in the RPV; 3) additional differences in corrected AVSD patients with moderate LAVV regur-
gitation are multiple compact recirculating flow patterns and delayed systolic peak flow in the 
LPV that was related to regurgitation fraction.
Vortex formation in the LA in healthy controls
During ventricular systole the LA is filled and serves as an expanding reservoir. Previous studies 
observed recirculating blood in the LA [1;3-5], which in some studies is addressed as vortex flow. 
The recirculating flow conceivably avoids stasis and thrombosis and minimizes static pressure 
on the atrial wall [17]. Recirculating flow also contributes to the preservation of momentum in 
blood flow during ventricular systole, when the atrium is filled. Preserved momentum may aid 
efficient LV filling during early diastole.
Previous MRI studies used vector graphs, streamline analysis and pathline analysis [1;4;18] to 
visualize recirculating flow in 3D, however quantification of duration and size (area) of recirculat-
ing flow was limited to a 2D plane. Park et al. used echocardiography [5], with the advantage 
of a high frame rate and real-time imaging, but the limitation of analyzing 3D structures on 2D 
images. Complementing the quantification based on streamlines, the current study used the 
lambda2-method [12], to allow quantification of atrial vortex flow in 3D. Volumes of streamline-
based recirculating flow were comparable to lambda2-detected atrial vortex cores, however, 
the shape of vortex cores appeared more irregular than the usually compact structures as seg-
mented on streamline representation. 
Postulations that flow from the LPVs mainly contributes to the LA recirculating flow formation 
and that flow from the RPVs is mostly directed along the LA wall with only little contribution to 
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the vortex, were thus far based on qualitative evaluations only [1]. The current study quantita-
tively showed that flow from LPVs in healthy controls has a substantially higher contribution to 
the vortex core than flow from RPVs (on average 49% versus 7%). The higher peak velocities in 
the flow from the LPVs compared with the RPVs might be a factor in this difference in contribu-
tion. However, even in healthy volunteers a large variation in venous contribution was observed, 
which is possibly caused by diversity in pulmonary vein anatomy [19], which was not assessed 
in this study. 
Left atrial flow in patients after AVSD correction
A recent 4DFlow streamline-based study showed frequent absence of a vortex core in the LA in 
patients with a variety of organic heart disease, which was related to pulmonary venous peak 
velocity, but not pulmonary vein insertion angle [18]. In studies using computer fluid dynamics 
[20], echocardiography [5] and 4DFlow MRI [3], abnormal LA flow was also described in patients 
with atrial fibrillation and a relation with thrombus formation was suggested in these patients 
[21].
Decreased contribution of blood flow from the LPVs to the vortex core was observed in cor-
rected AVSD patients with moderate as well as none to mild regurgitation. Therefore, the laterally 
directed regurgitation (i.e., towards the LPVs) can only partly explain the decreased contribu-
tion of flow from the LPVs to the atrial vortex core in corrected AVSD. Contributing effects may 
include the different pulmonary vein and LA anatomy after AVSD correction, possibly caused 
by remodeling after surgery. The delayed peak flow rate in the LPVs was predominately present 
in patients with moderate LAVV regurgitation and correlated to the regurgitation fraction and 
might therefore be a direct result of regurgitation or caused by increased atrial pressure second-
ary to regurgitation.
In the current study, patients after AVSD correction showed a disturbed recirculating flow 
pattern. Patients after AVSD correction often develop eccentric and dynamic regurgitation of 
LAVV. In patients with regurgitation, two recirculating structures were detected around the 
regurgitation jet(s). In an in vitro study, regurgitation jets with a high velocity in the presence of a 
prosthetic mechanical heart valve were related to aberrant LA vortex formation and an increase 
of shear stress in the blood flow near the wall, which directly activates platelets and has the abil-
ity to damage endothelial cells [22]. If endothelial cells fail to produce enough platelet inhibitors, 
this can lead to thrombus formation. The vortex formation observed around the regurgitant 
jet(s) in our study may similarly affect the atrial wall. Subsequently, it may contribute to the 
LA enlargement, diastolic dysfunction and atrial fibrillation observed in patients with chronic 
regurgitation of the LAVV [6]. On the other hand, others have suggested a protective property 
of LAVV regurgitation for thrombus formation, due to the increased velocity which may prevent 
stasis [23].
The clinical relevance of our preliminary findings comprises the role of disturbed LA flow 
patterns on outcome in patients with and without regurgitation. Early correction of moderate-
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severe regurgitation is debated even in asymptomatic patients [6] as regurgitation may result in 
LA dilatation, diastolic dysfunction and atrial fibrillation. Our study showed that LA blood flow in 
patients after AVSD correction is disturbed, and specifically LAVV regurgitation disturbs normal 
recirculating flow structures during ventricular systole. The parameters described in this study 
can be used in future studies to investigate if regurgitation in patients with other congenital or 
acquired heart disease similarly disturbs LA flow patterns. Further insights in LA flow patterns will 
help to better understand the effect of regurgitation on the LA and will eventually allow better 
prediction of the effect of regurgitation, which may be of benefit to optimization of timing of 
interventions.
Study limitations
Current study is a pilot study with small numbers of patients and no patients with severe LAVV 
regurgitation were available. Compact recirculating flow patterns were manually segmented 
based on streamline visualization. Streamlines only present the velocity field at an instant in time 
and therefore cannot represent the true trajectory of recirculating flow. To overcome the limita-
tions of streamlines and the manual segmentation, we have in addition used a semi-automatic 
method to detect vortex cores, which resulted in similar volumes. Particle tracing resembles the 
true pathlines of blood flow over time, however changes in velocity magnitude and direction 
faster than the temporal and spatial resolution allow to detect, cannot be represented in the 
tracing algorithm. The border between atrium and pulmonary veins was manually segmented, 
which might have introduced inaccuracies in quantification. 
CoNCLuSIoN
Using 4DFlow MRI, quantitative 3D analysis of recirculating flow structures and vortex cores in 
the LA blood flow during ventricular systole showed a higher contribution of blood flow from 
the LPVs versus RPVs in healthy controls. Furthermore, patients after AVSD correction with and 
without regurgitation presented a decreased contribution of flow from the LPVs to the vortex 
cores. Finally, LAVV regurgitation in patients with a corrected AVSD resulted in disturbed LA flow 
patterns with two recirculating flow structures around the regurgitation jet with an opposed 
circulation direction. Follow-up studies in patients with disturbed LA flow are needed to further 




 1. Fyrenius A, Wigstrom L, Ebbers T, et al. Three 
dimensional flow in the human left atrium. Heart 
2001;86:448-55.
 2. Pedrizzetti G, La CG, Alfieri O, et al. The vortex--an 
early predictor of cardiovascular outcome? Nat 
Rev Cardiol 2014;11:545-53.
 3. Fluckiger JU, Goldberger JJ, Lee DC, et al. Left 
atrial flow velocity distribution and flow coher-
ence using four-dimensional FLOW MRI: A pilot 
study investigating the impact of age and Pre- and 
Postintervention atrial fibrillation on atrial hemo-
dynamics. J Magn Reson Imaging 2013;38:580-7.
 4. Foll D, Taeger S, Bode C, et al. Age, gender, blood 
pressure, and ventricular geometry influence nor-
mal 3D blood flow characteristics in the left heart. 
Eur Heart J Cardiovasc Imaging 2013;14:366-73.
 5. Park KH, Son JW, Park WJ, et al. Characterization 
of the left atrial vortex flow by two-dimensional 
transesophageal contrast echocardiography using 
particle image velocimetry. Ultrasound Med Biol 
2013;39:62-71.
 6. Enriquez-Sarano M, Avierinos JF, Messika-Zeitoun 
D, et al. Quantitative determinants of the outcome 
of asymptomatic mitral regurgitation. N Engl J 
Med 2005;352:875-83.
 7. Dyverfeldt P, Kvitting JP, Carlhall CJ, et al. Hemo-
dynamic aspects of mitral regurgitation assessed 
by generalized phase-contrast MRI. J Magn Reson 
Imaging 2011;33:582-8.
 8. Hoohenkerk GJ, Bruggemans EF, Rijlaarsdam M, 
et al. More than 30 years’ experience with surgical 
correction of atrioventricular septal defects. Ann 
Thorac Surg 2010;90:1554-61.
 9. Lange R, Guenther T, Busch R, et al. The presence 
of Down syndrome is not a risk factor in complete 
atrioventricular septal defect repair. J Thorac 
Cardiovasc Surg 2007;134:304-10.
 10. Calkoen EE, Westenberg JJ, Kroft LJ, et al. Charac-
terization and quantification of dynamic eccentric 
regurgitation of the left atrioventricular valve after 
atrioventricular septal defect correction with 4D 
Flow cardiovascular magnetic resonance and 
retrospective valve tracking. J Cardiovasc Magn 
Reson 2015;17:18.
 11. Calkoen EE, Roest AA, van der Geest RJ, et al. Car-
diovascular function and flow by 4-dimensional 
magnetic resonance imaging techniques: new 
applications. J Thorac Imaging 2014;29:185-96.
 12. Elbaz MS, Calkoen EE, Westenberg JJ, et al. Vortex 
flow during early and late left ventricular filling in 
normal subjects: quantitative characterization us-
ing retrospectively-gated 4D flow cardiovascular 
magnetic resonance and three-dimensional 
vortex core analysis. J Cardiovasc Magn Reson 
2014;16:78.
 13. Calkoen EE, Roest AA, Kroft LJ, et al. Characteriza-
tion and improved quantification of left ventricular 
inflow using streamline visualization with 4DFlow 
MRI in healthy controls and patients after atrio-
ventricular septal defect correction. J Magn Reson 
Imaging 2015;41:1512-20.
 14. Napel S, Lee DH, Frayne R, et al. Visualizing three-
dimensional flow with simulated streamlines and 
three-dimensional phase-contrast MR imaging. J 
Magn Reson Imaging 1992;2:143-53.
 15. Buonocore MH. Visualizing blood flow patterns us-
ing streamlines, arrows, and particle paths. Magn 
Reson Med 1998;40:210-26.
 16. Westenberg JJ, Roes SD, Ajmone MN, et al. Mitral 
valve and tricuspid valve blood flow: accurate 
quantification with 3D velocity-encoded MR im-
aging with retrospective valve tracking. Radiology 
2008;249:792-800.
 17. Sengupta PP, Narula J.A LA mode atrioventricular 
mechanical coupling. JACC Cardiovasc Imaging 
2014;7:109-11.
 18. Suwa K, Saitoh T, Takehara Y, et al. Characteristics 
of Intra-Left Atrial Flow Dynamics and Factors 
Affecting Formation of the Vortex Flow. Circ J. 
2015;79:144-52.
 19. Porres DV, Morenza OP, Pallisa E, et al. Learn-
ing from the pulmonary veins. Radiographics 
2013;33:999-1022.
 20. Mouret F, Garitey V, Bertrand E, et al. In vitro atrial 
flow dynamics: normal conditions versus atrial 
fibrillation. J Biomech 2004;37:1749-55.
Chapter 3.7242
 21. Markl M, Lee DC, Ng J, Carr M, et al. Left Atrial 4-Dimensional Flow Magnetic Resonance Imaging: Stasis and 
Velocity Mapping in Patients With Atrial Fibrillation. Invest Radiol. 2015: in press.
 22. Milo S, Rambod E, Gutfinger C, et al. Mitral mechanical heart valves: in vitro studies of their closure, vortex and 
microbubble formation with possible medical implications. Eur J Cardiothorac Surg 2003;24:364-70.
 23. Fukuda N, Hirai T, Ohara K, et al. Relation of the severity of mitral regurgitation to thromboembolic risk in patients 
with atrial fibrillation. Int J Cardiol 2011;146:197-201.
 Part 4 




Summary and future perspectives 

247Summary and future perspectives
4.1
The aim of this thesis is to review the current knowledge on atrioventricular septal defect (AVSD) 
development, early diagnosis and long-term follow-up (Part 1), to study the pathogenesis of 
AVSD (Part 2) and finally to analyze cardiac outcome long-term after AVSD correction (Part 3) 
with special emphasis on intra-cardiac flow patterns. Studies are performed with novel imaging 
techniques as fetal echocardiography and 4-dimensional velocity-encoded cardiac magnetic 
resonance imaging (4DFlow MRI).
Chapter 1.2 of this thesis contains a bench to bedside overview of AVSD. The spectrum of 
AVSD, comprises a variability in the extent of the defects in the septal tissue in proximity of 
the atrioventricular valves and of abnormalities of the atrioventricular valves themselves. As 
controversy exists in literature regarding terminology of AVSD, nomenclature and classification 
are addressed. The discovered developmental aspects (i.e. looping, mesenchymal cap, endocar-
dial cushions and dorsal mesenchymal protrusion) and novel insights in genetic and maternal 
risk factors for AVSD are discussed. Additionally, an overview of innovations and challenges of 
diagnosis, which can already be made during the first trimester, is provided. The review displays 
that data on long-term follow-up of cardiac function after AVSD correction is limited and that 
literature mainly discourses the increasing survival rate and high incidence of surgical re-
intervention because of left atrioventricular valve (LAVV) regurgitation. Finally, the review high-
lights differences between non-syndromic patients and patients with Down syndrome in the 
incidence of AVSD and in the associated cardiac anomalies. Early studies report poor outcome 
in AVSD patients with Down syndrome, whereas more recent studies report equal survival and 
even lower incidence of surgical re-intervention of valve regurgitation in patients with Down 
Syndrome as compared with non-syndromic patients. Recognition of anatomical factors related 
to outcome may aid identification of riskfactors and predictors of outcome during follow-up of 
patients with AVSD.
PATHoGENESIS oF AVSD 
Contributing developmental factors 
In the first 10 weeks of gestation looping, remodeling and septation of the initially linear heart 
tube results in a heart with two atria, two atrioventricular valves, two ventricles and a septated 
outflow tract with a seperated pulmonary valve and aortic valve. In Chapter 1.2 it is shown that 
development of an AVSD can be a result of incomplete development of different congenital 
structures (i.e. endocardial cushions, mesenchymal cap, dorsal mesenchymal protrusion). The 
detected genes associated with AVSD affect one or more of these structures. The combination 
of an inflow- and an outflow-tract defect, as seen in patients with AVSD with Tetralogy of Fallot, 
stresses the assumption that a defect in genes expressed in the progenitor cells dorsal of the 
heart, also referred to as the second heart field (e.g. genes like vascular endothelial growth fac-
tor described in Chapter 2.4), can be the culprit of both inflow- and outflow-tract defects. On 
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the other hand, the variety of involved genetic and epigenetic factor can explain the range in 
subtypes of AVSD.
Within AVSD, variation exists in the location and extent of the defect of the (atrioventricular) 
membranous septum and atrioventricular valves. Around a quarter of patients with Down 
syndrome develop an AVSD. There are, however, signs that patients with Down syndrome 
without AVSD also develop abnormalities, evidenced by the observation of prenatal tricuspid 
regurgitation and mitralvalve prolapse. In Chapter 2.1 abnormalities of the membranous sep-
tum and atrioventricular valves are observed even in patients with Down syndrome without 
AVSD. Microscopy of fetal hearts shows differences, especially a larger membranous septum and 
dysplastic atrioventricular valves in fetuses with Down syndrome without AVSD as compared 
with normal hearts. Echocardiography reveals a shorter muscular ventricular septum in Down 
syndrome patients both with and without AVSD as compared with normal hearts. These findings 
confirm the hypothesis that the spectrum of AVSD forms a sliding scale. Therefore, an AVSD 
without shunting, i.e. an AVSD-valve morphology (common valve with linear insertion), where 
the common valve is attached to both the atrial and the ventricular septum, might also exist. 
We speculate that the extensiveness of AVSD is influenced by the degree of maldevelopment 
of the different structures involved in atrioventricular septation and may relate to differences in 
affected gene(s) involved. 
Fetal echocardiography: the impact of flow
The primitive heart tube starts to beat in the 5th week of pregnancy (22 days after conception). 
Eventhough organs are not depending on active fetal circulation yet, blood flow is crucial 
for haematopoesis and cardiogenesis. Studying blood flow during heart development might 
consequently give valuable information on normal and abnormal heart development. Current 
ultrasound techniques in human allow detection of an AVSD in the first trimester, between 10 
and 14 weeks of gestation, by skilled staff with high-end ultrasound equipment, as is reviewed 
in Chapter 2.2. Visualization of the heart and cardiac blood flow is not (yet) possible during the 
stages of early cardiac development in human, due to limited ultrasound frequency. In mouse, 
high-frequency ultrasound as early as embryonic day 10.5 (6 weeks after gestation in human), 
allows analysis of cardiac function before complete septation. In Chapter 2.3 reference values 
are provided of functional parameters measured at three subsequent stages of development 
(embryonic day 12.5, 14.5 and 17.5) in wild type mouse embryos. Reliable assessment of left and 
right ventricular function is possible and diastolic and systolic function improves during normal 
heart development. Additionally, application of high frequency ultrasound in genetically mu-
tated mouse models will potentially give further insight in hemodynamic during abnormal heart 
development. Vascular endothelial growth factor (VEGF) is in human related to development of 
AVSD and Tetralogy of Fallot. Murine Vegf120/1120 embryos, that overexpress the Vegf120 isoform, 
are known to develop a Tetralogy of Fallot phenotype. In Chapter 2.4, also abnormalities of the 
atrioventricular valves and an AVSD are described in Vegf120/1120 mouse embryos. Moreover, high 
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frequency ultrasound reveals a reduced heart rate in Vegf120/120 embryos at three developmental 
stages, which is confirmed by ex-vivo optical mapping. Subsequently, different possible causes 
of the reduced heart rate are analyzed. Immunohistochemistry analyses reveals a smaller and 
less compact sinoatrial node (SAN), with hyper-vascularization, which might contribute to the 
sinus bradycardia. Furthermore, the observed increased expression of the high conductance 
gap junction Connexin43 in the SAN, which is normally expressed in the working myocardium, 
potentially increases loading time of SAN cells and reduces essential isolation of the SAN from 
the surrounding atrial myocardium, which may contribute to the observed bradycardia.
LoNG-TERm FoLLoW-uP AFTER AVSD CoRRECTIoN
During the surgical correction of AVSD, one or two patches are placed to close shunt(s) between 
the left and right heart. Most often the remaining ‘cleft’ in the LAVV is surgically closed to pre-
vent regurgitation. Due to the different papillary muscle position, leaflet size and the surgical 
correction, the shape of the LAVV in corrected AVSD is different from the normal mitral valve. 
Survival after AVSD correction is as high as 100% in the current era. However, incidence of surgi-
cal re-intervention is reported between 2 and 29%, mainly because of regurgitation of the LAVV. 
Data on cardiac function long-term after AVSD correction is limited. Cardiac magnetic resonance 
imaging is the gold standard in the evaluation of cardiac function long-term after correction of a 
congenital heart defect. Furthermore, the recent introduction of 4DFlow allows comprehensive 
assessment of cardiac function and cardiovascular blood flow phenomena.
In Chapter 3.1 the use of 4DFlow MRI to assess cardiac function and the rapid development of 
applications to visualize and quantify cardiovascular blood flow are described. New visualization 
tools have enriched knowledge on blood flow hemodynamics and efficiency in the cardiovas-
cular system. Most reports focus on normal and abnormal flow in the aorta, whereas data of 
intra-cardiac flow is limited. One of the available visualization tools is streamline visualization. 
Streamlines are lines instantaneously tangent to the local velocity vector in each position at 
a specific time point and connected to all points along the direction of this line. Therefore, 
streamlines can be used to visualize the flow direction only at a given time point. This limitation 
can be overcome with particle tracing. With particle tracing virtual particles are positioned at 
a predefined position and time and subsequently released inside the three dimensional (3D) 
velocity field and then followed backwards or forwards in time. The trajectory of the particles 
is calculated in 3D by either forward or backward tracing, by using the local velocity at each 
position and time point and calculating the next or previous position of this particle.
Disturbed left ventricular inflow
In Chapter 3.2 streamlines are used to analyze inflow direction in patients after AVSD correc-
tion. In these patients a dynamic and more lateral inflow direction is observed as compared 
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with healthy controls. In addition, more accurate measurement of the trans LAVV flow can be 
achieved by adjusting the measurement plane perpendicular to the peak velocities as visualized 
by streamlines. In Chapter 3.3 the inflow is further investigated in 3D and in time with the 
use of particle tracing. In this study intra-cardiac particles are labelled as components of flow 
discriminating 1) direct flow entering and exiting the LV within the analyzed diastole and systole, 
2) retained inflow entering during diastole but remaining in the LV during the following systole, 
3) delayed ejection flow already present in LV prior to diastole but exiting the LV during the follow-
ing systole and 4) residual volume present and remaining in the LV during the analyzed diastole 
and systole cardiac cycle and 5) regurgitant flow. Subsequently, quantification of flow is done 
with the use of the American Heart Association standardized 16-segment left ventricular cavity 
model. In patients after AVSD correction direct flow components are decreased and the delayed 
ejection components and residual volume components are increased. Inflow into the (infero- 
and antero-) lateral segments confirms the lateral inflow direction observed using streamline 
visualization in chapter 3.2. In addition, an increase of flow into the apical segments is found. 
Interestingly, the flow in the (inferior) lateral and apical segments is predominantely retained 
flow, suggesting flow in these directions to be less efficient. 
An additional consequence of the more lateral inflow direction is that this may interfere with 
the assessment of diastolic function parameters with echocardiography as echocardiography 
relies on accurate alignment of the Doppler beam. One of these diastolic function parameters 
is velocity propagation. In Chapter 3.4 a novel velocity encoded MRI method to assess velocity 
propagation is introduced and a comparison is made with the traditionally used Color M-mode 
echocardiography approach. In healthy subjects and patients with ischemic heart failure, the 
new method demonstrates good agreement with echocardiography to identify LV impaired 
relaxation. In contrast to echocardiography, this novel approach allows retrospective placement 
of the measurement line parallel to the inflow direction. This might be beneficial in patients with 
abnormal inflow direction, such as AVSD patients or patients with a poor echo window, such as 
patients with Duchenne muscular dystrophy.
Disturbed vortex formation in the left ventricle
As the inflow direction is disturbed in corrected AVSD patients, the subsequent study aims to 
investigate whether vortex formation in the left ventricle is also affected. When blood enters the 
left ventricle through the LAVV during diastole, shear layers separate and a vortex ring forms. 
A vortex ring is a compact region of swirling blood flow and is purposed to aid transport of 
blood flow, minimize kinetic energy loss, help LAVV closure and prevent thrombus formation. 
In a previous study (Elbaz et al. JCMR 2014) we have shown that a separate ring forms during 
early and late diastole, with the late filling having a position closer to the atrioventricular valve 
and closer to the ventricular long axis. The shape of the late filling vortex ring is less circular 
compared with the early filling ring and this circularity is related to the circularity of the inflow 
jet. In chapter 3.5 the vortex formation in corrected AVSD patients is compared with the vortex 
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formation in healthy controls. In contrast to controls, who all display a vortex ring during early 
filling, in 18% of patients after AVSD correction the vortex ring in the left ventricle is found to be 
absent. Absence of vortex ring formation is related to a high vortex formation time (due to high 
inflow velocity) and abnormalities of the LAVV (i.e. single papillary muscle and double orifices 
LAVV). Moreover, when a vortex ring is present, the center of the vortex core is positioned more 
towards the lateral wall, closer towards the apex and more anterior. Furthermore the vortex ring 
is more tilted with its septal side down and with a less circular shape. The abnormal orienta-
tion is related to the inflow direction on streamlines. Because patients included in the study 
are relatively asymptomatic, correlation between vortex formation and conventional function 
parameters is difficult. However, the results from this study prove the impact of the valve shape 
on vortex formation in vivo and in 3D, which was previously suggested in in vitro studies or in 
2D analysis. 
Regurgitation of the left atrioventricular valve and atrial flow patterns
Regurgitation of the LAVV is common after AVSD correction and surgical re-intervention inci-
dence to correct LAVV regurgitation is high. Echocardiography is the technique most commonly 
used to evaluate regurgitation of the LAVV. However, poor inter-observer agreement is described 
for echocardiographic grading of regurgitation in corrected AVSD patients. In chapter 3.6 the 
regurgitation in corrected AVSD patients is characterized with streamlines. Multiple regurgitant 
jets are observed, with a dynamic behavior during systole, a non-circular shape and an overall 
eccentric (lateral) regurgitation direction. These findings explain why quantification of regur-
gitation with echocardiography is difficult in these patients, because Doppler quantification 
techniques (i.e. PISA and Vena Contracta measurements) are based on the assumption that the 
regurgitation jet is single and circular. Furthermore, echocardiography is known to underesti-
mate eccentric regurgitation. Streamline visualization allows retrospective positioning of the 
measurement plane perpendicular to the jet during systole, which results in quantification of 
the amount of regurgitation with excellent internal flow validation. Correlation between grading 
of regurgitation with echocardiography and 4DFlow valve tracking is modest. The eccentric and 
dynamic regurgitation of the LAVV in corrected AVSD patients disturbs the normal left atrial flow 
pattern as is shown in Chapter 3.7. With the combined use of streamlines, vortex core extraction 
and particle tracing, a single recirculating flow pattern is displayed in the left atrium of healthy 
volunteers. The recirculating flow was predominantly formed from blood coming from the left 
pulmonary veins. In corrected AVSD patients with regurgitation, multiple recirculating flow pat-
terns are seen around the regurgitant jet(s) and contribution of left pulmonary vein blood to the 
recirculating flow is diminished. Furthermore, the peak flow rate in the left pulmonary veins is 
delayed. The disturbed recirculating flow patterns in the left atrium may contribute to the poor 
clinical outcome of even asymptomatic patients with regurgitation of the LAVV.
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CoNCLuSIoNS AND FuTuRE PERSPECTIVES
AVSD development
This thesis shows diversity in subtypes of AVSD and highlights different developmental/genetic 
cascades that can result in an AVSD. The increasing amount of studies on genetic and epigenetic 
factors of heart development will step by step unravel the multiple factors involved in develop-
ment of AVSD. Studies in other genetically mutated mouse models of Down syndrome related 
genes (e.g DSCAM, CRELD1) or genes that are currently not related to Down syndrome (e.g. 
Pdgfr- α, Nkx2.5, Tbx5) will provide insight in the differences in AVSD between patients with 
Down syndrome and non-syndromic patients. Studies in mouse models will also provide better 
understanding of the effect that specific genes have on the different structures involved in AVSD 
pathogenesis and in which subtype of AVSD they result.
Furthermore, it is made plausible that AVSD is a sliding scale and that patients with Down syn-
drome without AVSD also have abnormalities of the membranous septum and atrioventricular 
valves. Future studies in these patients and in family members of AVSD patients are needed to 
further evaluate these cardiac abnormalities and determine if clinical outcome is also affected. 
In the current thesis, high frequency ultrasound in mouse embryos shows to be a promising 
technique to study cardiovascular flow in early stages of heart development. In humans with 
congenital heart disease sick sinus syndrome is observed. Disturbed VEGF signaling has been 
associated with congenital heart defects (AVSD and Tetralogy of Fallot) in human and in mouse 
models. Whether disturbed VEGF signaling, that in the current thesis is shown to disturb SAN 
formation in mouse embryos, also plays a part in abnormal SAN development in humans with 
congenital heart disease remains to be investigated. Also, the relevance of VEGF signaling in 
other components of the cardiac conduction system or its innervation remains to be deter-
mined. In zebrafish, a reduced heart rate showed to disturb valve development via shear stress 
related genes as Klf2. From our studies it is impossible to distinguish whether the abnormal atrio-
ventricular valves in Vegf120/120 embryos are solely an effect of the Vegf mutation or if a reduced 
heart rate also plays a part. Studies with pharmacological influenced heart rate combined with 
high frequency ultrasound in mouse embryos may gather more insight in the effect of heart rate 
on atrioventricular valve development and atrioventricular septation. 
Intra-cardiac flow in patients with congenital heart disease
In part 3 of this thesis, 4DFlow MRI data reveals that patients with an abnormal LAVV after AVSD 
correction have aberrant intra-cardiac flow patterns. During diastole the inflow into the left 
ventricle is directed more towards the lateral wall, more towards the apex and vortex formation 
is abnormal. The disturbed inflow is most likely due to the congenitally different morphology 
and position of the LAVV, as well as the cleft closure during correction of an AVSD. This stresses 
the impact of valve surgery on intra-cardiac flow. Next to the aberrant inflow, during systole the 
dynamic and eccentric regurgitation of the LAVV disturbs the normal recirculating flow patterns 
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in the left atrium. We cannot preclude that the aberrant flow in the atrium and ventricle is a 
coping mechanism of the heart and has a favorable effect on the cardiac function. However, 
in vitro studies have shown that a lateral inflow direction and disturbed vortex flow, as found 
in our studies, cause an increase in energy dissipation. Furthermore, the disturbed flow in the 
left atrium and left ventricle may affect myocardial remodeling through changes in wall shear 
stress and in that way cause regional hypertrophy and stiffening. Newly available applications to 
quantify different forms of energy from 4DFlow MRI data, will potentially be able to tell whether 
the disturbed intra-cardiac flow is indeed related to more energy loss and less efficient flow. 
Future long-term follow-up studies have to show whether the observed changes in blood flow 
in corrected AVSD patients eventually result in poor clinical outcome. 
In addition, in part 3 of this thesis it is shown that patients after AVSD correction have complex, 
multiple, dynamic and eccentric regurgitation jets. In patients after AVSD correction, streamline 
visualization from 4DFlow MRI can advance quantification of LAVV inflow and regurgitation. Ret-
rospective valve tracking with the use of streamline visualization has the potency to be similarly 
beneficial in other patient groups with congenital and acquired heart disease. The adjustment 
of the measurement plane perpendicular to the flow during the cardiac cycle will especially be 
beneficial in patients with a disturbed inflow direction and eccentric and dynamic regurgitant 
jets, that are challenging to quantify with echocardiography. Development of computerized 
valve tracking will enable shorter post-processing time and potentially reduce observer varia-
tion.
Intra-cardiac flow analyses with 4DFlow MRI provided interesting new data in patients with 
a congenital heart disease, however the limitations of the different imaging techniques have 
to be kept in mind. In addition, validation of techniques with phantoms and echocardiography 
remain important. Evaluation of intra-cardiac flow in patients with a congenital heart diseas is a 
relatively new field. The offered 4DFlow visualization techniques in the current thesis have the 
potency to provide valuable information of patients with other congenital heart defects (i.e. 
after single ventricular repair or in Tetralogy of Fallot). Additionally, knowledge on intra-cardiac 
flow may allow better understanding of diastolic (dys)function. Furthermore, quantification of 
flow component distribution and vortex cores in the left ventricle could potentially serve as an 
early predictor of cardiac dysfunction.
Continuing efforts to incorporate results of basic science studies into clinically oriented stud-
ies, will allow optimal comprehension of the mechanisms behind the phenomena observed in 










ATRIoVENTRICuLAIR SEPTum DEFECT: GEAVANCEERDE BEELDVoRmING VAN 
VRoEGE oNTWIKKELING ToT LANGE TERmIJN FoLLoW-uP
Dit proefschrift gaat over de aangeboren hartafwijking atrioventriculair septum defect (AVSD). 
Een hart met een AVSD heeft, in tegenstelling tot een ‘normaal’ hart met vier gescheiden hart ka-
mers (Figuur 1A), een opening tussen de linker en rechter hart helft ter plaatse van de overgang 
van de boezems naar de kamers (Figuur 1B). In deel 1 van dit proefschrift wordt een literatuur 
overzicht gegeven van het ontstaan, de diagnose, de therapie en de lange termijn gevolgen 
van een AVSD. Vervolgens wordt in deel 2 het ontstaan van een AVSD verder onderzocht en 
worden in deel 3 de lange termijn gevolgen van een AVSD meer gedetailleerd bestudeerd. In 
deel 2 en 3 is speciale aandacht voor de (veranderde) bloedstroom in het hart onderzocht met 
echocardiografie en magnetische resonantie imaging (MRI) technieken.
DEEL 1: LITERATuuR oVERZICHT
Hoofdstuk 1.2 geeft een literatuur overzicht van het AVSD vanaf de vroege ontwikkeling tot de 
lange termijn follow-up. De verschillende types AVSD en de gebruikte nomenclatuur worden 
beschreven. Daarnaast wordt ingegaan op de recent ontdekte genetische en epigenetische 
factoren betrokken bij AVSD ontwikkeling. Uit het review blijkt dat studies naar de lange termijn 
uitkomsten na AVSD correctie beperkt zijn tot gegevens van overleving en incidentie van een 
tweede operatie. Over de functie van het hart na een AVSD operatie is weinig bekend. Ongeveer 
de helft van de patiënten met een AVSD heeft het syndroom van Down. Uit het review komen 
verschillen naar voren in de anatomie en de lange termijn gevolgen van een AVSD tussen pati-
enten met en zonder het syndroom van Down.
DEEL 2: HET oNTSTAAN VAN EEN AVSD
In de eerste 10 weken na de bevruchting ontstaat vanuit het primaire hartbuisje, na buigen 
(‘loopen’), modellering en septatie, een hart met twee boezems, twee kamers, twee grote 
uitstroom vaten en vier hartkleppen. Door abnormale ontwikkeling van drie verschillende struc-
turen (de endocard kussens, de mesenchymal cap en de dorsal mesenchymal protrusion) kan 
een AVSD ontstaan. Bij patiënten met het syndroom van Down komt een AVSD veel voor. Er zijn 
echter ook aanwijzingen dat harten van patiënten met het syndroom van Down zonder septum 
defect verschillen van ‘normale’ harten. In hoofdstuk 2.1 wordt beschreven dat patiënten met 
het syndroom van Down zonder septum defect een groter bindweefsel (membraneus) septum, 
afwijkende kleppen tussen de boezems en de kamers (atrioventriculair kleppen) en een korter 
tussenschot van spierweefsel tussen het linker en rechter ventrikel (ventrikel septum) hebben. 
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Dit suggereert een glijdende schaal van een AVSD hart zonder shunt tot een compleet AVSD 
hart met een verbinding op boezem en kamer niveau.
Het primitieve hartbuisje klopt al vanaf de 22ste dag na de bevruchting. Verschillende studies 
hebben aangetoond dat de bloedstroom door het ontwikkelende hart bijdraagt aan septatie 
en het ontwikkelen van hartkleppen. Studies naar bloedstroom in het hart kunnen daarom 
mogelijk een bijdrage leveren aan het begrijpen van normale en abnormale hartontwikkeling. 
In hoofdstuk 2.2 wordt beschreven dat het met de huidige echo-technieken, uitgevoerd door 
ervaren onderzoekers, mogelijk is een AVSD te diagnosticeren tijdens het eerste trimester (tus-
sen 10 en 14 weken na de bevruchting). Echter het bestuderen van de bloedstroom tijdens de 
hartontwikkeling is nog niet mogelijk in mensen. Bij de muis is dit wel mogelijk. In hoofdstuk 
2.3 wordt getoond dat betrouwbare metingen kunnen worden verricht met hoog frequente 
echo tijdens verschillende stadia van ontwikkeling van het hart van normale muizen embryo’s. 
In dit hoofdstuk worden ook referentie waarden gegeven. Het gebruik van deze hoog frequente 
echo techniek in studies met genetisch gemodificeerde muismodellen kan in de toekomst veel 
kennis opleveren over abnormale hartontwikkeling. Het gen Vasculair Endothelial Growth Factor 
(VEGF) is bij de mens geassocieerd met een AVSD en een andere hartafwijking: Tetralogy van 
Fallot. In hoofdstuk 2.4 worden afwijkingen van de atrioventriculair kleppen in het muismodel 
VEGF120/120 beschreven. Bovendien wordt met hoog frequente echo getoond dat deze muizen 
een tragere hartslag hebben tijdens de hartontwikkeling. De trage hartslag wordt bevestigd 
met optical mapping. In dit hoofdstuk wordt vervolgens onderzocht waarom de hartslag van 
deze muizen embryo’s traag is. De sinusknoop van de VEGF120/120 muizen embryo’s is kleiner en 
minder compact, met veranderde vaat innervatie. Bovendien is er een verhoogde expressie van 
het snel geleidende transport kanaal Connexin43. Of de sinusknoop ook afwijkend is in mensen 
met afwijkingen in het VEGF gen moet verder onderzocht worden. Op basis van deze studie kan 
geen onderscheid gemaakt worden tussen het effect van de genafwijking en het effect van de 
trage hartslag op de klepontwikkeling. Studies die de hartfrequentie versnellen of vertragen met 
medicatie kunnen mogelijk meer inzicht geven in de rol van hartfrequentie op klepontwikkeling.
DEEL 3: VERSTooRDE BLoEDSTRoom NA AVSD CoRRECTIE
Een AVSD moet bij de meeste kinderen in het eerste levensjaar worden gecorrigeerd, om te 
veel bloedstroom naar de longen, met als gevolg verhoogde longvaatdrukken, te voorkomen. 
Tijdens de operatie worden één of twee stukjes kunststof gebruikt om de verbinding tussen de 
linker en rechter harthelft dicht te maken (Figuur 1C). Hierdoor wordt de klep tussen de boezem 
en de kamers (de atrioventriculair klep) gesplitst in een linker (in het normale hart de mitralis-
klep) en een rechter (in het normale hart de tricuspidalisklep) deel. Naast het dichtmaken van 
de verbinding worden vaak hechtingen in de linker atrioventriculair klep gezet om lekkage te 
voorkomen. Het oorspronkelijke verschil in anatomie en de chirurgische correctie zorgen ervoor 
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dat de vorm van de linker atrioventriculair klep afwijkt van de normale mitralisklep (Figuur 2A en 
E). Overleving na AVSD correctie is in de huidige tijd heel goed (tot 100%), maar de incidentie van 
een tweede operatie is hoog (tussen 2-29%), met name door kleplekkage. Over de hartfunctie 
na AVSD correctie is weinig bekend. Met cardiovasculaire MRI kan goed gekeken worden naar de 
hartfunctie en nieuwe technieken maken visualisatie van de bloedstroom in het hart mogelijk. 
Met zogenaamde ‘4DFlow MRI’ kan de bloedstroom in het hart in drie richtingen en in de tijd 
worden opgenomen. In hoofdstuk 3.1 wordt het gebruik van 4DFlow voor het bestuderen 
van de hartfunctie beschreven. Daarnaast worden nieuwe toepassingen om de bloedstroom 
te visualiseren en kwantificeren beschreven. Een van de toepassingen is ‘streamline visualisatie’ 
waarbij verbindingslijnen tussen snelheidsvectoren op een bepaald tijdsmoment worden 
weergegeven. Om de beweging van het bloed beter in de tijd weer te geven worden ‘pathlines’ 
gebruikt, waarbij op basis van de stroomrichting en snelheid een virtueel deeltje gevolgd wordt 
in de tijd. 
In hoofdstuk 3.2 wordt met streamlines laten zien dat de bloedstroom in gecorrigeerde AVSD 
patiënten een meer laterale instroom hoek heeft. Bovendien laat de studie zien dat de bloed-
stroom betrouwbaarder te kwantificeren is als gemeten wordt in een vlak loodrecht op deze 
streamlines. De analyse in deze studie is op één tijdsmoment en 2-dimensionaal. In hoofdstuk 
3.3 wordt de instroom richting door de linker atrioventriculair klep verder bestudeerd met 
behulp van pathlines. Hieruit blijkt dat in gecorrigeerde AVSD patiënten een kleiner deel van 
de bloedstroom dat het hart binnenkomt in de zelfde hartslag weer wordt uitgepompt in ver-
gelijking met de controle groep. Daarnaast wordt, 3-dimensionaal, de laterale instroom richting 
bevestigd en is er een groter aantal deeltjes dat via het apicale deel van het hart stroomt. In 
Figuur 1. Het AVSD.
Het normale hart met 2 gescheiden kleppen tussen de boezems en de kamers (A). Een compleet AVSD met verbind-
ing tussen de boezems en de kamers (pijlen in B). En een gecorrigeerd AVSD hart met in lichtblauw de met kunststof 
dichtgemaakte verbindingen (C). RA = rechter atrium/boezem, LA = linker atrium/boezem, RV = rechter ventrikel/
kamer, LV = linker ventrikel/kamer. 
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hoofdstuk 3.4 wordt een techniek beschreven om de golf voortplanting (propagatie) snelheid 
(velocity) te meten met behulp van MRI. Snelheid propagatie is een maat voor de diastolische 
functie van het hart. 
Tijdens het vullen van de hartkamers, vormt zich in de bloedstroom een vortex ring op de top 
van de atrioventriculair kleppen. Een vortex ring is een compact gebied van om zijn as draaiende 
(bloed)stroom. Een vortex ring minimaliseert verlies van kinetische energie, helpt bij het sluiten 
van de kleppen en voorkomt de vorming van bloedstolsels. In hoofdstuk 3.5 wordt de invloed 
van de veranderde instroom van bloed in het hart, die werd gevonden in de hoofdstukken 3.2 
en 3.3, op vortex ring vorming bestudeerd. In dit hoofdstuk blijkt dat de vortex ring in gecor-
rigeerde AVSD patiënten vaker afwezig is. Als hij wel vormt heeft de vortex ring een veranderde 
vorm en positie (Figuur 2). Deze veranderde vorm komt overeen met de abnormale vorm van de 
linker atrioventriculair klep. 
Kleplekkage na AVSD correctie komt vaak voor. Kleplekkage lijdt op langere termijn tot 
hartfalen. Het kwantificeren van deze lekkage is belangrijk voor de indicatie stelling van een 
her-operatie. Met echocardiografie is de lekkage niet betrouwbaar te meten. In hoofdstuk 3.6 
wordt de richting van de lekkage in de linker boezem bestudeerd met behulp van streamlines. 
Uit deze studie blijkt dat de lekkage excentrisch is en tijdens de systole van richting verandert. 
Dit verklaart waarom de lekkage moeilijk te meten is met echocardiografie. Met 4DFlow MRI 
kan het meetvlak gedurende de systole loodrecht op de van richting veranderende lekkage 
worden geplaatst. Met deze methode blijkt de lekkage wel betrouwbaar te meten. De 4DFlow 
Figuur 2. Bloedstroom in het hart.
In figuur a en e is het verschil te zien tussen de vorm van de linker atrioventriculair klep van een gezonde vrijwilliger 
(stippellijnen in a) en gecorrigeerde AVSD patient (stippellijnen in e). De streamlines laten de bloedstroom richting 
zien (b en f ). De rode vortex ring van de patient heeft een andere positie (g) en vorm (h) in vergelijking met de vrijwil-
liger (c en d). AO = aorta. RA = rechter atrium/boezem, LA = linker atrium/boezem, RV = rechter ventrikel/kamer, LV 
= linker ventrikel/kamer. 
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methode is daarom waardevol voor patiënten met (aangeboren) klepafwijkingen of lekkage. 
In hoofdstuk 3.7 wordt vervolgens getoond dat de lekkage door de atrioventriculaire klep de 
circulerende bloedstroom in de linker boezem verstoort.
De veranderde bloedstroom in het hart van gecorrigeerde AVSD patiënten benadrukt de 
invloed van congenitale chirurgie op de normale bloedstroom in het hart. Studies met com-
puter modellen hebben laten zien dat een laterale instroom richting en abnormale vortex ring 
vorming gepaard gaan met energie verlies. De veranderde bloedstroom in gecorrigeerde AVSD 
patiënten lijdt mogelijk ook tot meer energie verlies. Dit moet onderzocht worden in vervolg 
studies. Daarnaast moet verder onderzocht worden of de veranderde bloedstroom ook invloed 
heeft op de hartspier. De studies in deel 3 van dit proefschrift laten zien dat 4DFlow MRI waar-
devolle nieuwe inzichten geeft in de hemodynamiek in het normale hart en in de (verminderde) 
cardiale functie van patiënten met aangeboren hartafwijkingen.
Het blijft belangrijk om basale studies met klinische studies te combineren om steeds meer te 
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